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SUMMARY
This study investigated the cytogenetics of human oocytes 
and early embryos and related the findings to maternal 
factors and aspects of IVF methodology. Chromosome 
analyses supplemented embryological assessments in 
evaluation of the effects of luteinising hormone (LH) 
during follicular growth, the interval from administration 
of human chorionic gonadotrophin (hCG) to ovulation, the 
relative effects of in vivo and in vitro oocyte maturation 
and correlations between follicular and oocyte maturity.
Embryo quality assessed by morphology (score 1-10) and 
growth rate (embryo development rating; EDR, 'ideal' =
100) was predictive of implantation potential but not 
diagnostic. The mean score of embryos which implanted 
(8.84) was significantly higher (p<0.001) than those which 
failed to implant (8.07) and the minimum score associated 
with pregnancy was seven. Implanting embryos had a 
significantly higher (p<0.002) mean EDR (101.34) than 
those which failed to establish pregnancy (96.64). 
Assessment on day 3 after insemination allowed observation 
of a larger spectrum of development rate but observations 
on day 2 were highly predictive (p<0.001) of both 
assessment parameters on day 3 and no advantage of delayed 
embryo transfer (ET) was seen in pregnancy rates (day 2, 
16.9%; day 3, 16.4%) .
Suppression of endogenous pituitary function by adjuvant 
treatment with a gonadotrophin-releasing hormone analog 
(GnRH-a) during ovarian stimulation with human menopausal 
gonadotrophin (hMG) eliminated LH fluctuations and surges 
and all initiated cycles (n=32) proceeded to oocyte 
retrieval (OR) without complication. The cancellation rate 
(24/75; 32.0%) was significantly higher (p<0.001) in hMG 
alone cycles. Pregnancy rates after ET in the two groups 
(GnRH-a/hMG, 19.3%; hMG, 18.1%) confirmed that embryo
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quality was similar after both stimulation protocols. 
Post-mature (PM) oocytes were recovered from 10 hMG alone 
cycles and were absent (p<0.01) in analog treated cycles. 
Significantly fewer (p<0.01) oocytes cleaved in PM 
associated (37.7%) than unaffected (60.4%) cycles although 
not all oocytes were affected. Prior to hCG 
administration, all PM cycles showed an attenuated LH 
surge which was undetected by monitoring of serum 
progesterone concentrations.
A preliminary study investigated the interval between 
administration of hCG and ovulation in 73 women undergoing 
laparoscopic OR after ovarian stimulation with hMG and 
adjuvant GnRH-a. The earliest ovulation was observed at
39.5 hours and oocyte quality, assessed by cumulus 
expansion and fertilisation rates, improved with extended 
in vivo maturation (mature oocytes, <36h, 70.8% ; >36h, 
85.7%: fertilisation rate, <36h, 61.9%; >36h, 75.8%).
These data indicated that extension of the lutéinisation 
to oocyte retrieval delay (LORD) could be practiced with 
benefits at the level of the oocyte.
It is standard IVF practice to preincubate oocytes for 4- 
6h before insemination to minimise the incidence of 
polyspermie fertilisation and maximise embryo quality. The 
above study was extended to compare the relative effects 
of in vivo and in vitro maturation in 60 women randomly 
allocated to 34 or 39h LORDs. Each patient's oocytes were 
alternated between immediate insemination and 5h 
preincubation. The incidence of polyspermie fertilisation 
was highest in oocytes inseminated immediately after a 
short LORD (17/100) and was significantly reduced (p<0.05) 
by preincubation and/or an extended LORD. Fertilisation 
rates were significantly higher (p<0.05) after a 39h 
(84.2%) than a 34h LORD (76.8%) and the incidence of 
delayed fertilisation was reduced by extension of the in 
vivo maturation time (34h, 12.9%; 39h, 3.9%; p<0.001).
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The relative importance of follicle size and cumulus 
expansion as indicators of oocyte maturity was 
investigated by retrospective analysis of IVF data on 6922 
oocytes. Cleavage rates and embryo quality were 
significantly better (p<0.001) if the oocyte was retrieved 
from a large follicle (>2.5ml of follicle fluid; 63.4% 
cleaved, mean score 7.69) than a small follicle (<2.5ml; 
51.3% cleaved, mean score 7.22). Significantly higher 
(p<0.001) cleavage rates were observed if the associated 
cumulus was fully expanded (79.2%) than if the oocyte was 
scored as immature (73.8%); embryo quality was unaffected. 
The two parameters of assessment were not independent but 
combined data revealed that follicle size was a better 
indicator of fertilisation potential and subsequent embryo 
quality than cumulus expansion.
The nuclear status of 466 (71.4% of 653) oocytes could be 
determined after cytogenetic preparation; the majority 
(399, 85.6%) were at meiotic metaphase II and had a 
haploid chromosome complement. The first polar body had 
not been extruded in 6% (28) of oocytes which were 
classified as diploid metaphase II. Prematurely condensed 
chromatin of sperm chromosomes, indicating cytoplasmic 
immaturity, were observed in 9.3% (37/399) of metaphase II 
cells and 32.1% (9/280) of diploid metaphase II oocytes. 
The same phenomenon was present in 11/17 oocytes remaining 
uncleaved after a short LORD and immediate insemination. 
Approximately 5% (22) of uncleaved oocytes had mitotic 
chromosomes, three had been parthenogenetically activated. 
Chromosome fragmentation was significantly higher 
(p<0.001) in women over 39 (9/20, 45.0%) than younger 
groups (<30, 3.7%; 30-34, 6.3%; 35-39, 7.6%).
Karyotypes were prepared from 178 metaphase II and eight 
diploid metaphase II cells. Abnormalities were detected in 
43 (24.2%) haploid oocytes comprising 32 cells with whole 
chromosome aneuploidy, 11 with individual chromatids of
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one homologue, and two structural anomalies. Two cells had 
more than one abnormality and all diploid cells had a 
46,XX karyotype. Aneuploidy of acrocentric chromosomes (D 
and G group) was most frequent (10/20 hyperploid 
chromosomes) and 6/10 of cases with apparent pre-division 
of chromatids involved chromosome 16. The incidence of 
hyperploidy was significantly (p<0.05) higher in women >35 
(7/28; 25.0%) than those <35 (11/113; 9.7%). No 
association between abnormality and any aspect of IVF 
methodology was determined. The incidence of abnormality 
was similar in oocytes inseminated with normal (31/130; 
23.8%) and poor (8/24; 25.0%) quality sperm, suggesting 
that no selection against fertilisation of abnormal 
oocytes occurred.
Karyotype analysis of 178 diploid embryos revealed 
abnormalities in 40 (22.5%) cases. Single chromosome 
aneuploidy was detected in 19.1% of embryos, five cases 
(2.8%) involved two chromosomes and one embryo (0.6%) had 
both hyperploidy and hypoploidy involving three 
chromosomes. E group was most frequently involved in 
aneuploid karyotypes (10/23 hyperploid embryos) and 
trisomy 16 was detected in 2.2% of all embryos. Two 
structural anomalies were recorded and four embryos were 
mosaic. The incidence of aneuploidy increased with 
maternal age but did not reach statistical significance 
(<30, 7/52 [13.5%]; 30-34, 18/91 [19.8%]; 35-39, 6/26 
[23.1%]; >40, 1/2 [50.0%]). Embryo morphology and growth 
rate, assessed by EDR, did not distinguish between normal 
(mean score, 7.9; mean EDR, 96.1) and aneuploid (mean 
score 8.1; mean EDR, 92.1) embryos.
Numbers of hyperploid (n=17) and hypoploid (n=ll) embryos 
(non-mosaic cases involving single chromosomes) were not 
statistically different. Only one case of sex chromosome 
monosomy was detected. An excess of female karyotypes was 
detected in abnormal cases (sex ratio 0.48); the 74:64
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XY:XX ratio in normal cases was significantly (p<0.05) 
different. Small numbers of karyotyped triploid embryos 
revealed equal proportions of XXX, XXY and XYY embryos 
(3:2:3) .
In conclusion, this study detected a high incidence of 
chromosome abnormalities in human oocytes and 
preimplantation embryos. In vitro fertilisation 
methodology influenced oocyte maturity and IVF success 
rates but did not affect the frequency of aneuploidy. 
Factors influencing maternal meiotic nondisjunction 
require further investigation but this fundamental aspect 
of human reproduction is likely to be a limiting factor in 
the success of assisted conception treatments.
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SECTION 1 
OPTIMISING BIOLOGICAL 
CONDITIONS FOR IVF
CHAPTER 1 
INTRODUCTION
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1.1 Background
Natural fertility in the human female has evolved to 
produce approximately 10 children during the reproductive 
years between menarche and menopause (Edwards, 1980). 
However, the probability of a viable pregnancy occurring 
in any one month during which frequent intercourse 
occurred is only 15-28% (Short, 1979) . Considerable 
evidence from cytogenetic study of spontaneously aborted 
pregnancies (Boue et ai., 1985) has shown that 
approximately 50% of these are chromosomally abnormal.
This led to the conclusion that "a considerable part of 
embryonic death is unavoidable and should be regarded as a 
normal way of eliminating unfit genotypes in each 
generation" (Bishop, 1964).
Development of techniques for the recovery of human 
preovulatory oocytes from the ovary (Steptoe & Edwards, 
1970), their fertilisation in vitro and subsequent 
cleavage in culture (Edwards ^t âi., 1970) led to the 
birth of the first in vitro fertilisation (IVF) babies 
(Edwards ei a l ., 1980; Steptoe et al., 1980). Widespread 
use of such methods for the treatment of infertility has 
allowed direct observation of oocyte maturation, 
fertilisation, early embryonic development and cytogenetic 
examination of oocytes (Zenses et a l ., 1985) and embryos 
(Angell et ai., 1983).
Pregnancy rates after IVF and embryo transfer (ET) remain 
low 14 years after the birth of the first IVF baby. Eleven 
percent of cycles initiated in the United Kingdom during 
1989 resulted in the birth of a live child (ILA, 1991) 
although individual clinics reported higher 'take home 
baby' rates of up to 28%. Initial IVF successes were 
obtained after aspiration of single oocytes from natural 
cycles (Edwards et a l ., 1980) but improved pregnancy rates 
after transfer of multiple embryos (Jones et a l ., 1982;
29
Edwards ei al., 1984) led to increased use of methods for 
induction of multiple follicular growth. Ideal ovarian 
stimulation will achieve optimal follicle growth, provide 
the correct oocyte microenvironment and allow oocyte 
retrieval (OR) to be timed when oocyte maturity is 
reached. Synchrony with cyclical endometrial changes and 
adequate luteal function must also be attained.
It can be argued that the viability of an embryo is 
largely determined by the quality of the female gamete. 
Protein synthesis is dependent on maternal transcripts 
until the four to eight cell stage when the embryonic 
genome is activated (Braude al., 1988) and all 
ribosomes responsible for protein synthesis during the 
first three cell divisions are present at ovulation 
(Tesarik et al., 1986a). An endogenous supply of 
transcripts for the growth factors platelet-derived growth 
factor-A and transforming growth factor-alpha has been 
identified in unfertilised mouse oocytes (Rappolee et a l ..
1988) and may be essential for early development and 
implantation.
Preimplantation diagnosis of genetic disease has become a 
reality (Handyside ^  al., 1989) but the applicability of 
the complex and expensive techniques will be minimal while 
IVF pregnancy rates remain low. Accurate information on 
the incidence of chromosome anomalies in early embryos, 
including the extent of mosaicism, is also essential for 
future development of the methodology.
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1.2 Human gametogenesis and embryogenesis
1.2.1 Meiosls
Meiosis is the modified cell division which reduces the 
diploid chromosome complement to the haploid number 
present in male and female gametes. The significance lies 
in genetic variation induced by recombination after 
crossing-over between paired homologous chromosomes and 
the subsequent random segregation of each pair.
Female
Meiosis is observed in the human foetal ovary from nine 
weeks gestation (Hulten et ad., 1985) and the last oogonia 
enter meiosis at seven months (Peters, 1976). A single 
cycle of DNA synthesis occurs in early or preleptotene 
after which homologous pairs align and form bivalents by 
synapsis (zygotene). Chiasma formation occurs in pachytene 
which is first seen at week 11 and is predominant at 18-22 
weeks. This stage lasts for approximately two weeks when 
meiosis becomes arrested in dictyotene. Oocytes reach this 
modification of diplotene, in which homologous pairs repel 
each other until chiasmata form the only attachment, from 
week 13 and all have done so by birth. This nucleated 
stage remains until meiosis is reinitiated by the 
luteinising hormone (LH) surge preceding ovulation 
(Jagiello et a l ., 1975).
Approximately 2,000,000 oocytes in dictyotene are present 
at the time of birth but numbers continually decline by 
atresia and additionally, after puberty, by growth and 
ovulation (Edwards, 1980).
At the start of the LH surge the nucleus is visible in the 
cell periphery as a germinal vesicle (GV) with a large 
nucleolus (Bomsel-Helmreich et al. 1987). The first sign 
of resumption of meiosis is germinal vesicle breakdown
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(GVBD); the nucleolus pales, condensation of chromosomes 
continues and invaginations of the nuclear membrane signal 
its disappearance. Oocytes reach metaphase of the first 
division when bivalents assemble on the centre of a 
spindle. The first division is completed by centromeres of 
each bivalent moving towards opposite poles. Half of the 
chromosomes are absricted with a small amount of cytoplasm 
to form the first polar body (PBl) in the perivitelline 
space. These do not form a nucleus but remain associated 
with residual microtubules of the first meiotic spindle 
(Lopata et a l ., 1980). After normal meiosis, 23 
chromosomes, each composed of two chromatids form 
themselves on the equatorial plate of the second 
metaphase. The process is shown diagrammatically in Figure
1. The spindle is radially oriented, with one pole close 
to the vitelline membrane and the other pointing towards 
the centre of the oocyte (Szollosi ei ad., 1986). Oocytes 
remain in this condition during ovulation until induced to 
resume meiosis by the stimulus of sperm penetration.
The most extensive data on the timing of meiosis in vivo 
comes from stimulated cycles where OR was performed at 
intervals after human chorionic gonadotrophin (hCG) 
administration (Bomsel-Helmreich Êt al.., 1987). In mature 
follicles (>16 mm) the first signs of GVBD were seen 14 
hours after initiation of lutéinisation, metaphase I was 
observed between 20 and 26 hours and nuclear maturation 
was completed by extrusion of PBl at 35 hours. Lopata and 
Leung (1988) studied oocytes removed from follicles <10mm 
in diameter in unstimulated cycles and suggested that the 
process was more rapid. Both estimates for progression to 
metaphase II are less than early observations by Edwards 
(1965a).
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METAPHASE I
Attachment to 
spindle and 
movement of 
chromosomes to 
opposite poles.
METAPHASE II
Attachment to 
spindle and 
movement of 
chromatids to 
opposite poles.
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TELOPHASE II
All daughter cells 
have one 
chromatid.
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Figure 1
Diagrammatic representation of normal meiotic segregation. 
A chromosome of the D group with polymorphic satellites 
is illustrated.
Male
Primordial germ cells in the testis differentiate to form 
spermatogonia at the time of puberty. These in turn 
undergo differentiation to primary spermatocytes (Clermont 
& Leblond, 1959) which undergo meiosis I to form secondary 
spermatocytes. The second meiotic division follows 
immediately to produce two spermatids. These cells undergo 
considerable morphological changes including acrosome 
formation, nuclear condensation and formation of head, 
middle piece and tail formation to form spermatozoa 
(Leblond & Clermont, 1952). Spermatozoa are produced 
continually after puberty with a total time from 
spermatogonium to maturity of 61 days (Heller & Clermont, 
1963) .
1.2.2 Fertilisation
In vivo fertilisation occurs in the ampulla when a 
capacitated and acrosome reacted spermatozoa penetrates 
the cumulus oophorus, corona radiata and zona pellucida 
and fuses with the plasma membrane. In vivo capacitation 
occurs in the oviduct, appears to involve changes in the 
spermatozoal membrane (Friend et a l ., 1977) and is a pre­
requisite for the acrosome reaction. The process is not 
fully understood but can be achieved in vitro by exposure 
of sperm to defined culture media (Edwards, 1980) . The 
acrosome reaction occurs in the vicinity of the oocyte and 
involves fusion of the plasma membrane and the outer 
acrosomal membrane, releasing enzymes necessary for oocyte 
penetration. Hyaluronidase is implicated in breakdown of 
the cumulus matrix, which begins after two to three hours 
in vitro exposure to sperm (Edwards et ad., 1970), and is 
present in the oviduct (Edwards, 1980). Acrosin bound to 
the inner spermhead and outer acrosomal membrane 
(Bhattacharyyta & Zaneveld, 1978) is thought to be 
responsible for zona lysis.
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Fusion of gametes induces cortical granule release 
(Sathananthan & Trounson, 1982a) which forms the basis of 
the block to polyspermie fertilisation, probably at the 
level of the zona pellucida (Soupart & Strong, 1975). 
Meiosis is reinitiated and abstriction of the second polar 
body (PB2) in late telophase II is observed three hours 
after insemination in vitro (Lopata et al., 1980). The 
second PB forms a nucleus after extrusion.
After sperm penetration, female pronucleus (PN) formation 
is similar to reconstruction of an interphase nucleus 
after mitosis but male PN development from the highly 
condensed sperm head is more complex (Longo, 1973). The 
process can be divided into four stages (Tesarik &
Kopecny, 1989) . One and two involve rapid chromatin 
decondensation and can occur within an hour while the 
timing of three and four is variable and dependent on 
cytoplasmic factors for reformation of the nuclear 
envelope, reorganisation of chromatin and assembly of 
nucleolar precursors. Fully formed male PN are observed 
after 12 hours (Tesarik & Kopecny, 1989) and, unlike some 
rodents, cannot be distinguished from the female 
equivalent (Wiker et ad., 1990).
1.2.3 Follicular development during the natural ovulatory 
cycle
Follicles available for gonadotrophin recruitment in the 
late luteal/early follicular phase are 2-5 mm in size, 
contain a fluid filled antrum, approximately one million 
granulosa cells and a single oocyte (McNatty, 1982) . This 
stage develops after approximately ten weeks of growth 
from the primordial follicle, characterised by a single 
layer of granulosa cells around the oocyte (Gougeon,
1982) .
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An intercycle rise in pituitary follicle stimulating 
hormone (FSH), concurrent with corpus luteum regression 
(Baird ei , 1975), is implicated in initial recruitment 
of 'precursor' follicles, acting via receptors in the 
avascular granulosa layer. Early follicular phase 
secretion of FSH stimulates proliferation and 
differentiation of granulosa cells (Hillier, 1991), 
activation of aromatase enzymes (Dorrington gt a l ., 1975) 
and development of LH receptors (Zeleznik et al., 1974).
Relatively low concentrations of LH in the initial stages 
of the cycle maintain cell function (Zeleznik, 1981), 
including androgen biosynthesis (Tsang &t al., 1979), in 
the vascularised thecal cells. Development of granulosa 
cell aromatase activity results in utilisation of 
androgens to synthesise oestrogens (Baird, 1977). It is 
thought that these oestrogens act directly on granulosa 
cells to enhance FSH sensitivity, increasing LH receptor 
and aromatase production (Hillier ei â i ., 1985a), and have 
an interactive role with FSH to increase granulosa cell 
proliferation (McNatty & Baird., 1978).
Preovulatory follicles, which acquire functional LH 
receptors, can respond to both FSH and LH (Zeleznik êi
a l ., 1977) and subsequent development can be supported by
either, or both, hormones. The follicle which first 
acquires this reduced requirement for circulating FSH is 
'selected' from the precursor cohort in the latter stages 
of the follicular phase when pituitary secretion of FSH 
diminishes (Zeleznik & Hillier, 1984) under the influence 
of increased levels of circulating oestrogen (Marshall et 
a l .. 1983). The remaining follicles, devoid of FSH, 
undergo atresia.
After further growth, over four to five days, the 
preovulatory follicle is approximately 2 0 mm in diameter
(Hackeloer et a l ., 1979), contains around 50 million
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granulosa cells (McNatty, 1982) and is responsible for 
>90% of the secreted estradiol (E2 ; Baird, 1983). The 
circulating E 2 is believed to trigger the mid-cycle 
gonadotrophin surge (Liu & Yen., 1983) but this may not be 
the sole mechanism since supraphysiological levels 
produced by ovulation induction therapies do not always 
induce the response or, when produced, the response may be 
attenuated (Messinis et a l ., 1986).
Functions of the mid cycle LH surge include initiation of 
the processes leading to follicle rupture (Strickland & 
Beers, 1979), stimulation of luteal phase progesterone (P) 
secretion (Katz, 1981), reinitiation of meiosis in the 
oocyte (Jagiello et a l ., 1975) and induction of cumulus 
expansion with subsequent detachment from the follicle 
wall (Dekel et a l ., 1979).
1.3 Assisted conception methodology
1.3.1 Induction of multiple follicular growth
Multiple follicular growth can be effected by increasing 
gonadotrophin concentrations to allow development of all 
follicles acquiring sensitivity and thereby negating the 
'selection' process. Endogenous and exogenous 
gonadotrophins, and combinations of the two, have been 
utilised. Clomiphene citrate (CC) has anti-oestrogenic 
effects which stimulate LH and FSH secretion through 
poorly understood effects on the hypothalamo-pituitary 
axis (Adashi, 1984). Initial sources of exogenous 
gonadotrophins were derived from human pituitaries and 
contained LH and FSH in varying ratios (Bertrand e^ a l .. 
1972); a 1:1 ratio was considered most effective. Such 
preparations carry the risk of transmitting Jakob- 
Creutzfeldt disease (Baird, 1991) and are generally 
unavailable for clinical use. Commercially available human 
menopausal gonadotrophin (hMG) is obtained by purification 
from the urine of postmenopausal women and has bioactive
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LH and FSH present in equal amounts (Schwartz &
Jewelewicz, 1981) . Purified FSH is now available (Shaw ei 
a l .. 1985) and a recombinant DNA derived product (Germond 
et a l .. 1992) has been developed.
Most women undergoing ovarian stimulation in IVF 
programmes have normal ovulatory cycles and their 
functional pituitaries may respond to elevated E 2 levels 
by producing positive feedback LH rises. Where standard 
criteria for retrieval have been reached and the start of 
the surge accurately timed, it is possible to 
time OR in response to such endogenous LH rises with 
(Dreosch et a d ., 1988) or without (Eibschitz et al^., 1986) 
hCG augmentation. This approach requires intensive 
monitoring and places heavy demands on staff and 
facilities. Spontaneous lutéinisation before attainment of 
mature follicles results in cancellation of 20-30% of 
initiated cycles with both combined CC/hMG (Lejeune ^  
a l ., 1986; Harada et al,, 1991) and hMG (Vargyas & Marrs,
1987) stimulation regimens.
It is well accepted that cycles affected by an 
inappropriately timed LH surge, before development of 
mature follicles, should be cancelled (Lejeune et a l .. 
1986). However, such rises are frequently attenuated 
(Messinis et al., 1986) and may not be detected. Oocytes 
lack gonadotrophin receptors (Tsafiri et al., 1982) and 
reported detrimental effects of abnormal gonadotrophin 
environments (Moor & Trounson, 1977) may be mediated by 
follicular fluid steroids.
The paradoxical anti-gonadotrophic properties of agonistic 
gonadotrophin-releasing hormone analogs (GnRH-a) have been 
used to develop stimulation methods with improved clinical 
control for induction of multiple follicular growth 
(Fleming et al,, 1982). Following initiation of the GnRH-a 
therapy there is an initial rise in LH and FSH; the flare
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effect. Thereafter the pituitary becomes desensitised and 
exogenous gonadotrophins can be administered without risk 
of complication from endogenous LH rises or surges. The 
original protocol initiated GnRH-a in the luteal phase of 
the cycle preceding stimulation and has become known as 
long course combined therapy. Luteinising hormone 
concentrations during subsequent hMG induced follicular 
recruitment and growth are at, or close to, the limits of 
assay sensitivity (Fleming & Coutts, 1990). The relatively 
short half life (Diczfalusy & Harlin, 1988) of the hormone 
suggests that the 50% component of LH in hMG contributes 
minimally, if at all, to follicular stimulation.
Long course combined therapy is characterised by an 
initial delay in ovarian response (Coutts ei ai., 1989) 
and the cost implication of increased hMG requirements has 
resulted in development of adapted analog therapies using 
the flare effect for stimulation by initiation in the 
follicular phase (Frydman ei al., 1988; MacNamee ^i  a l ..
1989) .
1.3.2 Oocyte maturity 
Morphological assessment
During IVF treatment, all oocytes are inseminated and 
selection of embryos for ET, based on morphological 
criteria, is made from those which fertilise. Oocyte 
selection for gamete intrafallopian transfer (GIFT) 
requires identification of those with the highest 
potential for normal fertilisation and cleavage. The 
requirement for identification of 'good' oocytes is, as 
with IVF, to maximise conception rates while minimising 
high risk multiple pregnancies. Rapid assessment is 
required since selection is made at OR and immediately 
prior to replacement of gametes in the fallopian tubes, 
while the patient remains under anaesthetic. Information
38
from the oocyte/cumulus complex and the follicle of origin 
can be utilised.
The most common method of assessment of oocyte maturity is 
indirect, using cumulus expansion (Marrs et aJL., 1984). 
Accurate assessment of nuclear maturity can be achieved by 
spreading the cumulus mass on a flat surface (Veeck, 1988) 
but the technique has not been universally adopted because 
of the perceived dangers of excessive handling of oocytes 
(Fischer a l ., 1988; Pickering Qt a l ., 1990). A 
dissecting microscope does not generally have the 
necessary resolution and depth of field to visualise the 
PB and the method has been reported as invasive and 
impractical, especially when large numbers of eggs are 
involved (Khan et al., 1989).
Follicle size
The ultrasound (u/s) study of natural cycles which 
established the correlation between follicular diameter 
(FD) and circulating concentrations of E 2 also showed that 
the dominant follicle achieved a mean diameter of 2 0 mm 
(range 17-28 mm) on the day of the ovulatory LH peak 
(Hackeloer ei ai., 1979). Further measurements during 
spontaneous conception cycles showed ovulation of 
follicles reaching a maximum FD of >20 mm during the 
periovulatory period (Fleming et al., 1984).
In vitro fertilisation programmes differ in the u/s 
criteria considered minimal for administration of hCG (day 
0) or salvage of cycles following a spontaneous LH surge. 
Reported day 0 criteria range from two follicles of >15 mm 
(Edelstein ejt a l ., 1990) to one with a FD >19 mm (Lejeune 
et a l .. 1986) while other programmes require at least 
three structures in the 'mature' range (Gudmundsson et 
a l ., 1990) or a specific number of additional medium sized 
follicles (Lopata & Hay, 1989).
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Asynchronous development of the cohort due to recruitment 
as follicles reach gonadotrophin sensitivity throughout 
the stimulation period (Hillier ei ai., 1985a) leads to a 
range of FDs at the time of aspiration. Oocytes can be 
recovered from all sizes with varying efficiency. A 
recovery rate of 82% from follicles in the 18-20 mm range 
has been reported while only 39% of aspirated follicles 
less than 12 mm in diameter yielded an oocyte (Scott et 
al., 1989).
1.3.3 Interval from luteinising stimulus to ovulation
The lutéinisation stimulus to oocyte retrieval delay 
(LORD) employed in most IVF programmes has been 32 to 36 
hours (Hill et al., 1987; Khan et âl* / 1989; Simonetti êt 
al., 1985). This represents a compromise between maximum 
in vivo maturation of oocytes and retrieval before there 
is significant risk of ovulation and was based on studies 
in patients in whom follicular growth was induced using CC 
(Testart & Frydman, 1982) and/or hMG (Edwards & Steptoe, 
1975; Trounson et al., 1982a). Ovulation was observed in 
50% of patients in the period 37-39 hours after initiation 
of lutéinisation (Edwards & Steptoe, 1975; Testart & 
Frydman, 1982) .
The influence of endogenous LH fluctuations in such 
regimes may have contributed to the large variability in 
the reported time of observed ovulation. Precise timing of 
initiation of lutéinisation processes can now be achieved 
by induction of multiple follicular growth in a low and 
stable LH environment, using combined GnRH-a/hMG therapy 
but LORDS have not generally been altered (Chetkowski et 
al., 1989; Dandekar et al., 1990; Garcia et al., 1990, 
Tanbo et al., 1990).
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1.3.4 Interval from oocyte retrieval to insemination
Adoption of conservative LORDs may have influenced other 
aspects of IVF methodology. It is a common practice to 
include, before insemination, an in vitro oocyte 
preincubation (usually four to six hours) to minimise the 
incidence of polyspermie fertilisation and increase the 
proportion of oocytes which fertilise and develop into 
"normal embryos" (Trounson ^  al., 1982b).
The requirement for in vitro maturation before 
insemination was established by Trounson et ^ . , (1982b).
Results of this study are shown in Table 1.3.1. Oocyte 
retrieval was performed 34-37 hours after hCG 
administration or 26-29 hours after detection of urinary 
LH levels >2 standard deviations (SD) above baseline. 
Patients were either stimulated using CC or were monitored 
during a natural cycle. No difference was found between 
the groups and results were combined. Immediate 
insemination was associated with low fertilisation and 
cleavage rates of 'activated oocytes' (definition not 
given) and a high (30%) incidence of polyspermie 
fertilisation. Preincubation for four to six and a half 
hours maximised the yield of normal embryos.
1.3.5 Assessment of embryo quality
It is well established that the number of transferred 
embryos is a major factor affecting IVF pregnancy rates 
(Jones et al. , 1982; Edwards et. a l ., 1984; ILA, 1990). 
However, a conflict exists between achieving acceptable 
success and minimising the incidence of multiple 
pregnancies which has been identified as the main 
detrimental factor for the health of babies born after 
assisted conception (MRC, 1990).
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Table 1.3.1
Effect of oocyte preincubation on fertilisation and 
cleavage; from Trounson et a l ., 1982(b)
Preinc 'Activated' Pro- Multi Pro- Normal
Time Oocytes nuclear nuclear Cleavage
(h) (n) (n) (n) (n)
0-0.5 42 20 6 (30%)a 11 (26%)b
4-4.5 4 3 0 (0 %) 2 (50%)
5-5.5 37 34 0 (0 %) 33 (89%)
6 — 6 .5 36 28 2 (7%) 25 (69%)
a Percent is expressed as a proportion of
pronucleate zygotes.
b Percent is expressed as a proportion of activated
oocytes.
Factors affecting implantation after IVF and successful ET 
can be attributed to either embryo quality or uterine 
receptivity. These parameters may be related in some cases 
but an adequate uterine environment can be assumed if at 
least one embryo implants. Analysis of these pregnancies 
confirms that the potential of individual embryos for 
optimal development is variable. In 3,058 transfers of 
three embryos in UK clinics in 1988 (ILA, 1990) the 
overall implantation rate per embryo was 11.3% and in 
cycles with >1 gestation sac was 45%. A further study 
following 81 multiple pregnancies, in which at least one 
conception reached term, showed that the number of viable 
foetuses can reduce during gestation (Acosta et a l ..
1988).
The aim of embryo assessment is to identify those with the 
highest potential for full development. As well as the 
selection criteria for ET, the information is a useful 
adjunct to fertilisation and pregnancy rates for 
comparison of treatment regimes. Methods should be non-
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invasive, objective, able to be performed rapidly and 
amenable to statistical analysis. The two parameters used 
on a day to day basis for embryo assessment selection are 
gross morphology and growth rate (Cummins et al., 1986; 
Claman et ai., 1987, Puissant at al., 1987).
Morphology assessments are usually composites of 
blastomere regularity, number and size of cytoplasmic 
fragments and quality of cytoplasm, as assessed by 
granularity and vacuolisation. Scoring systems frequently 
use a range of one to four and assume that adverse 
parameters are correlated (Puissant ei ^ . , 1987; Bolton 
et a l . , 1989; Cummins Qt a l ., 1986).
Estimation of growth rate presents difficulties since 
cells spend 90% of their cycle in interphase. If observed 
on a single occasion it is not possible to differentiate 
between an embryo which has just cleaved and one about to 
undergo cleavage. Several approaches have been developed. 
Fishel Qt âl. (1985) observed individual embryos at 
regular intervals to obtain a calibration curve for cell- 
doubling time. Growth variables of subsequent embryos were 
assessed by multiple observations and their growth curve 
compared with the observed mean rate. Standardisation of 
assessment has also been attempted by observation at a 
fixed time after insemination (Claman et a l ., 1987,
O'Neill et ai., 1988). Both of these methods present 
practical problems for routine laboratories.
Cummins et ad. (1986) attempted to develop a method which 
would allow embryos to be assessed, irrespective of the 
time of observation, and which was also amenable to 
statistical analysis. Embryo development rating (EDR) was 
based on the ratio of the time at which the embryo was 
observed at a particular stage and the time it would be 
expected to reach that stage. The 'expected' time was 
calculated from a growth rate graph constructed by linear
43
regression analysis of a sample of embryos from their IVF 
programme. This ideal growth rate is a baseline for 
comparison and is not intended as an absolute measure but 
should represent an individual laboratory's conditions. 
Using this method a normally growing embryo would receive 
an EDR of 100.
Correlation of embryo quality and implantation is 
complicated by multiple embryo transfer. Precise 
information can only be obtained when all replaced embryos 
implant but some parameters can be deduced when similar 
embryos are transferred. Another approach is to give equal 
weighting to each embryo in cycles resulting in pregnancy.
1.3.6 Timing of embryo transfer after IVF
Embryo transfer has been performed at all stages of 
development from pronucleate zygotes (Quinn êi â i . / 1990) 
to blastocyst (Steptoe & Edwards, 1976). Replacement at 
two to four cells, two days after OR is most commonly 
practiced (Lejeune et a l ., 1990; Lowe ei ad., 1988; Tam et 
al., 1990).
The observation that a high proportion of in vitro 
cultured embryos cease development before blastocyst 
formation (Bolton et al., 1989, Fishel, 1986) prompted 
clinical trials of delayed embryo transfer to eliminate 
this population (Dawson et a l ., 1988; Bolton et a l .,
1991). Results did not compare well with conventional ET 
or transfer of donated blastocysts fertilised in vivo and 
recovered by uterine flushing (Buster ei al., 1985), 
suggesting an adverse effect of prolonged culture. This 
interpretation is supported by encouraging results from 
transfer of blastocysts co-cultured with monkey kidney 
cells (Boyer ei al., 1990). It has been shown that the 
main stage of arrest is at four to eight cells (Bolton ei
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a l .. 1989), possibly related to the switch from maternal 
to embryonic gene expression (Braude gi a l ., 1988). 
Replacement on day three after OR/insemination has been 
shown to be feasible (Belaisch-Allart et al., 1991; Van Os 
et al., 1989) and may represent a compromise between 
improved selection and detrimental culture effects.
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1.4 Aims
The aims of the work presented in section one of this
thesis were:
1. To assess EDR as a means of quantifying embryo growth 
rate. To investigate the relative merits of embryo 
morphology and growth rate as predictors of 
implantation potential and to identify the optimum time 
for embryo selection for ET.
2. To compare ovarian responses, oocyte/embryo quality and 
the outcome of treatment in patients in whom multiple 
follicular growth was induced using either hMG without 
endogenous gonadotrophin suppression or using combined 
GnRH-a/hMG where endogenous LH was suppressed.
3. To determine the time of ovulation after hCG 
administration in patients treated with combined 
therapy.
4. To investigate whether a prolonged LORD obviates the 
requirement for preincubation.
5. To compare the effects of in vivo and in vitro oocyte 
maturation upon development of the block to polyspermy, 
the fertilisation rate and development of ensuing 
embryos.
6 . To determine the relationship between cumulus expansion 
and follicular size, determined by FF volume, and 
investigate their relative importance as indicators of 
oocyte maturity.
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CHAPTER 2 
MATERIALS AND METHODS
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2.1 Chemicals
Chemicals used for the preparation of culture media and 
solutions used in cytogenetic methods and the 
abbreviations used for them in the text are listed in 
Table 2.1.1.
Table 2.1.1
Chemical components
Chemical Abbreviation Supplier
Barium hydroxide BaOH Sigma
Calcium chloride dihydrate CaC1 .2 H 2 0 Sigma
Ethanol BDH
Glucose Sigma
Hydrochloric acid HCl BDH
Magnesium chloride MgCl 2 .6 H 2 0 Sigma
Methanol BDH
N-2-hydroxyethylpiperazine-
N'-2-ethane sulphonic acid HEPES Sigma
Penicillin G Sigma
Phenol red Sigma
Potassium chloride KCl Sigma
Sodium bicarbonate NaHCOg Sigma
Sodium chloride NaCl Sigma
tri-Sodium citrate Sodium citrate Sigma
di-Sodium hydrogen
orthophosphate
dodecahydrate Na 2 HPO4 .1 2 H 20 BDH
Sodium hydroxide NaOH BDH
Sodium pyruvate Na pyruvate Sigma
Sodium lactate Na lactate Sigma
Streptomycin sulphate Streptomycin SO4 Sigma
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2.2 Induction of multiple follicular growth
2.2.1 Pituitary down regulation
Gonadotrophin-releasing hormone analog (Buserelin, Hoechst 
UK Ltd) was administered intranasally (5x100 pg daily, 
during the waking hours) or subcutaneously (12.5 jug every 
three hours) by pulsatile pump. Treatment was initiated in 
the mid-luteal phase (day 2 1 ) of the previous cycle and 
continued until administration of the ovulatory dose of 
hCG. Menstruation occurred 5-10 days after Buserelin 
initiation and the hypogonadal state was confirmed by the 
absence of follicular growth as assessed by ovarian u/s 
and basal plasma estradiol concentrations.
2.2.2 Stimulation of follicular growth
Human menopausal gonadotrophin (Pergonal, Serono UK Ltd), 
provided in ampoules containing 75 lU LH and 75 lU FSH, 
was used throughout the study period. Preliminary studies 
utilised a starting dose of four ampoules/day (im) but a 
lower dosage regime of three ampoules/day was later 
introduced. Doses were titrated depending on responses 
assessed by ovarian u/s and E 2 concentrations. Each cycle 
was reviewed before further treatment and the initial dose 
increased or decreased as appropriate.
Exogenous gonadotrophin therapy was usually initiated on 
day three or four following menstruation but could be 
delayed to suit programme management in patients down 
regulated with GnRH-a.
2.2.3 Monitoring
Ovarian responses to gonadotrophin treatment were 
monitored by rapid plasma E 2 radioimmunoassays (Fleming et 
a l .. 1985). Estradiol concentrations were used to indicate
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when serial u/s scans were required and the latter were 
used to time administration of hCG. Progesterone 
concentrations were estimated daily or twice daily 
(Fleming & Coutts, 1982a) in patients not down regulated 
by GnRH-a.
2.2.4 Criteria for hCG administration
The ovulatory injection of hCG (5000 lU; Profasi, Serono 
UK Ltd) was given when at least three mature follicles 
with a diameter of >17 mm were seen on u/s with 
appropriate concomitant E 2 concentrations (>1 . 0 ng/ml and 
<10.0 ng/ml). The definition of follicle maturity derived 
from the minimum follicular diameter observed on the day 
of the LH peak in normal (Hackeloer êi •/ 1979) and 
conception (Fleming êi al.., 1984) cycles.
2.2.5 Luteal support
A second injection of hCG (2500 lU) was given on day 4/5 
after the ovulatory dose and ovarian u/s on day 6/7 
determined the requirement for continued support; a 
further 2500 lU was given if ovarian diameters were 
<5.0cm. Supplementary hCG was replaced by progesterone 
(Cyclogest-200; vaginal pessaries 200 mg bd; Hoechst UK 
Ltd) in patients considered to be at risk of severe 
ovarian hyperstimulation syndrome.
2.2.6 Assays
Rapid assays for monitoring were performed on fresh plasma 
and samples were subsequently stored at - 2 0 ^ 0  until 
completion of the cycle. Selected samples were assayed for 
E 2 , P/ and LH using conventional radioimmunoassays (Coutts 
et al., 1981).
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2.2.7 Lutéinisation
Premature (pre-hCG) lutéinisation was diagnosed when 
plasma P concentrations of >1.5 ng/ml were assayed in two 
consecutive samples before attainment of criteria for hCG 
administration. This derived from normal cycle data and 
represented the mean value for day +1 after the LH surge 
(Fleming & Coutts, 1986).
2.3 Oocyte retrieval
The majority of retrievals during the study period were 
performed by laparoscopy using a carbon dioxide (CO2 ) 
pneumoperitoneum. Follicle fluid aspiration was effected 
by direct attachment of non-lubricated 10 ml syringes 
(Injekt; B. Braun Melsungen AG) to the aspiration needle. 
Follicles were routinely washed with an appropriate volume 
of flushing medium (2.4.3). Ultrasound guided OR by the 
vaginal route, introduced in the later stages of the 
study, utilised a controlled suction pump (100 mm Hg; 
Rocket of London Ltd) and double lumen needle (Casmed Ltd) 
for FF aspiration.
2.4 Culture methods
2.4.1 Disposable plastics
All vessels for media preparation and storage, sperm 
preparation, oocyte and embryo handling and culture were 
Falcon sterile disposable labware supplied by Becton 
Dickinson UK Ltd. Non-lubricated syringes (Injekt; B Braun 
Melsungen AG) of appropriate volume (2,5,10 or 20 ml) were 
used for media filtration and dispensing.
2.4.2 Glassware
Pasteur pipettes (230 mm; Volac) were soaked in detergent 
overnight (2% Decon 90, Decon Laboratories Ltd) then
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rinsed with tap water in an automatic pipette washer for a 
minimum of five hours. Pipettes were transferred through 
two washes (minimum 15 hours) of distilled/deionised 
water, dried in a hot air oven (45®C) and plugged with 
non-absorbent cotton wool (BDH). Sterilised pipettes (dry 
oven; 160°C for two hours) were used for all manipulations 
of oocytes, sperm and embryos.
2.4.3 Medium
Whittingham's T 6 modification of Tyrode's solution 
(Whittingham, 1971), prepared from basic ingredients as 
described by Hillier g_t âl. (1985b), was used for embryo 
culture throughout the study period. Three variants were 
used; culture medium was bicarbonate buffered for use in a 
5% CO2 environment and HEPES buffer was used in flushing 
and handling media (Table 2.4.1).
Table 2.4.1
Composition of Whittingham's T 6 modification of Tyrode's 
solution: culture, flushing and handling media
Component Culture medium Flushing medium
g/L (mM) g/L (mM)
NaCl 5.719 (98.02) 6.084 (104.10)
KCl 0.106 (1.42) 0.106 (1.42)
MgCl 2 .6H 2 0 0.096 (0.47) 0.096 (0.47)
Na 2 HP0 4 .1 2 H 2 0 0.129 (0.36) 0.129 (0.36)
CaC1 .2 H 2 0 0.262 (1.78) 0.262 (1.78)
NaHCOg 1.681 (21.25) 0.420 (5.00)
Na pyruvate 0.052 (0.47) 0.052 (0.47)
Na lactate 2.791 (24.90) 2.791 (24.90)
Glucose 1 . 0 0 0 (5.56) 1 . 0 0 0 (5.56)
Penicillin G 0.060 0.060
Streptomycin SO4 0.050 0.050
Phenol red 0 . 0 1 0 0 . 0 1 0
HEPES — 2.383 (1 0 .0 0 )
Handling medium: flushing medium + 4.0 g/L HSA.
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Chemical components were tissue culture grade supplied by 
Sigma Chemical Company with the exception of NaOH and 
Na 2HP0 4 .1 2 H 2O which were BDH 'Analar' grade (BDH Chemicals 
Ltd). Crystallised and lyophilized human serum albumin 
(HSA) prepared from Cohn fraction V was supplied by Sigma. 
Water for injections BP (Boots Company pic) was used for 
preparation of all stock solutions and culture media.
Stock solutions were freshly prepared for each batch of 
medium. Stock B3 was adjusted to pH 7.3 with 0.2N NaOH 
(Table 2.4.2) .
Table 2.4.2
Stock solutions used for preparation of culture medium and 
flushing medium
Stock
Solution
Component g/ 1 0 0  ml g / 1 0  ml
A (xlO) NaCl 5.719
KCl 0.106 -
MgC12.6H20 0.096 -
Na2HP04.12H20 0.126 -
Na lactate 4.651a -
Glucose 1 . 0 0 0 -
Penicillin G 0.060 -
Streptomycin S04 0.050 -
B1 (xlO) NaHC03 2 . 1 0 1 -
Phenol red 0 . 0 1 0 -
B2 (XlO) NaCl 1.461 -
Phenol red 0 . 0 1 0 -
B3 (XlO) HEPES 5.958 -
Phenol red 0 . 0 1 0 -
C (xlOO) Na pyruvate - 0.052
D (XlOO) CaC12.2H20
"
0.262
a 60% syrup
Medium was prepared as required but at least once every
two weeks. Volumes of stock solutions required per 100 ml
are shown in Table 2.4.3. After assembly of stock
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solutions and water the osmolarity of both media was 
adjusted to 285+2 mOsmol/kg using stock B2 or water. 
Culture medium was sterilised by Millex-GS filtration 
(Millipore SA) and aliquoted (18 ml) directly into 50 ml 
flasks. Flushing and handling media were passed through 
Sterivex-GS (Millipore SA) filters into 50 ml flasks and 
16 ml tubes respectively.
Table 2.4.3
Preparation of culture and handling medium from stock 
solutions. Volume of stock solutions required for 100 ml 
of complete medium
Stock solution Culture medium Flushing medium
A 10.0 (ml) 10.0 (ml)
B1 8.5 2.0
B2 0-1.5& 2.5-4.0a
B3 - 4.0
C 1.0 1.0
D 1.0 1.0
H 2 O to 100.0 to 100.0
a variable volume to permit fine adjustment of osmolarity.
Each patient's own serum was used for culture medium 
supplementation. Venous blood (20 ml) was obtained onr to 
five days prior to OR (before or after hCG administration) 
and allowed to clot in a plain glass tube (ZIO; LIP 
[Equipment and Services] Ltd.). Serum was removed after 
centrifugation at 1000 g for 20 minutes and spun for a 
further 10 minutes. Supernatant was transferred to a fresh 
tube and heat inactivated in a waterbath at 56®C for 30 
minutes. After cooling to room temperature, serum was 
filtered through a 0.22 um membrane (Millex-GS; Millipore 
SA) into a Falcon storage tube. Samples were stored at 4®c 
until required. Cloudy or lysed sera were discarded.
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Medium for each patient was prepared by adding 2 ml of 
prepared serum to a flask containing 18 ml of culture 
medium. This was used for sperm preparation, insemination 
tubes and oocyte and embryo culture. Culture vessels were 
individually gassed with humidified 02:C02:N2 (5:5:90; 
v:v:v; BOC Ltd) after each manipulation. Incubation at 
37.0®C was in a non-gassed, non-humidified chamber 
(Heraeus GmbH; model B5060).
2.4.4 Sperm preparation
A preliminary sample from the male partner was analysed 
within the laboratory to determine suitability for 
treatment. After measurement of volume, a wet film was 
prepared for assessment of motility and progressive 
motility (non, poor, normal, and good progression). Sperm 
density was determined by dilution of whole semen (1:9 in 
buffered formalin) and counting in an Improved Neubauer 
chamber. Poor and borderline samples were prepared using 
the standard IVF method (see below) to determine if 
sufficient motile sperm for assisted conception could be 
obtained.
Semen samples were produced before OR and processed in the 
laboratory within three hours. A standard analysis was 
performed to determine the preparation method or the 
requirement for a further sample.
Standard preparation: a 1 ml aliquot was centrifuged at 
200g for five minutes, the pellet resuspended in 1 ml of 
culture medium and recentrifuged. After repeating the 
washing process, tubes were left at room temperature for 
up to one hour to allow motile sperm to 'swim-up'. The 
supernatant was removed without disturbing the pellet 
containing cells, debris and non-motile sperm and the 
concentration of motile sperm was estimated (Improved 
Nauebauer counting chamber). Samples were immediately
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diluted to two million motile/ml for GIFT and 100,000 
motile/ml for IVF after the number of oocytes obtained was 
known. Viscous samples were diluted (1:3) with culture 
medium before initial centrifugation and the pellet 
removed from under the supernatant and transferred to a 
fresh tube. Cryopreserved samples were thawed quickly and 
reconstituted by dropwise addition of medium to avoid 
osmotic shock.
Duplicate swim-ups were used in samples with low counts 
and/or poor motility. In extreme cases where the swim-up 
fraction did not contain sufficient motile sperm for the 
number of oocytes obtained, the pellet was resuspended and 
diluted. This method was not used for GIFT. In cases with 
severe agglutination, culture medium was layered over 
whole semen and left at room temperature for one hour. The 
supernatant was centrifuged once and vigorously 
resuspended in 1 ml of medium. Overall semen quality was 
recorded as poor if insufficient motile sperm were 
recovered from a single swim-up.
2.4.5 Oocyte recovery
An embryology work station was positioned in theatre or an 
adjacent room. Syringes, flushing medium and culture tubes 
were stored in an incubator (37^0) until required.
Handling medium was maintained at 37^0 on a heating block 
during the procedure. The volume of single FFs was 
recorded and the aspirate immediately transferred to a 
60mm petri dish for microscopic examination (VMZ stereo 
microscope with transmitted light source; 10-40 
magnification; Olympus Optical Co Ltd). Each identified 
oocyte/cumulus mass was assessed for maturity, washed in 
handling medium and transferred to a pre-equilibrated 
culture tube containing 1 ml of culture medium.
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An initial assessment of oocyte maturity was made on the 
basis of cumulus expansion (Figure 2). Compact and partly 
expanded cell masses were scored as one and two 
respectively; these were considered immature. A score of 
three was given to fully expanded, mature cumuli and post- 
mature (PM) oocytes with very dispersed, friable cumuli 
containing aggregations of dark cells were recorded as 
four. All assessments during the study period were made by 
the same embryologist (MEJ).
2.4.6 Insemination
A sperm tube containing 100,000 motile sperm was prepared 
for each oocyte and heated to 37®C before insemination; 
generally four to six hours after OR. Exceptions to this 
procedure are described in the text. Oocytes were 
transferred to the insemination tube to further reduce any 
FF and/or blood contamination.
2.4.7 Assessment of fertilisation
Examination for PN was performed 15-21 hours after 
insemination. The fragment of the cumulus mass containing 
the oocyte was identified in the culture tube using a 
stereo microscope (SV8 stereo microscope with transmitted 
light source; 10-80 magnification; Carl Zeiss (Oberkochen) 
Ltd) and transferred to a culture dish containing 4 ml of 
handling medium at 3 7®C. Remaining cumulus and corona 
cells were manually removed by repeated aspirations into a 
finely drawn Pasteur pipette controlled by mouth suction. 
The ooplasm was examined for PN and the PB status recorded 
before the oocyte/zygote was transferred to a fresh 
culture tube. This process was performed prior to ET in 
cases not checked for the presence on PN. Figure 3 
illustrates an unfertilised oocyte with IPB, a normally 
fertilised zygote with 2PN and an apparently polyspermie 
zygote with 3PN.
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Figure 2
Assessment of oocyte maturity based on cumulus expansion: 
a) Immature, b) mature and c) post-mature (overleaf).
Figure 2c
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Figure 3
Appearance of oocytes/zygotes 15-21 hours after Insemination: 
a) an unfertilised oocyte, b) normal fertilisation and c) three 
pronuclei (overleaf).
Figure 3c
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2.4.8 Assessment of embryo morphology
Embryos were assessed prior to ET and given a score (range 
1-10; Figure 4) based on a composite of two parameters; 
the regularity of cell size (1-5) and degree of 
fragmentation (1-5). Totally fragmented embryos were given 
a nominal score of one and cases with a single 
blastomere+fragments were recorded as two. All assessments 
during the study period were made by the same embryologist 
(MEJ).
2.4.9 Assessment of embryo growth rate
The number of blastomeres and the examination time (hours 
from insemination) were used to calculate an EDR based on 
the method described by Cummins et al (1986; 1.3.5).
Calculation of a growth rate graph to reflect laboratory 
standards was based on single observations made between 
36h and 68h on 250 consecutive embryos. Two cell embryos 
were excluded from analysis since the earliest 
observations were made after the expected time of the 
first cell division (Cummins et al., 1986). Embryos were 
given a logarithmic score (S) of 2 log2 of the number of 
cells (Table 2.4.4) and a regression analysis of S in 
relation to hours from insemination was performed. Results 
of this analysis are shown in Table 2.4.5 and in Figure 5. 
In Table 2.4.5 the results are compared with those of the 
original authors. The estimated cell cycle length of 11.6 
hours was comparable with that of other programmes 
(Cummins el a l ., 1986; Trounson et al., 1982b) and was 
adopted as the 'ideal' for subsequent analyses.
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Figure 4
Examples of embryo morphology scores.
Score
'S'
Cell number 'Ideal growth
rate'
8
7
Expected
6
Observed
5
4
3
2
0
10 7020 50 604030
Hours after Insemination
Figure 5
Ideal growth rate and calculation method for EDR.
The ’Ideal growth rate’ represents the mean growth rate 
of embryos in the programme. The cell cycle length was 
estimated at 11.6 hours.
Subsequent EDR calculations compared the observed 
time with the ’expected’ time for that cell number.
The EDR for the example shown was calculated using the 
formula:
Time expected (hours) 
Time observed (hours)
58.5
X 100
40.0
X 100 =  146.25
Table 2.4.4
Logarithmic conversion of number of blastomeres
Cell
Number
S Cell S 
Number
2 2 7 5.5
3 3 8 6
4 4 8+ 8
5 4.5 Morula 10
6 5
Table 2.4.5
Expected time for cell stages (midpoint) calculated by
regression analysis and comparison with Cummins Qt a l .
(1986)
Cell Time
Number Expected Cummins et a l .
2 35.4 33.6
4 46.9 45.5
8 58.5 56.4
16 70.0 68.3
The EDR for each embryo was calculated by comparing the 
'observed' time with the 'expected' for that number of 
cells.
ie Time expected (h) 
Time observed (h)
In the example shown in Figure 5, an embryo observed at 40 
hours had eight cells. The 'expected' time for this stage 
was 58.5 hours; EDR was calculated as 58.5/40 x 100 = 
146.25 (rounded to 146). Appendix 1 lists EDRs 
subsequently assigned to all embryos.
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2.4.10 Embryo transfer
Embryos for transfer were selected on the basis of 
morphology and growth rate immediately prior to transfer 
(day 2 or day 3 after O R ) . Transfer medium (25% culture 
medium: 75% prepared patient's serum) was prepared at 
least two hours before ET and incubated at 37®C. When the 
patient was prepared, embryos were transferred into the 
medium and drawn in a volume of 10-20 pi into a heated 
catheter (Edwards-Wallace replacement catheter; HG Wallace 
Ltd) using a 1 ml syringe (Plastipak; Beckton Dickinson). 
After ET the catheter was checked for the presence of 
blood and mucus and flushed through with medium to confirm 
that all embryos had been ejected. A maximum of four 
embryos was replaced until 1/4/88 after which the number 
was reduced to three.
2.4.11 GIFT
Oocytes selected for GIFT during or immediately after OR 
were transferred to an organ culture dish containing 2 ml 
of prepared sperm (2.2.4). Oocytes (1-4) were drawn with 
50 ul of sperm into a catheter (GIFT catheter; Rocket of 
London Ltd) primed with culture medium. After the total 
contents of the catheter were ejected into the fallopian 
tube, the catheter was flushed through with medium and 
examined microscopically to check that all oocytes were 
transferred.
Supernumerary oocytes were inseminated to assess oocyte 
quality, the fertilising ability of sperm and 
compatibility of gametes.
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2.5 Study design
2.5.1 Assessment of embryo quality
All embryos generated by IVF during the study period were 
included. Embryos from 'spare' GIFT oocytes were excluded
Comparison of successful and non-implanted embryos was 
made using two methods.
1. Identification of individual embryos which implanted
Both morphology score and EDR of implanted embryos could 
be identified with certainty when all transferred embryos 
gave rise to a gestation sac. Deduction of one or both 
parameters could be made in cycles where similar embryos 
were replaced. In the example shown, both successful 
embryos had a score of 10 and one implantation from an 
embryo with an EDR of 109 could be identified.
Example: Twin pregnancy
Score EDR
Embryo 1 10 124
Embryo 2 10 109
Embryo 3 10 109
2. Identification of pregnancy associated embryos
All embryos transferred in pregnancy cycles were recorded 
as successful and comparison was made with those in non­
pregnant cycles.
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Comparison of embryo morphology and growth rate on day 2 
and 3
Gross morphology and EDR were assessed on both day 2 and 
day 3 in 37 IVF cases designated for day 3 replacement.
All embryos (234; range 1-10) were included in the 
prospective study. Comparison was made using the paired t- 
test.
2.5.2 Luteinising hormone: effects upon oocytes during 
the periovulatory period
One hundred and seven women undergoing induction of 
multiple follicular growth for IVF were included in the 
study. Patients were allocated to hMG alone (n=75) or long 
course combined GnRH-a/hMG therapy (n=32) with the analog 
administered by pulsatile pump. The initial dose of hMG in 
both groups was 4 amps/day and all ORs were performed by 
laparoscopy.
Oocytes were not checked for fertilisation at the PN stage 
during this study and results are expressed as cleavage 
rate (cleaved embryos as a percentage of viable oocytes).
Blood samples taken twice daily were assayed for P and E 2 ; 
treatment was discontinued if pre-hCG lutéinisation 
(2.2.7) was diagnosed.
Endocrinology data on all combined therapy patients and 
the first 40/51 of hMG cycles reaching OR were determined 
by conventional radioimmunoassay.
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2.5.3 Interval from lutéinisation stimulus to ovulation 
in women treated with combined therapy: implications for 
assisted conception methodology
Study 1: Timing of the observation of ovulation and the 
effects of extended LORD on oocyte quality and 
fertilisation rates in patients treated with combined 
therapy
Seventy-three patients undergoing laparoscopic OR for IVF 
(n=50) or GIFT (n=23) were treated with long course 
combined GnRH-a/hMG therapy. All had normal menstrual 
rhythm (39 tubal and 34 unexplained infertility). Human 
menopausal gonadotrophin was initiated at a dose of three 
amps/day; monitoring and criteria for hCG administration 
were those used throughout these studies.
Lutéinisation stimulus to oocyte retrieval delay was 
defined as the time from administration of hCG until 
aspiration of the first follicle at OR. Patients were 
randomly allocated to one of five groups, each with a two 
hour time span (Table 2.5.1). The shortest LORD was 33 
hours and the longest 41 hours 25 minutes.
Table 2.5.1
Study 1: Distribution and range of LORD groups
Group
Range
(htmin)
Actual
LORDS
(h:min)
IVF
(n)
GIFT
(n)
TOTAL
(n)
32:00-33:59 33:00-33:55 8 1 9
34:00-35:59 34:10-35:55 10 4 14
36:00-37:59 36:00-37:55 13 6 19
38:00-39:59 38:10-39:50 13 9 22
40:00-41:59 40:00-41:25 6 3 9
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Ovulation
Ovaries were examined for stigmata of ovulation and fluid 
was aspirated from the Pouch of Douglas (POD) before the 
initial ovarian puncture. Ovulation was judged to have 
taken place if follicle collapse was observed or an oocyte 
was identified in the sample of POD fluid.
All inseminations were performed at the same time relative 
to OR (6+/-1 h ) . Oocytes were not checked for 
fertilisation at the pronuclear stage during this study 
and results are expressed as cleavage rates (cleaved 
embryos as a percentage of viable oocytes).
Statistical comparison was made between individual groups 
and between conventional (<36 h) and extended (>36 h)
LORDS.
Study 2: In vivo and in vitro fertilisation of human 
oocytes: effects upon embryo development and polyspermie 
fertilisation
Sixty women with tubal (n=50) or unexplained (n=10) 
infertility undergoing ovarian stimulation for IVF were 
included in the study. Male problems were excluded. 
Multiple follicular growth was induced by long course 
combined GnRH-a therapy with hMG initiated at three 
ampoules/day.
Patients were randomly allocated to a short (34 hours, 
n=30) or long (39 hours, n=30) LORD. Each patient's 
oocytes were alternated between immediate (0) insemination 
and a 5 hour (5) preincubation (Figure 6). The total time 
between hCG and insemination (total maturation time) 
therefore varied from 34 hours (short/0) to 44 hours 
(long/5). The two intermediate groups (short/5 and long/0)
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Figure 6
LORD study 2 : d iagram m atic representation  
of experim ental design.
each had 39 hours, with differing proportions in vivo and 
in vitro.
Examination for the presence of pronuclei was performed 
15-21 hours after insemination; checking was performed at 
the same time relative to insemination in both short (mean 
= 18.1 h, range 16-21 hours) and long (mean = 18.1, range 
15-20 hours) LORD groups. Oocytes with a single PN were 
considered to be parthenogenetically activated and were 
not included in calculations of fertilisation rates or 
embryo evaluations. Embryo quality was assessed by the 
standard scoring system (2.4.8) prior to replacement on 
day 2 or day 3 after OR. The preincubation time of oocytes 
was not considered at embryo selection for ET.
Because of possible detrimental effects of immediate 
insemination, only patients with seven oocytes or more 
were included in this study and at least four oocytes were 
given standard treatment (5 hours preincubation). Patients 
in whom <7 oocytes were obtained or whose partner's semen 
sample was poor on the day of OR were excluded from the 
study and replaced by the next patient fulfilling all 
criteria. This requirement necessitated initial 
recruitment of >60 patients. The cancellation rate was 
minimised by excluding women with poor ovarian responses 
to stimulation and those whose partners had previous semen 
problems.
2.5.4 The relationship between follicle size and cumulus 
expansion and their relative importance as indicators of 
oocyte maturity
Estimation of follicle size
All oocytes recovered in IVF cycles were included in the 
study. Follicular size was estimated by volume of 
follicular fluid aspirated at OR. Follicles were 
considered to be spherical and the formula 4/3 pi r^ used
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to calculate diameter (2 x radius). Only data from 
discrete follicles was included in analyses.
Follicles were grouped according to diameter and 
appropriate cut off points of FF volume selected (Table 
2.5.2).
Table 2.5.2
Limits of follicle diameter and volume used in analyses
Follicle Diameter (mm) Volume (ml)
Size Minimum Maximum Minimum Maximum
Small 12.9 1.0
Medium 13.0 16.9 1.1 2.4
Large 17.0 24.9 2.5 7.9
Very Large 25.0 8.0
Where individual groups were too small for statistical 
comparison, data has been combined ie. <2.5 ml; small and 
>2.5 ml; large.
A proportion of oocytes were not checked for fertilisation 
during the study and results are expressed as cleavage 
rate (cleaved embryos as a percentage of viable oocytes).
2.6 Data storage and analysis
Data for all studies was recorded on Dbase III files 
(Ashton-Tate) and analysed using Kwikstat (Mission 
Technologies) statistics package.
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CHAPTER 3 
RESULTS
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3.1 Assessment of embryo quality
3.1.1 Assessment of EDR as a means of quantifying growth 
rate
Embryos were observed prior to embryo transfer on either 
day 2 (range 35-51h) or day 3 (range 59-70h). Embryos from 
the day 2/3 comparison were included in this study but 
only the assessments on the day of ET were used. The mean 
EDR (+/-SD) for each one hour interval is shown in Table
3.1.1 and Figure 7. Values ranged from 106 at 38h to a 
minimum of 66 in the group observed at 70h. The mean EDR 
of all embryos was 94.5.
Table 3.1.1
Mean EDR values at one hour intervals from insemination
Time
(h)
Dav
EDR
(mean)
2
SD n Time
(h)
Dav
EDR
(Mean)
3
SD n
35 93.0 3 59 92.7 3
36 104.1 20.2 29 60 91.9 16.6 23
37 98.6 12.2 53 61 94.8 16.5 40
38 106.4 18.0 150 62 88.0 14.5 143
39 98.8 14.4 179 63 88.5 15.3 131
40 101.0 14.9 340 64 82.3 17.6 136
41 99.6 15.3 330 65 82.1 14.5 63
42 98.2 15.4 302 66 89.1 16.7 103
43 96.7 15.9 416 67 80.4 15.9 84
44 96.2 15.8 199 68 80.6 14.7 68
45 93.8 14.5 131 69 77.9 15.7 62
46 89.5 16.2 78 70 66.0 6
47 93.1 15.5 87
48 90.6 13.3 61
49 89.8 13.9 18
50 94.7 9.7 10
51 92.0 3
Mean EDR values of pregnancy associated embryos were 
compared with those from non-pregnant cycles observed at 
the same interval from insemination (Table 3.1.2). Embryos 
replaced in pregnant cycles had a significantly higher (t-
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Figure 7
Distribution of EDR values (+/-SD) for one 
hour intervals after insemination.
test, p<0.001) EDR than the non-pregnant group. This 
difference was apparent whether embryos were observed on 
day 2 or day 3.
Table 3.1.2
Mean EDR of embryos transferred in pregnant and non­
pregnant cycles
Time
(h)
Preanant 
EDR (n)
Npn
EDR
Prea
(n)
P
(t-test)
38-39 111 36 104 125 0.031
40-41 104 0 101 267 0.034
42-43 100 59 99 294 0.440
44-45 98 39 98 125 0.895
46-47 90 25 91 140 0.781
48-49 93 4 90 75 0.665
50-61 Insufficient data
62—63 100 40 89 101 0.001
64—65 85 53 81 146 0.201
66-67 93 46 82 141 0.001
68-69 83 27 78 103 0.131
Day 2 99 209 96 791 0.011
Day 3 89 234 83 665 0.001
All embryos 98 205 93 795 0.001
3.1.2 Investigation of embryo morphology and growth rate 
as predictors of implantation potential
The EDR values of embryos known to have implanted are 
shown in Table 3.1.3. The mean value representing growth 
rate was significantly higher (t-test, p<0.002) in the 
implanted embryos than the unsuccessful group. No 
implantation from an EDR less than 70 could be deduced and 
the fastest growing embryos (EDR >110) were most frequent 
in the successful group.
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Table 3.1.3
EDR of individual embryos known to have implanted and 
those which failed
EDR Implanted 
n (%)
Not
n
implanted
(%)
<50 0 0
50-59 0 26 (2. 0 )
60-69 0 21 (1. 6 )
70-79 1 (0.9) 99 (7. 7)
80-89 25 (22.7) 302 (23. 6 )
90-99 25 (22.7) 277 (21. 6 )
100-109 28 (25.4) 288 (22. 5)
>110 31 (28.2) 268 (20. 9)
Total 110 1281
Mean EDR 101.34a 96.,64
a t-test. p<0.002
The morphology scores of implanted and non-implanted 
embryos are detailed in Table 3.1.4. The minimum score of 
an implanted embryo was seven and 38.3% of all successful 
embryos had a 'perfect' score of 10 compared with 19.7% of 
those which did not implant. The mean morphology score of 
successful embryos was significantly higher (t-test, 
p<0.001) than that of embryos replaced in unsuccessful 
cycles.
Eighty-two embryo transfers were performed where all 
embryos scored less than seven. One pregnancy (1.2%) 
resulted. The pregnancy rate after transfer of embryos 
scoring seven or more was significantly (chi-sq., p<0.001) 
higher (165/694; 23.8%).
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Table 3.1.4
Morphology score of individual embryos known to have 
implanted and those which failed
Score Implanted Not implanted
n (%) n (%)
1 0 0
2 0 2 (0.2)
3 0 2 (0.2)
4 0 15 (1.2)
5 0 43 (3.4)
6 0 98 (7.6)
7 6 (8.8) 195 (15.2)
8 18 (26.5) 374 (29.2)
9 18 (26.5) 300 (23.4)
10 26 (38.3) 252 (19.7)
Total 68 1281
Mean score 8 .84a 8 .07
a t-test. p<0.001
The relative contribution of embryo growth rate and 
morphology to pregnancy rate was investigated by placing 
embryos in an array based on both parameters. Table 3.1.5 
shows the numbers of embryos in each group, the number 
transferred and those replaced in pregnancy cycles. Table
3.1.6 shows the same data expressed as percentages. The 
number of pregnancy associated embryos in each group was 
compared with all other transferred embryos using the chi- 
squared test. The probability of differences between 
groups and the whole population is shown in Table 3.1.5.
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Table 3.1.5
Comparison of EDR and embryo morphology as predictors of 
implantation
Embryo
quality
<80
Embrvo Development Ratina 
81-90 91-100 >100 Total
1-4
n 36 32 19 53 140
ET 1 8 2 10 21
Pr 0 2 0 0 2
P 0.599 0.820 0.457 0.096 0.174
5+6
n 91 106 98 210 505
ET 29 38 33 65 165
Pr 1 7 2 10 20
P 0.007 0.621 0.028 0.208 0.002
7+8
n 177 377 312 569 1435
ET 62 163 180 324 729
Pr 7 29 48 76 160
P 0.043 0.203 0.087 0.391 0.824
9+10
n 132 305 211 410 1058
ET 71 189 150 316 726
Pr 6 47 26 95 174
P 0.006 0.261 0.175 <0.001 0.047
Total
n 436 820 640 1242 3138
ET 163 398 365 715 1641
Pr 14 85 76 181 356
P
n =
<0.001 
Number of
0.851 
embryos.
0.647 0.002
ET Number of embryos transferred
Pr = Number of embryos associated with pregnancy.
P Significance of difference of pregnancy associated
embryos from general (ET) population (tested using 
chi-sq).
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Table 3.1.6
Comparison of EDR and embryo morphology as predictors of
implantation; data expressed as percentages
Embryo Embrvo Development Ratina
quality
<80 81-90 91-100 >100 Total
1-4
% n 1.1 1.0 0.6 1.7 4.5
% ET 2.8 25.0 10.5 18.9 15.0
% Pr 0 25.0 0 0 9.5
5+6
% n 2.9 3.4 3.1 6.7 16.1
% ET 31.9 35.8 33.7 30.9 32.7
% Pr 3.4 18.4 6.1 15.4 12.1
7+a
% n 5.6 12.0 9.9 18.1 45.7
% ET 35.0 43.2 57.7 56.9 50.8
% Pr 11.3 17.8 26.7 23.5 21.9
9+10
% n 4.2 9.7 6.7 13.1 33.7
% ET 53.8 62.0 71.1 77.1 68.6
% Pr 8.5 24.9 17.3 30.1 24.0
Total
% n 13.9 26.1 20.4 39.6
% ET 37.4 48.5 57.0 57.6 52.3
% Pr 8.6 21.4 20.8 25.3 27.7
% n — % of total number of embryos.
% ET = % of embryos transferred.
% Pr = % of transferred embryos associated with 
pregnancy.
Embryos with EDR values <80 or morphology scores of five 
and six were infrequently associated with pregnancy 
cycles. The fastest growing embryos (EDR >100) and those 
with the highest morphology scores were significantly
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(chi-sq., p=0.002; p=0.047) associated with pregnancy. 
Results from individual groups suggested that both 
parameters contributed to the probability of implantation. 
Only 13.1% of embryos were in the fastest growing group 
with morphology scores of nine or ten. Seventy-seven 
percent of these were selected for ET and the proportion 
associated with pregnancy (30.1%) was significantly higher 
(chi sq., p< 0 .0 0 1 ) than the general population.
3.1.3 Investigation of the optimum time for selection of 
embryos for transfer
Both embryo morphology and EDR were strongly correlated 
(paired t-test, p< 0 .0 0 1 ) when examined on successive days 
(Table 3.1.7) .
Table 3.1.7
Comparison of embryos quality assessments on day 2 and day 
3 following OR
Day 2 Day 3
Time of observations: 
Range (h) 40-53 61-72
Mean (h) 45.1 66.5
Embryo assessment: 
Mean embryo score 8 . 0 7.6a
Mean EDR 1 0 0 . 0 87.2a
a paired t-test. p< 0 . 0 0 1
Comparison was made between all IVF replacements performed 
on day 2 and those delayed until day 3. It should be noted
that the day of ET was decided only by logistical
considerations. Pregnancy rates (Table 3.1.8) and
implantation rates (Table 3.1.9) were similar on day 2 and
day 3, irrespective of whether the number of embryos 
available for ET exceeded the number replaced (selected
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replacements) or all available embryos were transferred 
(non-selected replacements). Pregnancy rates were not 
significantly different if selection on day 2 was made 
before 42 h (87/371; 23.4%) or between 42 and 52h (19/97; 
24.4%).
Table 3.1.8
Comparison of pregnancy rates when ET was performed on day 
2 or day 3 after OR
ET
(n)
Dav 2 
Preg 
(n) (%)
ET
(n)
Dav 3
Preg 
(n) (%)
Non-selected
replacements 305 27 8 . 8 143 11 7.7
Selected
replacements 386 90 23.3 161 39 24.2
All cycles 691 117 16.9 304 50 16.4
Table 3.1.9
Comparison of implantation rates when ET was performed on
day 2 or day 3 after OR
ET
(n)
Dav 2 
Implant 
(n) (%)
ET
(n)
Dçty 3
' Implant 
(n) (%)
Non-selected
replacements 645 37 5.7 297 12 4.0
Selected
replacements 1 2 1 2 128 1 0 . 6 500 59 1 1 . 8
All cycles 1857 165 8.9 797 71 8.9
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3.1.4 Summary
Embryo development rating was an effective method of 
assessing growth rate if groups under comparison were 
examined at the same time, relative to insemination.
Embryo quality assessed by morphology and EDR was 
predictive of implantation potential but not diagnostic. 
The mean score of embryos which implanted (8.84) was 
significantly higher (p<0 .0 0 1 ) than those which failed to 
implant (8.07) and the minimum score associated with 
pregnancy was seven. Implanting embryos had a 
significantly higher (p<0.002) mean EDR (101.34) than 
those which failed to establish pregnancy (96.64). 
Assessment on day 3 after insemination allowed observation 
of a larger spectrum of development rate but observations 
on day 2 were highly predictive (p<0 .0 0 1 ) of both 
assessment parameters on day 3 and no advantage of delayed 
ET was seen in pregnancy rates (day 2, 16.9%; day 3,
16.4%) .
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3.2 Luteinising hormone: effects upon oocytes during the 
periovulatory period
3.2.1 Patient responses
Twenty-four (32.0%) of cycles on hMG alone were cancelled 
as a result of premature lutéinisation (Table 3.2.1). All 
patients on combined therapy attained minimum criteria for 
hCG administration without any evidence of lutéinisation.
The mean number of oocytes recovered per cycle and the 
proportion which subsequently cleaved were similar in the 
two groups (Table 3.2.2). Post-mature (PM) oocytes were 
recovered from 10 patients on hMG alone and were absent in 
combined therapy cycles; this difference was statistically 
significant (chi-sq., p<0.01). Embryo quality assessed by 
morphology and growth rate was not affected by the 
stimulation regime.
The pregnancy rate per ET was similar in the two groups 
but success per cycle was higher after combined therapy 
since all cycles proceeded to OR (Table 3.2.1).
Profiles of estradiol, LH and P during the eight days 
prior to day 0 are shown in Figure 8 and Table 3.2.3 lists 
the plasma hormone concentrations on the day of hCG 
administration. These results omit those of cycles 
cancelled prior to OR.
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Figure 8
Mean plasma concentrations of E2 , LH and P 
during the eight days prior to hCG 
administration in women treated with hMG 
alone or combined therapy.
* t-test, p<0 .01 .
Table 3.2.3
Steroid and gonadotrophin concentrations at hCG 
administration in cycles treated with hMG alone or in 
combination with GnRH-a
hMG GnRH-a/hMG
Day 0 estradiol (+/- SD) 
[ng/ml]
2.63(1.77) 3.16(2.01)
Day 0 P (+/- SD) 
[ng/ml]
0.74(0.32) 0.64(0.34)
Day — 1 LH (+/— SD) 
[lU/L]
4.8 (6.46) 1.45(1.02)a
a t-test. p< 0 . 0 1
Concentrations of estradiol on day 0 were similar in the 
two groups, reflecting the degree of stimulation required 
for hCG administration. Luteinising hormone concentrations 
in the hMG group were significantly higher throughout the 
final five days of stimulation but did not exceed normal 
follicular phase levels at any point. Elevations were not 
reflected in P concentrations which were similar in the 
two treatment regimes and were within normal laboratory 
limits.
3.2.2 Characteristics of cycles yielding post-mature 
oocytes
Cycles yielding PM oocytes were characterised by 
significantly reduced (chi-sq., p< 0 .0 1 ) cleavage rates, 
absence of pregnancies after ET (Table 3.2.4) and P 
concentrations >lng/ml at the time of hCG administration 
(Table 3.2.5). Mean endocrine profiles of PM cycles 
(Figure 9) disguise an attenuated LH surge, with 
subsequent P rise, occurring in each patient. An
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Figure 9
Mean (+/- SD) plasma concentrations of E2 , LH and P 
prior to hCG administation in cycles which 
yielded post-mature oocytes.
individual profile in shown in Figure 10. Progesterone 
levels exceeded the 1.5 ng/ml cut-off in one sample only 
and the lutéinisation escaped detection.
Table 3.2.4
Comparison of cleavage rates and pregnancies in cycles 
where PM oocytes were or were not recovered
Cycles % Oocytes Pregs
(n) cleaved (n)
PM Absent 73 60.4 14
PM Present 10 37.7 0
Chi sq. p<0.01 NS
Rises in circulating LH levels occurred during the final 
five days of stimulation with the mean LH peak 57 hours 
before hCG was given. Maximum P concentrations were 
detected 27 hours later (Table 3.2.6).
Table 3.2.5
Progesterone concentrations and the occurrence of PM 
cycles
Progesterone Cycles >1 PM oocyte
Day -1 (ng/ml) (n) recovered
<1.0 59 0
>1.0 24 10
chi-sq.y p< 0 . 0 0 1
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Table 3.2.6
Timing of LH and P peaks in cycles yielding PM oocytes
LH Peak P Peak Delay
(h pre-hCG) (h pre-hCG) (h)
Mean 57 32 27
SEM 8.5 8 . 6 4.4
In cycles affected by pre-hCG LH rises, only 16/68 
recovered oocytes were scored as PM. In only one case were 
all oocytes (2/2) PM.
3.2.3 Characteristics of post-maturity
During the total study period 75 PM oocytes were 
recovered. These were associated with larger FF volumes 
(mean 6 .1ml) than those scored as immature or mature 
(n=8322; mean 4.1ml) and a reduced cleavage rate (27.3% v 
61.8%) was observed. Embryo quality was similar in the two 
groups (PM; mean score 7.1, mean EDR 92.3: non-PM; mean 
score 7.5, mean EDR 94.0).
The majority of PM oocytes were recovered during a period 
when PN checking was not routinely performed and 
information on fertilisation is limited. However, 7/48 PM 
oocytes which had not cleaved on day 2/3 had multiple PN, 
one had 3PN, twelve had IPB, three had no PB and a further 
four showed signs of degeneration. Remaining oocytes were 
not informative. Apparently normal oocytes recovered from 
PM cycles did not display fertilisation anomalies but 4/18 
which remained unfertilised had failed to reach metaphase 
II.
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3.2.4 Summary
Suppression of endogenous pituitary function by adjuvant 
treatment with GnRH-a during ovarian stimulation with hMG 
eliminated LH fluctuations and surges and all initiated 
cycles (n=32) proceeded to OR without complication. The 
cancellation rate (24/75; 32.0%) was significantly higher 
(p<0.001) in hMG alone cycles. Pregnancy rates after ET in 
the two groups (GnRH-a/hMG, 19.3%; hMG, 18.1%) confirmed 
observations that embryo quality was similar after both 
stimulation protocols. Post-mature oocytes were recovered 
from 10 hMG alone cycles and were absent (p<0.01) in 
analog treated patients. Significantly fewer (p<0.01) 
oocytes cleaved in PM associated (37.7%) than unaffected 
(60.4%) cycles although not all oocytes were affected. 
Prior to hCG administration, all PM cycles showed an 
attenuated LH surge which was undetected by monitoring of 
serum progesterone concentrations.
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3.3 Interval from lutéinisation stimulus to ovulation in 
women treated with combined therapy: implications for 
assisted conception methodology
3.3.1 Study 1: Timing of ovulation
The mean number of oocytes obtained was 9.5 and there was 
no difference between any of the five study groups (Table 
3.3.1). Two patients in each of the 39h and 41h groups had 
at least one collapsed follicle at initiation of OR. The 
earliest observation of ovulation was at 39h 30min.
Oocytes were recovered from unruptured follicles in all 
cases and from a number of collapsed follicles, flushed 
with culture medium, in patients with evidence of 
ovulation.
Table 3.3.1
Study 1: Yield of 
LORD groups
oocytes and incidence of ovulation in
Group Oocytes (n) Ovulation
(Midpoint) Range Mean (patients)
(h)
33 5-10 8 . 0 0 0
35 6-18 9.79 0
37 4-17 10.37 0
39 2-23 9.41 2
41 2-14 8.89 2
3.3.2 Study 1: cumulus expansion
The proportion of oocytes with an associated mature 
cumulus increased with extension of the LORD (Table 3.3.2) 
and this increase was significant (chi-sq., p< 0 .0 0 1 ) when 
conventional and extended groups were compared. No post- 
mature oocytes were recovered in any group.
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Table 3.3.2
Study 1: Cumulus expansion in LORD groups
Group
(Midpoint)
(h)
Immature 
(n)(%)
Mature 
(n)(%)
Total
(n)
33 25 (34.2) 48 (65.8) 73
35 32 (26.2) 90 (73.8) 1 2 2
37 25 (13.1) 166 (86.9) 191
39 31 (16.2) 160 (83.8) 191
41 9 (12.3) 64 (87.7) 73
Combined
groups
<36 57 (29.2) 138a (70.8) 195
>36 65 (14.3) 390a (85.7) 455
a chi-sq., p< 0 . 0 0 1
3.3.3 Study 1: Cleavage rate
Table 3.3.3 shows the proportion of viable oocytes which 
cleaved in individual and combined LORD groups. GIFT 
cycles and any case with an apparent male factor were 
excluded. Cleavage rate increased with extension of the 
LORD with the exception of the small 41 h group. 
Significantly (chi-sq., p<0.02) more oocytes cleaved after 
extended in vivo maturation.
3.3.4 Study 1: Pregnancy rate
The pregnancy rate per OR was 22.0% (11/50) for IVF and 
30.4% (7/23) for GIFT (Table 3.3.4). Significantly (chi- 
sq., p<0.05) more IVF pregnancies were achieved in the 
extended LORD groups (10/32; 31.2%) than those treated 
conventionally (1/18; 5.6%). Pregnancy rates after GIFT 
were not different in the different LORD groups.
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Table 3.3.3
Study 1: Cleavage rate in LORD groups. Results from IVF 
cases excluding those with male factors
Group Cleaved Not Total
(Midpoint) cleaved
(h) (n) (%) (n) (%) (n)
33 28 (52.8) 25 (47.2) 53
35 42 (70.0) 18 (30.0) 60
37 63 (75.0) 21 (25.0) 84
39 61 (80.3) 15 (19.7) 76
41 23 (67.6) 11 (32.4) 34
Combined
groups
<36 70 (61.9)a 43 (38.1) 113
>36 147 (75.8)a 47 (24.2) 194
a chi- sq., p< 0 .0 2
Table 3.3.4
Study 1: Pregnancies in LORD groups
Group IVF GIFT
(Midpoint) OR ET Pregs OR Pregs
(h) (n) (n) (n) (n) (n)
33 8 6 0 1 0
35 10 10 1 4 1
37 13 12 6 6 1
39 13 11 2 9 4
41 6 5 2 3 1
Combined
groups
<36 18 16 1 a 5 1
>36 32 28 10 a 18 6
a p < 0.05
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3.3.5 Study 2: Patient details
Table 3.3.5 details LORD times and the numbers of oocytes 
recovered.
Table 3.3.5
Study 2: Details of LORD groups
SHORT LONG
Number of cycles 30 30
LORD (h:min): mean 34:20 39:20
LORD (h:min): range 33:20-35:00 38: 10-40:00
Oocytes (n): total 321 328
Oocytes (n): mean/cycle 10.7 10.9
Oocytes (n): range 7-20 7-23
3.3.6 Study 2: Cumulus Expansion
The proportion of oocytes scored as mature on the basis of
cumulus expansion was higher in the 39 h group than in the
34h group (83.1% v 77.6%) . The difference was not
statistically significant (Table 3.3.6) .
Table 3.3.6
Study 2: Cumulus expansion in LORD groups
Immature Mature
n (%) n (%)
Short LORD 70 (22.4) 243 (77.6)
Long LORD 55 (16.9) 270 (83.1)
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3.3.7 Study 2: Fertilisation Rate
The proportion of oocytes which fertilised was 
significantly (chi-sq., p<0.05) higher in those oocytes 
with a long hCG/OR delay (long/0 + long/5) than in the 
combined short groups (Table 3.3.7). The same trend was 
seen in individual groups but the differences were not 
statistically significant (Table 3.3.8). Preincubation 
time did not affect the fertilisation rates (Table 3.3.9) 
Oocytes with a single PN observed between 15 and 21 hours 
(n=7) were considered to be parthenogenetically activated 
and were classified as unfertilised for the purposes of 
this study.
Table 3.3.7
Study 2: Details of fertilisation and pregnancies in 
groups with short or long LORD
LORD
SHORT
(n)
LONG
(n)
Viable oocytes 302 303
Fertilised (%) 232 (76.8) a 255 (84.2) a
Fertilisation 
not observed (%) 30 (12.9) b 10 (3.9) b
Pregnancies (%/OR) 6 (2 0 .0 ) 8 (26.7)
a chi-sq., p < 0 .05
b chi-sq., p< 0 . 0 0 1
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Table 3.3.8
Study 2: Details of fertilisation and implantation in 
groups with short or long LORDs, with or without 
additional in vitro incubation
SHORT/0 SHORT/5 LONG/0 LONG/5
Viable 
oocytes (n) 152 150 155 148
Fertilised (n) 116 116 129 126
Fertilised (%) 76.3 77.3 83.2 85.1
2 PN (n) 83 94 118 1 1 1
3/4 PN (n) 17 a 8 7 9
3/4 PN (%) 17.0 7.8 5.6 7.5
Fertilisation 
not observed (n) 16 14 4 6
Fertilisation 
not observed (%) 13.8 1 2 . 0 3.1 4.8
Embryo morphology 
(mean score) 7.7 7.5 7.3 7.4
Implanted 
embryos (n) 3 2 6 1
a chi-sq., p<0.05
3.3.8 Study 2: Polyspermie Fertilisation
Table 3.3.8 shows the incidence of polyspermie 
fertilisation in those oocytes where PN were visualised at 
the first observation between 15 and 21 hours. Forty-one 
out of 447 oocytes had >2PN. The majority of abnormal 
fertilisations had 3 PN but two showed four. These were 
combined for analysis. The incidence of polypronuclei was 
highest in the short/ 0 group and was significantly lower 
(chi-sq., p<0.05) in all other groups.
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Table 3.3.9
Study 2: Details of 
immediately or after
fertilisation in oocytes 
preincubation
inseminated
Preincubation Time
0 5
(n) (n)
Viable oocytes 307 298
Fertilised (%) 245 (79.8) 242 (81.2)
Fertilisation
not observed (%) 20 (8 .2 ) 20 (8.3)
3.3.9 Study 2; Delayed Fertilisation
Forty oocytes which did not have recognisable PN at first 
examination subsequently showed evidence of fertilisation 
or had cleaved on day 2 (Table 3.3.8). Significantly fewer 
(chi-sq., p< 0.001) oocytes in the 2 long groups (3.9%) 
showed late fertilisation and/or cleavage compared with 
those in the short groups (12.9%; Table 3.3.7). 
Preincubation time did not affect the incidence of delayed 
fertilisation (Table 3.3.9).
3.3.10 Study 2: Embryo Quality
No difference in embryo quality related to the hCG/oocyte 
retrieval interval or preincubation time was observed 
(Table 3.3.8). Examination times relative to insemination 
were not equivalent in the two LORD groups and EDR could 
not be utilised to evaluate embryo growth rate (3.1.1).
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3.3.11 Study 2: Pregnancy rate
The pregnancy rates in the short and long groups was not 
different (Table 3.3.7). Twenty-one embryos implanted; the 
preinsemination treatment of 12 could be deduced. Nine 
followed immediate insemination (Table 3.3.8).
3.3.12 Summary
A preliminary study investigated the interval between 
administration of hCG and ovulation in 73 women undergoing 
laparoscopic OR after ovarian stimulation with adjuvant 
GnRH-a. The earliest ovulation was observed at 39.5 hours 
and oocyte quality, assessed by cumulus expansion and 
fertilisation rates, improved with extended in vivo 
maturation (mature oocytes, <36h, 70.8% ; >36h, 85.7%: 
fertilisation rate, <36h, 61.9%; >36h, 75.8%). These data 
indicated that extension of the LORD could be practiced 
with benefits at the level of the oocyte.
It is standard IVF practice to preincubate oocytes for 4- 
6 h before insemination to minimise the incidence of 
polyspermie fertilisation and maximise embryo quality. The 
above study was extended to compare the relative effects 
of in vivo and in vitro maturation in 60 women randomly 
allocated to 34 or 39 hour LORDs. Each patient's oocytes 
were alternated between immediate insemination and five 
hours preincubation. The incidence of polyspermie 
fertilisation was highest in oocytes inseminated 
immediately after a short LORD (17/100) and was 
significantly reduced (p<0.05) by preincubation and/or an 
extended LORD. Fertilisation rates were significantly 
higher (p<0.05) higher after a 39 hour (84.2%) than a 34 
hour LORD (76.8%) and the incidence of delayed 
fertilisation was reduced by extension of the in vivo 
maturation time (34h, 12.9%; 39h, 3.9%; p<0.001).
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3.4 The relationship between follicle size and cumulus 
expansion and their relative importance as indicators of 
oocyte maturity
3.4.1 Follicle size
The cleavage rate increased with follicle size and was 
significantly different between all individual groups 
using the chi-squared test (small/medium; p<0.05; all 
others; p< 0 .0 0 1 ) with the exception of large/very large 
(Table 3.4,1). Combined data showed a significantly (chi- 
sq., p< 0 .0 0 1 ) higher cleavage rate of oocytes from large 
follicles than those from small volumes (63.4% v 51.3%).
Table 3.4.1
Proportion of oocytes which cleaved related to follicle 
size
Follicle
size
Total
oocytes
(n)
Oocytes
cleaved
(n)
Percentage
cleaved
(n)
Small 412 194 a 47.1
Medium 718 386 a 53.8
Large 2080 1304 a 62.7
V. large 412 276 a 67.0
Combined data:
Small 1130 580 b 51.3
Large 2492 1580 b 63.4
Total 3622 1462 59.6
a Cleavage rates of all individual groups with the
exception of 
different, 
b p< 0 . 0 0 1
large/very large were isignificantly
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3.4.2 Cumulus expansion
Table 3.4.2 details the cleavage rate of oocytes related 
to cumulus expansion. The proportion of oocytes which 
cleaved increased with apparent cumulus maturity. All 
individual and combined groups were significantly 
different using the chi-squared test (1/3 & 2/3; p<0.001 
1/2 ; p< 0 .0 1 : immature/mature; p<0 .0 0 1 ).
Table 3.4.2
Cleavage rate related to cumulus expansion
Cumulus Total Cleaved Percentage
score oocytes embryos cleaved
(n) (n) (%)
1 38 12 a 1 . 6
2 1433 802 a 56.0
3 5451 3356 a 61.6
Combined data:
Immature 1471 814 b 55.3
Mature 5451 3356 b 61.6
Total 6922 4170 60.2
a Cleavage rates of all individual groups were
significantly different (chi-sq.). 
b chi-sq., p< 0 .001
3.4.3 Combined data
The relationship between follicle size and the degree of 
cumulus expansion of the associated oocyte is shown in 
Table 3.4.3. The proportion of oocytes with a fully 
expanded cumulus increased with FF volume. The difference 
was significant (chi-sq., p< 0 .0 0 1 ) when combined groups 
for follicle size were compared.
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Table 3.4.3
Relationship between follicle size and expansion of the 
associated cumulus.
Follicle
size
Cumulus expansion 
Immature Mature
n (%) n (%)
Small 
Medium 
Large 
V large
Combined data
Small
Large
121 (27.9) 
185 (25.3) 
451 (21.0) 
83 (19.7)
306 (26.2)a 
534 (20.8)a
313 (72.1) 
547 (74.7) 
1698 (79.0) 
339 (80.3)
860 (73.8) 
2037 (79.2)
a chi-sq., p< 0 . 0 0 1
Embryo morphology, as assessed by the mean score of all 
cleaved embryos, was significantly (t-test, p< 0 .0 0 1 ) 
better if the follicle of origin was large than if the 
oocyte was recovered from a small volume (Table 3.4.4).
The proportion of embryos with a score of >7 (minimum 
score associated with pregnancy; 3.1.2) was also 
significantly (chi-sq., p<0.001) higher in the large FF 
volume group (78.7% v 67.6%). Embryo morphology was not 
affected by the degree of cumulus expansion as assessed at 
OR (Table 3.4.4).
No correlation was found between embryo growth rate and 
either follicle size or cumulus maturity.
Figure 11 shows the cleavage rate and mean embryo score 
when oocytes are grouped according to both follicle size 
and cumulus expansion. The fertilisation/cleavage rates of 
oocytes from large follicles were significantly (chi-sq., 
p< 0 .0 0 1 ) higher than those from small volumes, regardless 
of the degree of cumulus expansion. Mature oocytes had a
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CLEAVAGE RATE
IMMATURE MATURE
SMALL
LARGE
47.7%
60.3%
(n=486)
53.0%
(n=283) (n=775)
65.3%
(n=1B77)
MEAN EMBRYO SCORE
IMMATURE MATURE
SMALL
LARGE
7.22
(n-133)
7.78
(n-288)
7.28
(n=401)
7.68
(n=1199)
p < 0.05
p < 0.01 
p < 0.001
Figure 11
Relationship of cleavage rate and embryo 
morphology with follicle size and cumulus 
expansion: combined data.
higher fertilisation rate than those with non-expanded 
cumuli but the difference only reached statistical 
significance when the follicle of origin was large. Embryo 
quality was better if oocytes originated from large 
follicles, regardless of apparent maturity at OR.
Table 3.4.4
Effects of follicle size and cumulus maturity upon embryo 
quality; combined groups
Embryo quality 
Morphology EDR
mean score (n) mean (n)
Follicle size:
Small
Large
Cumulus expansion:
Immature
Mature
7.22a (558) 
7.69a(1517)
7.54 (808)
7.55 (3294)
95.1 (575)
94.5 (1559)
96.6 (810)
95.2 (3308)
a t-test, p< 0 . 0 0 1
3.4.4 Summary
The relatiye importance of follicle size and cumulus 
expansion as indicators of oocyte maturity was 
inyestigated by retrospectiye analysis of IVF data on 6922 
oocytes. Cleayage rates and embryo quality were 
significantly better (p<0 .0 0 1 ) if the oocyte was retrieyed 
from a large follicle (>2.5ml of follicle fluid; 63.4% 
cleayed, mean score 7.69) than a small follicle (<2.5ml; 
51.3% cleayed, mean score 7.22). Significantly higher 
(p<0 .0 0 1 ) cleayage rates were obseryed if the associated 
cumulus was fully expanded (79.2%) than if the oocyte was
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scored as immature (73.8%); embryo quality was unaffected. 
The two parameters of assessment were not independent but 
combined data revealed that follicle size was a better 
indicator of fertilisation potential and subsequent embryo 
quality than cumulus expansion. These data suggested that 
follicle size should be the primary criterion when 
selecting oocytes for GIFT.
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CHAPTER 4  
DISCUSSION
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4.1 Assessment of embryo quality
4.1.1 Predictive value of morphology and EDR for 
pregnancy potential of embryos
Mean values for EDR assessed at different times relative 
to insemination varied within, and more markedly, between 
days 2 and 3. Two factors appeared to contribute. The 
earlier observations on day 2 identified the modal time of 
transition from two to four cells. The majority of embryos 
had reached four cells when examined during the latter 
part of day 2 and received successively lower EDRs 
(Appendix 1). The greater spread of cell stages observed 
at 62-63 h (Figure 12) suggests the reason for lower mean 
EDR values on day 3.
Cummins êi ad., (1986) concluded that the objective of
'normalising’ growth rate data was only partially met by 
the EDR method but that it's advantage lay in the ability 
to compare groups of embryos at disparate stages. This 
study suggests that this is only true when groups have 
been assessed at the same time relative to insemination.
Both embryo morphology and growth rate were predictive of 
implantation potential but neither were specific. Lower 
values were more indicative of lack of viability than high 
scores were of success. For example, only one pregnancy 
could be attributed to an embryo scoring less than seven 
but more than 75% of replacements where all embryos were 
>7 did not result in pregnancy.
The distribution of embryos in the analysis which combined 
both assessment parameters (Tables 3.1.5 and 3.1.6) 
suggested growth rate and morphology were not correlated. 
The finding that rapid cleavage could not compensate for 
poor morphology and vice versa suggests that a combined 
assessment might be feasible. A scoring system combining a 
morphology score and an addition for embryos reaching four
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cells 48h after 'fertilisation' has been reported 
(Puissant ei a l ., 1987). The present study suggests that 
the choice of cut-off used by these authors is 
inappropriate.
Mean values of EDR were maximal when embryos were assessed 
before 42h. This was also the period during day 2 when the 
EDR of pregnancy associated embryos was significantly 
higher than those in non-pregnant cycles (Table 3.1.2). 
Figure 12 illustrates the total embryo population and 
those selected for ET at 38-39 h, 44-45 h and on day 3 at 
62-63h. In the first group only 30% of embryos had reached 
four cells and were preferentially selected for ET. Six 
hours later, 50% were at four cells and comprised the 
majority of replaced embryos. This data suggests that EDR 
is predictive of implantation potential if selection takes 
place at a time when the fastest growing population can be 
identified. In the 62-63h group 30% had four cells or 
fewer, 71% of transferred embryos were at eight or more 
cells and EDR was highly predictive (p<0.001) of pregnancy 
potential. The methodology used could not determine if 
those embryos with fewer than eight cells were arrested, 
growing slowly or were growing normally after delayed 
fertilisation.
4.1.2 Timing of embryo replacement
Despite apparent separation of slow and rapidly growing 
embryos on day 3 (Figure 12), improved selection was not 
apparent in pregnancy (Table 3.1.8) or implantation (Table 
3.1.9) rates. It would appear that the correlation between 
both selection criteria on days 2 and 3 (Table 3.1.7) 
allowed prediction on day 2 of those most likely to 
continue normal growth. This data also excluded an 
influence of embryo/endometrium synchrony.
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(122)
38 - 39 h
% 44 - 45 h
62 - 63 h
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Cel l  N u m b e r
All embryos j | |  ET embryos ( ) EDR
Figure 12
Developmental stage of embryos at 38-39,  
44-45 and 62-63 hours after insemination.
4.1.3 Other methods of assessing embryo quality
The conclusion that gross assessment of preimplantation 
embryos is an insensitive predictor of implantation 
potential is supported by several studies investigating 
aspects of embryo metabolism, production of maternal 
pregnancy recognition factors and culture methods.
Sensitive assays capable of monitoring the uptake of 
energy substrates from droplets of embryo culture medium 
have been developed (Hardy et ad., 1989). This non- 
invasive technique showed that the main nutritional source 
changed from pyruvate in the early cleavage stages to 
glucose from days 2.5 to 4.5 post-fertilisation. Pyruvate 
uptake was 20% higher in embryos which developed to 
blastocyst than those which arrested in culture. This 
difference was detectable before any apparent change in 
growth rate. Although embryo morphology was better in the 
group which reached blastocyst, 70% of the group which 
arrested were equally good.
Embryo-derived platelet-activating factor (PAF) is 
secreted by human (O'Neill & Saunders, 1984) and mouse 
(O'Neill, 1985) preimplantation embryos and has been 
identified as possibly having a function in maternal 
recognition of pregnancy. The biologically active 
phospholipid causes platelet aggregation and sequestration 
leading to thrombocytopoenia when injected into 
splenectomised mice. This formed the method for the 
original bioassay in which PAF containing solutions were 
injected to mice (O'Neill, 1985). Analysis of culture 
medium showed that embryos which resulted in pregnancy 
secreted significantly more PAF than those which failed to 
implant (O'Neill et al., 1987). An improved, in vitro, 
assay using purified phospholipid extracted from the test 
solution showed higher secretion of PAF from 
preimplantation embryos with good morphology and growth
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rates, but identified a macroscopically normal population 
with deficient production (O'Neill et al., 1988).
The potential effects of light and room temperature on 
pre-implantation rabbit embryos were assessed by thymidine 
incorporation, electron microscopy and gross morphology 
(Fischer et al., 1988). Adverse effects of simultaneous 
exposure were apparent first as a reduction in thymidine 
incorporation indicating decreased cell proliferation. 
After longer exposure, signs of degeneration such as fatty 
vacuolisation, lamellar bodies, clustering of organelles 
and dead blastomeres within the perivitelline space were 
detectable by EM. Gross morphology proved to be too 
inaccurate to evaluate embryo damage.
Individual cells within the embryo may have differing 
potential. Low levels of extranuclear RNA synthesis 
associated with absent nucleolar activity were observed in 
a proportion of blastomeres in morphologically normal 
embryos (Tesarik ei ad., 1986b). Although destruction of 
up to 50% of blastomeres after cryopreservation is not 
incompatible with implantation (Troup et g d ., 1990), it is 
not a good prognostic factor.
Current methods for determination of energy substrate 
uptake (Hardy et al., 1989) and PAF production (O'Neill Qt 
a l .. 1988) are impractical for routine embryo assessment 
but may provide a basis for future developments. Another 
method is suggested by a study using videocinematography 
which allowed detailed study of 11 morphological 
parameters of fresh and cryopreserved embryos (Cohen et 
a l .. 1989) without time constraints imposed by protecting 
the embryo. The system was found to be easily learned by 
inexperienced embryologists and was considered relatively 
objective. Initial results for the predictive value of 
interleukin-l-alpha and immunosuppressive factors secreted 
into culture fluid (Sheth et ad., 1991) are encouraging
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but require verification using media from individual 
embryos.
4.1.4 Conclusions
In conclusion, embryo morphology and growth rate are both 
indicators of embryo viability but are not specific. Both 
show correlations with direct measurements of metabolism, 
ability to continue in vitro development and to transmit a 
maternal recognition message. They presently offer the 
best method for rapid selection of embryos for ET and it 
can be assumed that with fertilisation and pregnancy rates 
they offer a method of comparing and contrasting the 
relative success of treatment regimes. Embryo morphology 
and EDR can predict implantation potential and prevention 
of multiple pregnancy will involve analysis of these and 
assessment of other factors such as maternal age and 
previous pregnancy (Dawson al., 1991; Waterstone êi 
â i w  1991).
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4.2 Luteinising hormone: effects upon oocytes during the 
periovulatory period
4.2.1 Patient responses during cycles stimulated using 
hMG or combined GnRH-a/hMG therapy
All cycles treated with long course analog therapy during 
this study attained standard criteria for hCG 
administration without complication from endogenous 
pituitary activity, confirming previous reports that the 
use of adjuvant GnRH-a therapy significantly reduces the 
necessity for cycle cancellation due to inappropriate LH 
surges (Fleming & Coutts, 1986; Rutherford ei a l ., 1988).
The number of oocytes recovered in the two groups was 
similar, as were cleavage rates and indices of embryo 
quality. Comparable pregnancy rates per ET confirmed that 
embryos had similar potentials for implantation. In analog 
treated patients this rate (19.3%) was similar to that per 
OR (18.7%), and perhaps of most importance to patients, 
per cycle started (18.7%). Cancellation of 32% of hMG 
cycles resulted in a disparity between the rate per ET 
(18.1%) and that per initiated treatment (10.7%).
4.2.2 Advantages and disadvantages of adjuvant GnRH-a 
therapy
Published studies comparing adjuvant GnRH-a therapy with 
exogenous gonadotrophins (Berg van de-Helder et. al.», 1990; 
Thanki & Schmidt, 1990) or CC/hMG (Rutherford gt a l .,
1988; Abdalla et ai., 1990; Lejeune et al.., 1990; Kubik gt 
a l .. 1990) agree that elimination of spontaneous LH surges 
results in increased success, when related to initiated 
stimulation cycles. Five studies reported higher oocyte 
yields but, with the exception of Lejeune et al. (1990), 
fertilisation rates were similar. An increased conception 
rate/ET and a high (33%) incidence of multiple pregnancy
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suggested improved embryo quality in one programme 
(Rutherford ad., 1988) but this was the exception. No 
other group reported significantly increased success/ET 
and Lejeune ei ad. (1990) found that assessments of embryo 
quality and subsequent implantation rates were similar.
Interpretation of individual studies is complicated by 
variations in methodology between treatment groups. 
Different criteria for hCG administration were applied to 
the treatment regimens compared in two studies (Rutherford 
et a l .. 1988; Thanki & Schmidt, 1990) and Abdalla ei a l . 
(1990) utilised the flexibility afforded by analog therapy 
to avoid weekend recoveries. Since follicle size has an 
influence on the recovery rate of oocytes (Scott ei a l .. 
1989) and subsequent fertilisation, cleavage and embryo 
quality (3.4) some apparent advantages of pituitary 
desensitisation may be attributable to extended follicular 
growth.
A further investigation suggested improved uterine 
receptivity as the factor responsible for higher pregnancy 
rates/ET in analog cycles compared with those following 
CC/hMG treatment (Testart et ad., 1989). A detrimental 
influence of CC may be implicated (Rogers et al.., 1986) 
but improved synchronisation between the embryo and 
endometrium by elimination of pre-hCG lutéinisation might 
also be important.
4.2.3 Oocyte post maturity
It is of interest that embryology results in the present 
study were comparable despite inclusion of a sub­
population, adversely affected by pre-hCG lutéinisation, 
in the group treated with hMG alone.
Post-maturity was exclusively associated with cycles in 
which an LH surge (often attenuated) was retrospectively
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detected and affected fewer than 25% of the oocyte 
population. Typically, PM oocytes were recovered from 
large acellular cysts, cumulus cells were aggregated 
within a friable matrix and the oocyte was obscured by a 
darkened, contracted corona radiata. The aspiration 
process or gentle pipetting was often sufficient to detach 
cumulus and corona cells. Fertilisation anomalies and 
meiotic failure were frequent.
A relationship between these phenomena and subnormal 
lutéinisation is supported by experimental evidence from 
the rabbit showing that functions of the mid-cycle LH 
surge can become dissociated if the signal is insufficient 
(Bomsel-Helmreich ei a l ., 1989). Superovulated does were 
given hCG doses ranging from five to 100 lU. Although 5-10 
lU could reinitiate meiosis, progressively higher doses 
were required for completion of each meiotic stage and >15 
lU induced asynchronous nuclear development among oocytes 
in preovulatory follicles of the same ovary. Some oocytes 
attained metaphase II after 15-20 lU of hCG but the 
associated cumulus was only partially dissociated. Thirty 
lU were required for lutéinisation of granulosa cells but 
a proportion of follicles showed cystic transformation and 
condensation of cumulus cells around the oocyte. Ovulation 
was the function requiring the largest stimulus with the 
number of ruptured follicles being dose proportional.
4.2.4 Classification of sub-optimal oocytes
A retrospective study of 219 patients undergoing OR after 
CC or CC/hMG ovarian stimulation grouped cycles according 
to the pre-hCG concentration of LH (Munabi et a l ., 1990). 
Luteinising hormone levels >50% above baseline were 
associated with a significant reduction in pregnancy rate 
and higher concentrations (>2 x baseline) resulted in 
elevated P levels. These results suggest that cycles were 
affected by attenuated LH surges but abnormal oocytes
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recovered from affected cycles were considered 'atretic'. 
This highlights the fact that, although there is broad 
agreement on classification of 'normal' oocytes, 
considerable confusion exists over the terms atresia, 
post-maturity, over-maturity and dysmaturity.
Clarification is important since different factors may be 
involved in their origin.
Trounson et al», (1983) reported that if hCG was given 
when E 2 showed a marked fall the follicles were 'atretic' 
and recovered oocytes had no potential for fertilisation 
or development. A similar report found that if hCG was 
withheld until E 2 plateaued or declined following CC or 
CC/hMG stimulation (Kerin et. aj^., 1984), 'postmature' 
oocytes were recovered and the pregnancy rate declined. 
These cycles did not have a detected LH surge but were 
associated with rising concentrations of P and low levels 
of FF androstenedione. Mechanisms involved may be 
lutéinisation, reducing FSH levels in CC cycles failing to 
maintain follicular growth (Fleming & Coutts, 1982b) or a 
mixture of both.
A high (35%) incidence of follicular 'atresia' and 
recovery of morphologically abnormal oocytes has been 
reported in a programme where patients are 'coasted' for
2-3 days between final administration of gonadotrophin and 
hCG (Jones, 1984). This anomaly may also be due to 
cessation of developmental stimuli. Oocytes recovered from 
leading follicles of >23mm, which were associated with 
increased polyspermy, decreased recovery, fertilisation 
and cleavage rates (Ben-Rafael et a l ., 1986a) may 
represent another phenomenon. Lobo ei ai. (1985) described 
'dysmature' oocytes from CC/hMG cycles and compared FF 
steroid concentrations with those of classically atretic 
follicles recovered from unstimulated patients. The 
abnormal oocytes were aspirated from large (>18mm) 
follicles, had no cumulus, corona or first PB but had
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undergone GVBD. They were associated with higher levels of 
P and E 2 and lower androgen concentrations than atretic 
FF.
Some aspects of follicular lutéinisation and atresia are 
similar (Bomsel-Helmreich & Huyen, 1982) and this may be 
reflected in oocyte morphology. However, if recovery of 
abnormal oocytes is considered relevant, publication of 
full descriptions and photographs might lead to a 
consensus on nomenclature.
4.2.5 Abnormal luteinising hormone profiles in human 
reproduction
Elevated follicular phase concentrations of LH have been 
implicated in several aspects of impaired human 
reproduction. Stanger and Yovich (1985) found reduced in 
vitro fertilisation, embryo quality and pregnancy rate in 
patients with basal LH levels >1SD above the population 
mean. Similarly reduced implantation and an increased 
abortion rate occurred when high tonic levels of urinary 
LH were measured during CC/hMG stimulation for IVF (Howies 
et a l .. 1986). Cycles affected by LH surges were 
eliminated from both studies. Thomas si âi.. (1989) 
questioned the relevance of these results since parametric 
statistical methods were applied to non-Gaussian 
distributions and investigated the hypothesis by comparing 
follicular phase profiles of 596 consecutive patients with 
LH ranges from similarly stimulated conception cycles. No 
relationship between LH and IVF outcome was found.
However, in vivo studies have added further evidence for 
an adverse effect of LH elevations on fecundity. Homburg 
et al. (1988) investigated patients with polycysic ovarian 
syndrome undergoing ovulation induction with pulsatile 
luteinising hormone releasing hormone. Basal LH levels 
were significantly lower in patients who conceived than
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those whose treatment failed. Elevated concentrations 
during the latter stages of follicular development were 
correlated with non-ovulation and early pregnancy loss. A 
similar relationship with conception and abortion rates 
was reported in a population of normally cycling women 
followed over an 18 month period during which they were 
attempting to conceive (Regan, 1991).
In the absence of direct experimental evidence, the 
mechanism for these effects upon oocyte development can 
only be a matter of speculation. Investigations using 
isolated mouse follicles have shown that oocyte health can 
be adversely affected by changes in the FF hormonal milieu 
caused by altered patterns of steroid synthesis (Tyler & 
Collins, 1980). Contrary evidence is provided by an 
investigation of the predictive value of pre-hCG P 
concentrations in patients stimulated with hMG and/or FSH 
after suppression with the GnRH-a leuprolide acetate 
(Edelstein et al», 1990). No significant effect on the 
number or classification of oocytes recovered, 
fertilisation rates or resulting pregnancy was found. A 
slight but significant correlation was found between P and 
E 2 . Another possible effect at the follicular level is 
suggested by in. vitro studies showing that LH reduces 
granulosa cell DNA synthesis (Hillier, 1991) .
The mid-cycle LH surge initiates resumption of meiosis, 
mediated by a complex array of inhibitory and stimulatory 
factors (Plachot & Mandelbaum, 1990). Premature initiation 
of these processes might result in ovulation of 'aged' 
oocytes still capable of fertilisation. Evidence from IVF 
programmes has shown reduced implantation rates after late 
fertilisation (Oehninger gt. ai., 1989; Trounson & Webb, 
1984; Pampiglione et ai., 1990), possibly reflecting an 
increased incidence of genetic anomalies (Ben Rafael et. 
ai., 1986b; Plachot et ai., 1988a). An observed 
association between increasing miscarriage rate and
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extension of the delay from ovulation to intercourse would 
support a similar effect in vivo (Guerrero & Lanctot,
1970; Guerrero & Rojas, 1975) .
Meiosis in the rabbit can be reinitiated by relatively low 
doses of hCG (Bomsel-Helmreich êi al., 1989) but 
completion of the process may be dependent on other LH 
controlled functions. One feature of cumulus expansion is 
a reduction in coupling of the oocyte with the corona 
cells (Eppig, 1982). The cytoplasmic processes through the 
zona pellucida which form gap junctions with the oolemma 
permit low molecular weight substances to pass between the 
cells and may permit one cell type to influence another 
(Lawrence ejt aJL., 1978). These processes are completely 
retracted at the time of ovulation (Dekel ei. al.., 1978) 
under the influence of the oviductal environment. Both 
Eppig (1982) and Moor ei al. (1981) suggest that meiotic 
resumption is not a function of reduction in intercellular 
coupling but that the gap junctions are required for 
transmission of the signal.
4.2.6 Conclusions
A great variety of methods for induction of multiple 
follicular growth for IVF and GIFT are currently utilised, 
reflecting a lack of consensus on which regime provides 
the most acceptable balance of efficacy and costs.
Adjuvant GnRH-a therapy has considerable advantages for 
clinical management and allows oocyte development without 
interference from LH fluctuations. The effects of 
detectable LH surges are reflected in oocyte morphology 
and developmental potential but the full role of LH in 
human fecundity remains unclear.
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4.3 Interval from lutéinisation stimulus to ovulation in 
women treated with combined therapy: implications for 
assisted conception methodology
4.3.1 Oocyte maturation in vivo and in vitro
The hours following the luteinising stimulus are a period 
of intense nuclear and cytoplasmic activity in human 
oocytes. The resumption of meiosis from the dictyotene 
stage to metaphase II when the process is again arrested, 
awaiting fertilisation, is accompanied by changes in the 
zona pellucida and ooplasm. These allow recognition and 
penetration by a spermatozoon, formation of pronuclei, 
further reduction of the maternal genome, early cleavage 
stages and transition from maternal to embryonic gene 
expression.
Pincus and Enzmann (1935) first showed that mammalian 
oocytes, removed from healthy antral follicles, resumed 
meiosis when cultured in vitro. This has been shown to be 
true for all mammalian species studied, including humans 
(Edwards, 1965b), but the capacity of such oocytes for 
normal fertilisation and development is minimal without an 
inductive in vivo period followed by further in vitro 
maturation (Moor & Trounson, 1977; Niwa & Chang, 1975). 
Zona pellucida maturation (Plachot & Mandelbaum, 1978) and 
development of factors involved in male pronucleus 
formation (Thibault & Gerard, 1973) have been implicated 
in this phenomenon.
4.3.2 Timing of ovulation after hCG administration
Study 1 (3.3) showed that, in patients whose endogenous LH 
was suppressed, a 39 h post-hCG in vivo maturation time 
could be practiced without risk of pre-operative ovulation 
(Table 3.3.1). Cumulus expansion increased with extended 
LORD (Table 3.3.2) and cleavage rates were significantly
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higher (p< 0.02) in oocytes retrieved >36 hours after the 
luteinising stimulus than in those from ORs <36 hours 
after hCG. All oocytes were preincubated for the same 
period (6 +/-1 h) in this preliminary study.
4.3.3 Ovulation processes
It is of interest that oocytes were successfully recovered 
from a proportion of 'ovulated' follicles by introducing 
the aspiration needle through the point of rupture and 
flushing with medium. Evidence suggests that ovulation is 
not an explosive event. In. vivo experiments on the baboon 
(Beck & Blair, 1977) using a method to distinguish between 
ovarian contractions and movement of surrounding ligaments 
and mesenteries could not confirm previous reports of 
spontaneous ovarian contractions (Virutamasen e±. ad.,
1973). No significant change in intrafollicular pressure 
could be measured in the periovulatory period in the 
rabbit (Espey & Lipner, 1963) and direct observation in 
the human described a gradual flow of fluid (Edwards & 
Steptoe, 1975) without evidence of muscle contractions.
4.3.4 In vitro oocyte maturation before insemination
The study which indicated a requirement for an in vitro 
incubation before insemination in human IVF programmes was 
conducted on patients treated using a variety of 
stimulation regimes (Trounson et a l ., 1982b; Table 1.3.1). 
Oocyte retrieval was timed from either spontaneous or 
induced lutéinisation and although minimum criteria for 
hCG administration included u/s visualisation of a 
follicle >17mm in diameter, some decisions to proceed with 
OR were based on changes in cervical mucus in the absence 
of detectable follicle growth. Subsequent observations 
have suggested that a more individual approach to each 
oocyte could be beneficial. A preincubation period for 
preovulatory oocytes from leading follicles (>18mm)
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appeared to be unnecessary for CC/hMG stimulated oocytes 
recovered 36 h post-hCG but the fertilisability of 
secondary follicles was enhanced by in vitro maturation 
(Lopata, 1983). Optimal timing of OR after an endogenous 
LH surge also obviated the requirement for an incubation 
period before insemination (Edwards ^  a d ., 1984).
Variation of preincubation time from 6-24h, according to 
apparent oocyte maturity based on the degree of cumulus 
expansion achieved comparable fertilisation rates among 
three categories of oocyte maturity (Laufer e^ ad., 1983). 
This approach was extended by examining nuclear maturity 
and delaying insemination until extrusion of the first 
polar body was observed (Veeck, 1985). More than 80% of 
immature oocytes were successfully matured in vitro and 
82.3% subsequently fertilised. However, fertilisation 
rates were lowest where in vitro maturation was necessary 
from the GV stage. No pregnancies resulted from 27 
transfers of embryos derived solely from this group but 
embryos from oocytes which had undergone GVBD but had not 
extruded PBl had implantation rates similar to those from 
mature oocytes (Veeck, 1988).
Transfusion of ooplasm from metaphase II to GV oocytes has 
been shown to overcome this developmental block (Flood ei 
a l .. 1990). Ribonuclease A was shown to interfere with the 
process, implicating a messenger RNA as the cytoplasmic 
factor necessary for oocyte competence.
4.3.5 Influence of in vivo maturation time upon 
fertilisation
In study 2, the highest incidence of fertilisation was 
again observed in oocytes removed from the ovary after an 
extended (39 hour) hCG/OR delay (Table 3.3.7). Normal 
fertilisation occurs by penetration of the oocyte by a 
single spermatozoon. Subsequent penetration is prevented
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by modification of the zona pellucida by release of 
cortical granule contents into the perivitelline space. 
Cortical granules are produced in the prematurational 
period by the Golgi complex and migrate to the cortex 
during maturation (Sathananthan & Trounson, 1982b; Bomsel- 
Helmreich et ai., 1987). Close association of cortical 
granules with the vitelline membrane is considered 
essential for cortical granule release and the zona 
reaction (Longo, 1973).
The high incidence of polyspermy observed in the short/0 
group was significantly reduced (p<0.05) by either in 
vitro preincubation and/or extension of the in vivo 
maturation, suggesting that migration of cortical granules 
and development of the block to polyspermy are phenomena 
dependent on the time from initiation of the luteinising 
stimulus.
4.3.6 Animal models
The outcome of oocytes inseminated after premature removal 
from the follicular environment has been investigated in 
two animal species. Oocytes were removed from preovulatory 
follicles of sheep at various intervals from hCG 
administration and transferred to the oviducts of 
simultaneously inseminated recipients (Trounson êi a l .. 
1982a). Embryos were recovered seven days after 
transplantation and classified as single-cell, abnormal or 
fully differentiated blastocysts. The number of 
unfertilised oocytes decreased as duration of in vivo 
maturation increased and an initially high incidence of 
abnormality decreased with time, the lowest frequency 
being from ovulated oocytes. Normal embryos were found in 
significant numbers after a 12h follicular maturation and 
comprised 97% of those originating from ovulated oocytes.
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Badenas gt al. (1989) investigated the effects of 
immaturity (immediate insemination of oocytes removed from 
ovaries 2-3 and 3-4h before ovulation and overmaturity 
(3,6 and 12h in vitro preincubation) on fertilisation 
rate, polyploidy, polyspermy and digyny in the mouse. The 
control group comprised oocytes obtained from the oviducts 
immediately after ovulation. Fertilisation rates were 
lowest in immature oocytes. Only 16.6% of those harvested
3-4h before ovulation fertilised, despite 81% having 
attained nuclear maturity. Cytoplasmic immaturity was 
suggested by arrest at the pronuclear stage (16.7%) and 
failure of male pronucleus development (45.5%). 
Fertilisation was improved in oocytes obtained 2-3 before 
ovulation (65.6%) but was still significantly lower than 
controls (78.2%).
In vitro maturation of ovulated oocytes for 3 hours 
increased fertilisation but the effect decreased after 6 h 
and significantly fewer oocytes fertilised after 12h 
preincubation. Increased cumulus expansion has been 
implicated in the short term improvement by in vitro 
maturation (Yanagimachi, 1981) and zona hardening (Inoue & 
Wolf, 1974) in the subsequent reduction in sperm 
permeability. No such effects of overmaturity were 
observed in the present study, but the intervals may not 
be comparable.
Chromosome analysis revealed an increased incidence of 
polyploidy in embryos derived from immature oocytes and 
the 3 and 6h overmature groups. This was related to 
polyspermy in all groups and to fertilisation of diploid 
eggs, mainly caused by endoreduplication, in the immature 
group. This anomaly, a duplication of the haploid 
chromosome complement without cytokinesis, would be 
visualised as 2PN after fertilisation and is not therefore 
implicated in the high incidence of 3PN in the short/0 
group of study 2.
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4.3.7 Cytoplasmic maturation during the periovulatory 
period
A final maturational stage in pre-ovulatory oocytes 
matured in vitro has been reported (Sundstrom & Nilsson, 
1987). In oocytes with a first polar body extruded, the 
distribution of mitochondria and the appearance of 
endoplasmic reticulum (ER) was influenced by the duration 
of hCG and in vitro culture time. Aggregates of ER 
surrounded by mitochondria appeared after 3-5h in vitro 
culture and were found in an oocyte recovered at mid-cycle 
in a natural cycle. It was suggested that asynchrony 
between nuclear and cytoplasmic maturity was corrected by 
preincubation and that this maturation was responsible for 
the increase in the proportion of normal embryos described 
by Trounson ei al. (1982b).
4.3.8 Timing of in vitro fertilisation
In the 2 short groups (short/0 and short/5), 30 ( 12.9%) 
of the 232 fertilised oocytes did not have PN visualised 
between 15 and 21 hours after insemination. The incidence 
was significantly less (3.9%, p< 0.001) in the groups with 
39 hours in vivo maturation. Failure to observe multiple 
PN will allow genetically abnormal embryos, which may be 
morphologically indistinguishable after cleavage, to be 
transferred. Embryos which develop after late 
fertilisation, either spontaneously (Oehninger et al.. 
1989; Trounson & Webb, 1984) or following reinsemination, 
(Oehninger êi a l ., 1989, Trounson & Webb, 1984; Ben-Rafael 
et a l .. 1986b; Pampiglione ei â l . , 1990) are associated 
with reduced implantation rates. This may be related to 
the observed increase in the incidence of polyspermy, 
chromosome anomalies and mosaicism (Ben-Rafael et a l .. 
1986b; Plachot et ai., 1988a).
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Several factors may be implicated in the apparent delay in 
fertilisation. Post lutéinisation changes include 
modification of the zona pellucida which decreases its 
resistance to sperm penetration (Tesarik et âJL* / 1988) and 
development of factors which support pronucleus formation 
(Lopata & Leung, 1988). Complete failure of male PN 
formation can be visualised as prematurely condensed 
chromosomes (Schmiady Qt al,, 1986). The inverse 
association of this phenomenon with elapsed time from hCG 
has been demonstrated experimentally in the mouse 
(Calafell et ad., 1991). Lopata and Leung (1988) have 
shown that resumption of meiosis and extrusion of the 
second polar body occurs rapidly in spontaneous cycle 
oocytes which have been matured in vitro for 30 hours, but 
more slowly after a 24 hour incubation despite apparent 
nuclear maturity. Mouse oocytes recovered either 13 or 17 
hours after hCG administration exhibited a similar pattern 
of oocyte response to fertilisation and showed an 
increased rate of PN development in the older oocytes 
(Fraser, 1979).
4.3.9 Conclusions
Embryo quality, as assessed by gross morphology, was 
unaffected by the hCG/OR interval or by immediate or post­
incubation insemination. Previous investigation has 
reported that fragmentation and abnormal cleavage were 
common sequelae of the attempted fertilisation of immature 
bovine oocytes and those matured in. vitro (Trounson ei 
a l ., 1977). Incubation in vitro of oocytes matured in vivo 
for 39 hours had no observed influence on normal 
fertilisation, embryo development or implantation compared 
with 39 hour oocytes inseminated immediately.
Laboratory management can be simplified to allow 
insemination at a time suitable for PN checking the 
following day. Insemination at the time of OR would reduce
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the number of manipulations required, minimising exposure 
to the potentially harmful effects of temperature change, 
light (Fischer Qt a l ., 1988) and pH fluctuations when 
incubators are opened.
In conclusion, extension of the in vivo maturation time of 
human oocytes increased fertilisation rates and obviated 
the requirement for preinsemination incubation, allowing 
simplification of laboratory procedures.
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4.4 The relationship between follicle size and cumulus 
expansion and their relative importance as indicators of 
oocyte maturity
4.4.1 Predictive value of follicle size and cumulus 
expansion for fertilisation and normal embryo development
The capacity of oocytes for fertilisation and cleavage was 
related to both follicle size and the degree of associated 
cumulus cell expansion. This study confirmed the 
relationship between the two parameters previously 
determined using both FF volume (Simonetti êi â i . / 1985) 
and direct measurement by u/s at OR (Scott et aJL., 1989).
When the outcome of each viable oocyte was assessed in 
relation to both criteria, follicle size was a more 
reliable indicator of the probability of
fertilisation/cleavage. Embryo quality was correlated with 
FF volume alone (Fig 11).
4.4.2 Limitations of assessment methods
Accurate estimates of follicle size are best obtained by 
u/s measurement at the time of aspiration but this method 
cannot be utilised at laparoscopy and is not suitable for 
routine use during u/s recoveries due to time restraints. 
Follicle fluid volume has been reported to correlate well 
with u/s measurements (O'Herlihy ejt ^ . , 1980). Although 
measurement does not present the same logistic problems, 
apparent FF volume can be affected by leakage at the site 
of aspiration, accidental puncture of adjacent cysts and 
variation in fluid content of the dead space in collection 
needles and tubing.
In spontaneous cycles the degree of cumulus mucification 
and corona dispersal has been found to correlate well with 
the stage of meiotic maturation (Testart et al., 1983a)
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but this relationship may be disrupted by ovarian 
stimulation regimes. The degree of cumulus mucification 
quantified by time required for enzymatic digestion showed 
no correlation with nuclear maturity of enclosed oocytes 
following hMG therapy (Laufer et al., 1984). Use of 
cumulus expansion as an assessment criterion may be 
further compromised by the optical limitations of 
dissecting microscopes. Stereoscopic observation was 
unable to differentiate between cell densities of 210 and 
40 c e l l s / m m ^  corresponding to the limits of cumulus 
expansion observed during the 18 hours preceding ovulation 
(Bomsel-Helmreich et aJ^., 1987).
4.4.3 The relationship between follicle growth and oocyte 
maturation
Follicle size has been implicated in many aspects of 
oocyte and follicle function. A cytological examination of 
in vivo matured oocyte/cumulus complexes at various 
intervals after hCG suggested that nuclear synchrony could 
be assumed in follicles of >16mm, regardless of the degree 
of cumulus dissociation (Bomsel-Helmreich ei â i * / 1987).
In comparison, oocytes from 16mm follicles showed delayed 
resumption of meiosis and those from 8 - 15.5mm did not 
complete GVBD. Secretion of PAF, shown to be related to 
implantation potential, was found to be higher in embryos 
originating from 4 - 6ml follicles than from either larger 
or smaller (O'Neill et ^ . , 1987). Spontaneous 
lutéinisation of cultured granulosa cells, shown by 
secretion of P, is likewise dependent on follicle size 
(Suzuki et a l ., 1981).
The pregnancy potential of embryos related to their 
follicle of origin was investigated in a programme using 
CC/hMG ovarian stimulation (Nayudu ei al.., 1987). Volumes 
between 2.5 and 6.5ml were associated with normal 
pregnancy and followed six days of sustained E 2 rises.
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Embryos derived from larger follicles led to either 
abnormal pregnancy (biochemical, blighted ovum, early 
abortion) or no conception. Those from small volumes did 
not cleave or if replaced, did not implant. These results 
differ from those reported by Simonetti et al.. (1985) who 
used hMG stimulation and found that pregnancies could be 
obtained from preovulatory oocytes derived from very small 
follicles. However, the subsequent abortion rate (10/21; 
47.6%) in the small size group was high while all 
conceptions derived from large (>2ml) follicles (n=16) 
continued to term. The report concluded that embryo 
quality was compromised despite apparent oocyte maturity.
It thus appears that the capacity to respond to the 
lutéinisation stimulus by meiotic maturation is acquired 
earlier than full cytoplasmic and follicular maturity and 
that small follicles are immature in some respects despite 
their ability to yield oocytes which have reached 
metaphase of the second meiotic division. Oocytes from 
follicles in the mature size range should, therefore, be 
the primary choice for replacement during GIFT treatment.
4.4.4 Implications for timing of hCG administration
These results have implications for the criteria used to 
time administration of hCG prior to OR and choice of 
follicles for aspiration. Trounson et âl. / (1982b)
reported that if hCG was given before follicles reached 
17mm diameter, oocytes did not have typical preovulatory 
appearance and rarely fertilised. An IVF programme 
utilising CC stimulation found that the probability of a 
patient having embryos available for ET was related to the 
number of follicles >20mm in diameter (Quigley &t a l ..
1982) and suggested that follicles <20mm should not be 
aspirated; preferring to retain the enclosed granulosa 
cells to support luteal function. Results from this study 
would not support such extreme action but suggest that the
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size of follicles should be considered if aspiration 
involves any surgical risk such as proximity of vascular 
structures or bowel.
Conservative criteria for proceeding with OR may be 
related to the possibility of complications due to 
endogenous LH rises. The use of GnRH-a has eliminated this 
difficulty and improvement in fertilisation and pregnancy 
rates resulted when administration of hCG was delayed for 
at least 24h after attainment of standard criteria to 
avoid weekend ORs (Conaghan et ad., 1989). Follicle size 
at the time of hCG was not reported but it can be assumed 
that an average increase of 2-4mm in follicle diameter 
would result from this delay (Bomsel-Helmreich, 1985). No 
patient in the delayed group suffered from severe ovarian 
hyperstimulation syndrome suggesting that a change in u/s 
criteria for hCG administration could be considered.
4.4.5 Conclusions
In conclusion, both the size of the follicle of origin and 
expansion of the associated cumulus were indicators of the 
ability of an oocyte to fertilise and cleave. Combined 
data suggested that FF volume should be the primary 
selection criterion for oocyte selection for GIFT .
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SECTION 2 
THE CYTOGENETICS OF EARLY 
HUMAN DEVELOPMENT
CHAPTER 5 
INTRODUCTION
121
5.1 Cytogenetics
5.5.1 The human chromosome complement
The normal human diploid chromosome number is 46; 
comprising 22 homologous pairs of autosomes and two sex 
chromosomes. This number was determined in 1956 (Tjio & 
Levan, 1956) following some years of controversy. Twenty- 
three meiotic bivalents were counted in a primary 
spermatocyte (Ford & Hamerton, 1956) the same year. A 
nomenclature system based on relative chromosome size and 
centromere position (Denver Study Group, 1960) was agreed 
in 1960.
Group A (1-3) have approximately median centromeres and 
can frequently be distinguished from each other on the 
basis of size and centromere position.
Group B (4 and 5) have distal centromeres and are 
generally indistinguishable.
Group C (6-12) is the largest group and consists of medium 
sized chromosomes with sub-median centromeres. The X 
chromosome is similar to the largest components of this 
group.
Group D (13-15) contains three chromosomes with almost 
terminal centromeres (acrocentric). Variable (polymorphic) 
satellites representing a region of reduced coiling at the 
site of a nucleolus organiser region (NOR) may be present 
on the short arm.
Group E (16-18) have median or submedian centromeres and 
can be distinguished from each other.
Group F (19 and 20) consists of two small metacentric 
chromosomes.
Group G (21 and 22) contains the two smallest chromosomes 
which are acrocentric and polymorphic. The Y chromosome is 
similar.
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5.1.2 Chromosome identification
Individual homologues can be differentiated by staining 
techniques reliant on variation in DNA and protein 
composition of chromosomes. Distinctive banding patterns 
on each chromosome were first visualised after staining 
with quinacrine mustard (Caspersson et a l ., 1970) which 
shows enhanced fluorescence in AT-rich DNA (Comings,
1978). This affinity also highlights the polymorphic short 
arms of the acrocentric D and G group chromosomes. The 
most widely used technique in clinical laboratories is G- 
banding which involves partial chromosome digestion with 
the proteolytic enzyme trypsin. The mechanism is poorly 
understood (Comings, 1978). C-banding stains 
heterochromatin at the centromere region and on the long 
arm of Y (Sumner, 1972) and is used to visualise the 
polymorphic regions of chromosomes 1, 9, 16 and Y.
Polymorphisms on 10/22 human autosomes can be readily 
detected using standard cytogenetic methods (Hassold,
1985). These techniques identify variation in inherited 
heterochromatic chromosome regions which, because of their 
proximity to the centromere are rarely involved in 
crossing-over (Mikkelsen et al., 1980). Visually assessed 
staining techniques are subject to limitations; scoring is 
somewhat subjective and is affected by technical factors. 
Use of restriction fragment length polymorphisms (RFLPs) 
and the Xg blood are more objective but, because many 
identify sites affected by genetic exchange, are only 
useful for identification of the parental origin, not the 
meiotic division.
Cells spend a relatively small proportion of their cycle 
in mitosis, when contracted chromosomes can be visualised 
(Zetterberg, 1970), and cytogenetic techniques frequently 
utilise mechanisms for maximising the proportion of cells 
in metaphase. Colchicine was the first mitotic arrestant
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found and, with its synthetic derivative Colcemid, remains 
the most frequently used. The alkaloid, derived from 
Colchicum species, prevents tubulin polymerisation into 
microtubules without interference in cell growth. Cells 
entering mitosis are blocked at metaphase but chromosome 
condensation continues (Hsu & Satya-Prakash, 1985) .
5.1.3 Terminology
Aneuploidy is a condition in which an organism (or cell) 
possesses fewer (hypo) or more (hyper) chromosomes than an 
exact multiple of the haploid number.
Nondisjunction is the term commonly used to describe any 
defect giving rise to aneuploidy. Used more specifically 
(Bridges, 1913), it refers to the failure of chromosomes 
to disjoin during division. Both homologues pass to one 
pole and hypoploid and hyperploid products result. Figure 
13 illustrates non-disjunction at metaphase I; the 
bivalent passes to one cell during anaphase I and, after 
normal separation of chromosomes at the second division, 
two nullosomic and two disomic gametes are formed. 
Centromeric polymorphisms are heterozygous. This feature 
differentiates the phenomenon from non-disjunction at the 
second division (Figure 14) which results in homozygous 
polymorphisms in disomic daughter cells.
Nonconjunction (Sturtevant & Beadle, 1940) is lack of 
homologue pairing, whether due to initial failure of the 
process (asynapsis) or it's subsequent breakdown 
(desynapsis).
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Diagrammatic representation of primary non-disjunction
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Diagrammatic representation of secondary non-disjunction
5.2 Human fecundity
5.2.1 Definition and estimate of fecundity
Demographic studies of populations ranging from 18th 
century rural French villagers to modern day British women 
ceasing non-hormonal contraception have shown remarkably 
similar estimates of fertility (Short, 1979) .
Fecundability, defined as the probability of full term 
pregnancy per menstrual cycle during which intercourse 
took place, ranged from 21 to 28% between the ages of 2 0  
and 30 with a suggestion of maximal rates at age 25; an 
incidence considerably lower than domestic mammals (Hanly, 
1961).
5.2.2 Foetal mortality
Evidence that low fecundity is related to early foetal 
mortality has accumulated from several sources. A 
statistical model devised by Roberts and Lowe (1975) 
postulated that 2,437 million married women in England and 
Wales participated in 63,362 million acts of unprotected 
coitus of which 1/14 (2,263 million) would be within 48h 
of ovulation. They assumed a 50% fertilisation rate and 
concluded that 505,000 recorded deliveries represented 
only 2 2 % of zygotes, the majority being lost before any 
delay in menstruation.
Evidence from investigations using B-hCG assessments, in 
normal women attempting to conceive, initially suggested 
postconceptual pregnancy losses of 62% (Edmonds ^  a l .. 
1982) and 43% (Miller et a l ., 1980). Walker et a d . (1988)
criticised these studies on the basis of assay 
crossreaction with LH in cycles where ovulation was 
predicted from menstrual dates alone. Their own 
investigation used a specific but insensitive B-hCG assay 
and failed to find any evidence of 'biochemical' pregnancy 
in 75 cycles, which included 25 clinical pregnancies.
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Investigation of 707 cycles with an equally specific, but 
more sensitive, assay detected biochemical evidence of 
pregnancy in 198 patients. One hundred and fifty-five were 
clinically confirmed, suggesting 2 2 % subclinical pregnancy 
loss (Wilcox et ad., 1988). Confirmation that early 
studies may have overestimated the phenomenon comes from 
the reported 15% incidence of transitory B-hCG rises after 
IVF-ET (Edwards, 1986).
Hertig et (1959) painstakingly examined the
reproductive tracts of 107 women of known fertility 
undergoing therapeutic hysterectomy. The group comprised 
patients with demonstrated ovulation, coital dates within 
24 hours of ovulation and absence of ovarian, tubal or 
uterine pathology. The success of ova recovery was related 
to the expected site, based on menstrual dates and 
endometrial morphology, at the time of hysterectomy. 
Recovery was poorest (1/9) when specimens were expected to 
be in the "relatively voluminous" fallopian tube. Uterine 
flushing was efficient for recovery of pre-implantation 
morulae and blastulae (7/15) but early implantation was 
difficult to observe (2/30). The authors considered that 
embryonic stages after day 12 (>day 25 of the menstrual 
cycle) "gave us the best opportunity to deduce the 
fertility rate in patients who are known to be fertile". 
Five of 18 implanted embryos observed at this stage were 
morphologically abnormal. All 34 recovered 'ova' had 
undergone cleavage and it was assumed that unfertilised 
oocytes had degenerated, although the actual number could 
not be deduced. Overall, 10/34 embryos were considered 
abnormal and the relative proportions of normal and 
abnormal conceptuses in pre (4:4) and post (20:6) 
implantation stages lead to the conclusion that "some bad 
eggs are worse than others" and that the degree of 
abnormality was reflected in implantation rates.
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Limited information on the earliest stages of in vivo 
development was provided by 53 cycles of uterine lavage of 
women donating embryos for transfer to infertile 
recipients (Buster et a l ., 1985). Artificial insemination 
was consistently performed on day 0 or + 1 relative to the 
LH peak followed by lavage, initially attempted on day 
five, when 24 of 25 recovered ova were identified. 
Recovered ova suggested a trimodal distribution with peaks 
at one cell (4/25), 8-15 cells (7/25) and blastocyst 
(5/25). All intrauterine pregnancies (n=3) resulted from 
blastocyst transfer. This source of information ceased 
because of the problem of retained pregnancy in donors 
(Sauer et al., 1989) .
5.2.3 Involvement of chromosome abnormality in pregnancy 
loss
Two reports, in 1961, of triploid cell lines derived from 
abortus material (Delhanty et a l ., 1961; Penrose & 
Delhanty, 1961) were the stimuli for systematic 
cytogenetic investigation of spontaneous and induced 
abortions. A review of initial studies revealed 
inadvertent selection of both patients and culture tissue 
(Carr, 1971) but implicated karyotypic anomaly as a 
causative factor in pregnancy loss.
The incidence of spontaneous pregnancy loss after delayed 
menses has been estimated at 15% on the basis on personal 
interviews (Warburton & Fraser, 1964) and life table 
analysis (Harlap et al.., 1980), with highest losses during 
the first trimester. Comparison of published studies with 
the distribution pattern of reported miscarriage has shown 
a not unexpected deficiency of karyotyped samples from the 
first weeks of pregnancy (Burgoyne et al., 1991), 
attributable to the occurrence of abortions at home and 
difficulty in obtaining suitable tissue for culture from 
the earliest developmental stages (Kajii et a l ., 1980).
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However, it is clear that approximately 50% of abortions 
occurring between eight and eleven weeks are associated 
with a major chromosome abnormality, regardless of 
geographical location (Kajii et a l ., 1980; Hassold et a l .. 
1980; Creasy et a l ., 1976; Warburton et a l ., 1980a). Given 
the limitations of these studies, perhaps the most 
reliable data on the incidence of numerical abnormalities 
in clinical pregnancies has come from surveys of early 
induced abortions (Burgoyne et ai., 1991; Yamamoto & 
Watanabe, 1979; Zhou et a l ., 1989). These studies found 
similar rates of abnormality (4.6%, 6.1%, 5.1% at 7-8 
weeks gestation) but represented an abnormal maternal age 
distribution. Burgoyne et al. (1991) corrected the pooled 
data for the general population and obtained a figure of 
4.7% for a gestation equivalent to five weeks of foetal 
development; an incidence considerably higher than any 
other mammalian species investigated (Chandley, 1981) .
Expulsion of chromosomally abnormal conceptions continues 
throughout pregnancy but they comprise a lower proportion 
of later abortions (Creasy a l ., 1976; Warburton êi a l .. 
1980a) and are detected in only 5% of stillbirths (Angell 
et a l ., 1984). Natural processes are therefore responsible 
for reduction of the heavy genetic load apparent in early 
conceptions to 0.6% of newborns (Evans, 1977).
5.2.4 Types and origin of chromosome abnormalities 
detected in spontaneous abortion
Table 5.2.1 summarises the types and proportions of 
chromosome defects diagnosed in five surveys of unselected 
spontaneous abortions (Boue et al., 1975; Creasy et a l .. 
1976; Kajii et. al., 1980; Hassold et â i ., 1980; Warburton 
et al., 1980a). There was considerable agreement between 
studies and with the smaller numbers from induced abortion 
series. (Yamamoto & Watanabe, 1979).
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5.2.5 Autosomal aneuploidy
The presence of an additional autosome was responsible for 
50% of all abnormal karyotypes (Table 5.2.1). Composite 
data from studies which utilised banding techniques to 
differentiate individual chromosomes (Table 5.2.2) showed 
that all autosomes, with the exception of number 1 , were 
represented in trisomies (Boue et â l ./ 1985). The 
frequency of abnormality showed considerable variation 
among chromosomes.
Table 5.2.1
Types of chromosome abnormalities detected in 2196 
spontaneous abortions and their relative frequency; from 
Boue et al., 1985
Abnormality Number
detected
(n)
Proportion 
of total 
(%)
Numerical abnormalities
Autosomal trisomy 1105 50.3
Autosomal monosomy 2 0 . 1
45,X 410 18.7
Triploidy 361 16.4
Tetraploidy 123 5.6
Mosaicism 48 2 . 2
Structural abnormalities 85 3.9
Other 62 2 . 8
Almost one third of cases involved number 16, a sub- 
metacentric member of the E group with a large 
heterochromatic region at the centromere. Acrocentric D 
and G group chromosomes collectively comprised more that 
37% of karyotypes but individually did not approach the
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frequency of trisomy 16. Trisomies 3, 5, 6, 11, 12 and 17 
occurred rarely.
Table 5.2.2
Autosomal trisomies found in spontaneous abortions and 
their relative frequency; from Boue et al., 1985
Trisomy Number Percent Trisomy Number Percent
1 0 0 12 9 1 . 0
2 53 5.1 13 63 6 . 1
3 8 1 . 0 14 51 5.0
4 26 2.5 15 75 7.2
5 1 1 . 0 16 326 31.4
6 3 1 . 0 17 7 1 . 0
7 46 4.4 18 51 4.9
8 37 3.6 19 1 1 . 0
9 33 3.2 20 28 2.7
10 22 2 . 1 21 89 8 . 6
11 2 1 . 0 22 107 10.3
The recognised association between maternal age and Down's 
Syndrome (Penrose, 1934) in livebirths has also been found 
for trisomies 13 and 18 detected at amniocentesis 
(Ferguson-Smith, 1983). Aneuploid abortions show a similar 
overall relationship (Kajii et ad., 1980; Hassold et a l .. 
1980) but individual chromosomes, again, are variable. 
Maternal ages were highest for trisomies involving the 
smallest chromosomes (13-22) with the exception of number 
16 which, with groups A, B and C was only moderately 
associated with increasing maternal age (Hassold ei ad.,
1984). Suggestions of a paternal age effect for trisomy 21 
(Stene et ad., 1977) were not confirmed by a larger series 
of cases detected at amniocentesis (Ferguson-Smith, 1983).
The polymorphic nature of the most common trisomie 
chromosomes has allowed investigation of the parental 
origin of the additional material in both livebirths and 
abortions. Seventy-six percent of 110 families with a
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Down's syndrome child were informative using fluorescence 
heteromorphisms (Mikkelsen et âi.., 1980). The majority 
(80.5%) of errors occurred in the ovary with 60.9% of 
informative cases attributable to a defect of maternal 
meiosis 1 although DNA polymorphisms have suggested that 
this may be an underestimate (Antonarakis & Down Syndrome 
Collaborative Group, 1991). A similar distribution of 
parental origin has been detected in the larger variety of 
abnormalities found in abortus material (Hassold & Jacobs,
1984). Maternal first division errors were predominantly 
responsible for the small numbers of trisomies 3,4,9,14 
and 15 which were informative. Nine of 17 trisomies 21 and 
21/28 trisomies 22 were similarly assigned. It is of 
interest that the same error was responsible for 25/34 
supernumerary 16s (Hassold & Jacobs, 1984), despite a 
limited association with maternal age.
Theoretically, non-disjunction gives rise to equal numbers 
of trisomie and monosomie gametes but autosomal monosomy 
occurs very rarely in human clinical pregnancies (Table
5.2.1). Only deficiency of chromosome 21 has been 
consistently noted (Ohama & Kajii, 1972) .
A mouse model for production of trisomie and monosomie 
embryos by matings involving carriers of Robertsonian 
translocations has been developed to investigate the 
viability of aneuploid offspring. Initial studies 
demonstrated trisomies but no monosomies after 12-13 days 
of gestation (Epstein ^  a l ./ 1977) and prompted 
investigation of preimplantation stages (Epstein & Travis, 
1979) . Equal numbers of trisomie and monosomie embryos 
were found in three day late morulae and early blastocysts 
but 24 hours later monosomy for chromosome 19, the 
smallest in the complement, had virtually disappeared. The 
phenomenon did not appear to involve expression of a 
lethal recessive allele. Differential survival of 
trisomies has also been demonstrated with only trisomy 19
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compatible with viability beyond term (Gropp et al.,
1974). A similar mechanism is probable in man since both 
the number and range of aberrations reduce during 
gestation and those detected in late abortions and 
perinatal deaths are, mainly, compatible with birth 
(Angell et a l ., 1984). A strong correlation between 
individual anomalies and developmental age, regardless of 
gestational age at expulsion, would also support this 
hypothesis (Boue et , 1985).
5.2.6 Sex chromosome monosomy (45,X)
The most common abnormal karyotype detected in human 
abortions is 45,X; monosomy X (Table 5.2.1). Losses in 
early pregnancy occur at a developmental age of 6 weeks, 
frequently with embryonic maceration (Boue Qt ad., 1985). 
Later abortions can be identified by oedema, cystic 
hygroma and horseshoe kidneys (Singh & Carr, 1966) and the 
phenotype of those who survive to term constitutes 
Turner's Syndrome (Turner, 1938).
In contrast to autosomal anomalies, the incidence shows an 
inverse relationship with maternal age (Warburton ei a l .. 
1980b; Kajii & Ohama, 1979) and maternal meiotic non­
disjunction is not implicated. Restriction length fragment 
polymorphisms of the X chromosome have indicated the 
absence of a male sex chromosome in 6/10 45,X spontaneous 
abortions (Hassold et a l ., 1985); an incidence not 
inconsistent with 77% identified by Xg blood grouping in 
women with Turner's syndrome (Sanger ei al,., 1977). This 
incidence is incompatible with the demonstrated frequency 
of sex chromosome nullisomy in sperm (Martin & Rademaker, 
1990) and the observed relationship between expected 
reciprocal karyotypes (XXX and XXY) and maternal age 
(Kajii & Ohama, 1979). A similar phenomenon in the mouse 
can largely be attributed to loss of the paternal
132
chromosome after fertilisation (Russell & Montgomery,
1974) .
5.2.7 Triploidy
Using the above data for the incidences of miscarriage, 
chromosomally abnormal abortuses and types of abnormality 
(Table 5.2.1), it can be deduced that approximately 1% of 
recognised pregnancies are triploid; an incidence 
corroborated by data from induced abortions (9/1250, 0.7%; 
Yamamoto & Watanabe, 1979). Analyses using chromosome 
polymorphisms (Jacobs et a l ., 1978; Uchida & Freeman,
1985) and HLA typing (Couillin et ad., 1987) indicate that 
the majority (69%) of triploids arise from diandry: an 
additional haploid set of paternal chromosomes. Thirty- 
eight percent could be attributed to dispermy; 
fertilisation of a haploid oocyte by two sperm, and this 
origin could not be excluded in cases attributed to a male 
meiotic error. The apparent rarity of diploid sperm would 
support this interpretation (Brandriff et al., 1984 &
1985; Martin et al., 1983).
A strong correlation between the origin of the additional 
haploid set and phenotype has been demonstrated (Jacobs et 
a l .. 1982). Partial moles, with hydatidiform changes in 
the placenta, are associated with paternally derived 
triploids and probably represent a weaker version of 
complete hydatidiform moles, which are paternally derived 
parthenogones (Kajii & Ohama, 1977). They are not, 
however, associated with trophoblast disease (Szulman & 
Surti, 1978). The expected ratio of XXX:XXY:XYY sex 
chromosome complements in triploids of dispermic origin is 
1:2:1. The ratios of XXX to XXY (Jacobs et al., 1982) 
generally fit this hypothesis but XYY complements are 
under-represented (Kajii & Niikawa, 1977). The observation 
is generally explained by non-implantation or early 
expulsion of XYY triploids but poor growth in culture
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prior to chromosome analysis may artificially affect data 
(Boue et a l ., 1985).
The anomaly rarely continues to term and no correlation 
with maternal age has been detected (Boue et a l . , 1975; 
Creasy et al., 1976; Kajii et al., 1980).
5.2.8 Tetraploidy
The sex chromosome constitutions of all analysed 
tetraploids have all been XXXX or XXYY, suggesting 
replication of a normal diploid complement without 
cytokinesis at an early stage of development (Kajii & 
Niikawa, 1977). Superimposed aneuploidy has also been 
duplicated in a 94,XXXX,+16,+16 abortus (Boue et a l ..
1985). Embryonic development is rarely observed (Boue et 
al., 1985) and development to term is uncommon (Golbus et 
al., 1976; Pitt et al., 1981). An observation of three 
paternal contributions was made in a complete mole 
investigated by Sheppard êt al. (1982).
5.2.9 Mosaicism
The mean figure of 2.2% mosaicism given in Table 5.2.1 
disguises considerable variation among studies (1 .6 - 8 .7%), 
probably reflecting differences in methodology such as 
tissue used for culture, number of cells and tissues 
analysed, length of culture and number of passages. The 
occurrence of 'true' mosaicism in amniotic cell cultures 
is similarly variable (Ferguson-Smith, 1983) but in some 
cases, abnormal lines are confined to extra-embryonic 
tissues and normal healthy infants have been born 
(Ferguson-Smith & Ferguson-Smith, 1983) . This finding has 
been confirmed at earlier gestations investigated by 
chorionic villus sampling (Goldberg & Golbus, 1988) . 
Mosaicism in abortuses rarely involves acrocentric
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chromosomes (Stene & Warburton, 1981) and meiotically 
derived trisomy with subsequent loss of one homologue may 
be the origin of the normal cell line (Hassold, 1982).
5.2.10 Structural abnormalities
Surveys of liveborn children have shown a mean rate of
0.05% for unbalanced structural abnormalities and 0.19% 
for apparently balanced rearrangements (Evans, 1977) . 
Warburton et al. (1980a) concluded that 85% of unbalanced 
karyotypes with implicit partial trisomy and/or monosomy 
were aborted. Both miscarriage and livebirth data show 
approximately equal numbers of Robertsonian and reciprocal 
translocations and a similar ratio of inherited and de 
novo anomalies. An excess of apparently balanced de novo 
translocations in surveys of individuals in mental 
institutions (Funderburk et al., 1977) was thought to 
reflect undetected deletions or duplications. No such 
surplus was detected in spontaneously aborted pregnancies 
(Warburton et a l ., 1980a).
5.2.11 Chromosome anomalies at conception
Estimates of the incidence of chromosome abnormality at 
conception have been based on extrapolation of data from 
spontaneous abortion and have assumed that abnormalities 
arise with equal frequency in each chromosome. Boue ^  
a l .. (1975) postulated that the most frequent anomalies
detected (trisomy 16 and 45,X) represented the true 
incidence for all chromosomes and that other anomalies 
perished before establishment of a clinical pregnancy.
This gave an estimate of 50% abnormality at conception. 
Burgoyne ^  a l ., (1991) used another approach; using a
calculation based on the proportion of anomalies 
attributable to male meiotic abnormality and their 
observed incidence in sperm, he suggested that 2 0 % of 
embryos would be aneuploid. This figure is in good
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agreement with the small numbers of observations from IVF 
embryos (Angell et al., 1986a).
136
5.3 Aims
The aims of the work presented in section two of this
thesis were:
1. To determine the nuclear condition of oocytes remaining 
uncleaved after insemination in vitro and relate 
cytogenetic findings to aspects of IVF methodology.
2. To determine the incidence of chromosome abnormalities 
in human oocytes and investigate the origin of 
anomalies.
3. To investigate maternal factors affecting the 
occurrence of chromosome abnormalities and determine 
whether selection against fertilisation of abnormal 
gametes operates.
4. To investigate the incidence and types of chromosome 
abnormality in early cleavage stages of human embryos 
and correlate cytogenetic and morphological assessments 
of embryos.
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CHAPTER 6  
MATERIALS AND METHODS
1 3 8
6.1 Cytogenetic techniques
6.1.1 Microscope slides
Glass slides (pre-washed; Berliner Glas KG) were soaked in 
2% Decon 90 (Decon Laboratories Ltd) overnight, washed 
(minimum one hour) under running tap water and soaked 
overnight (x2) in distilled water. Slides were dried in a 
hot air oven (45°C) and stored in sealed containers until 
required.
6.1.2 Oocyte and embryo fixation 
Solutions
Colchicine (Sigma) stock solution; 80 ug/ml in Hanks 
Balanced Salt Solution (Gibco BRL); stored frozen. 
Colchicine working solution (0.4 ug/ml) was prepared daily 
in culture medium supplemented with 1 % patient's serum
(2.4.3).
Hypotonic solution; 1% sodium citrate in distilled H 2O; 
freshly prepared.
Fixative 1: 100% methanol.
Fixative 2: 5:1; methanol : acetic acid; freshly prepared.
Fixative 3: 3:1; methanol : acetic acid; freshly prepared.
Leishman's stock solution was prepared by dissolving 1.5 g
of Leishman’s stain (BDH Chemicals Ltd) in 1 1 methanol 
and was filtered before storage.
Leishman's stain was prepared daily from stock solution in 
Gurrs buffer; pH 6 . 8 (BDH). Dilutions are given in the 
text.
Methods
Oocytes for cytogenetic analysis were re-examined for PB 
and PN before fixation and were processed individually. 
After an initial 15 minute incubation in hypotonic 
solution at room temperature, each oocyte was transferred 
in a minimal droplet of solution to a microscope slide.
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Three to five drops of each fixative (1, 2 and 3) were 
sequentially dropped onto the cell from a height of 1 - 2 cm 
under microscope observation (microscope as for 2.4.7). 
Premature collapse or movement of the oocyte was recorded 
and the final position of the cell noted. Slides were air 
dried, stained in 25% Leishman's stain, rinsed in tap 
water and air dried.
Embryos were reassessed before transfer to individual 
culture tubes containing colchicine solution; an overnight 
incubation (mean 19.3 hours) was generally used. Fixation 
and staining methodology was identical to that described 
for oocytes.
6.1.3 C-banding 
Solutions
HCl: 50% (in distilled H 2O ) ; used immediately.
BaOH: a saturated solution was prepared by dissolving 0.5g 
in 50 ml distilled H 2O using a magnetic stirrer. The 
solution was filtered and used immediately.
2 X saline sodium citrate (2 x SSC): 17.5 g NaCl + 8 . 8  g 
sodium citrate, 2 hydrate in 1 1 distilled H 2O; adjusted 
to pH 7.0 using IM NaOH.
Method
After initial analysis slides for C-banding were de­
stained in methanol and air dried. Slides were treated for 
30 minutes in 50% HCl, rinsed in distilled water and 
transferred to BaOH at 60°C. An initial exposure of 45 
seconds was used on test slides and time in BaOH was 
adjusted as required. A further incubation in 2xSSC at 
60®C for 90 minutes was performed, slides were rinsed, air 
dried and stained in 10% Leishman's stain.
140
6.1.4 Microscopy and photography
Analyses were performed using a BH-2 microscope (Olympus 
Optical Co Ltd) fitted with xlO (D Plan 10), x40 (D Plan 
40) and xlOO (S Plan 100 oil immersion) lenses and a x 3 .3 
photographic eyepiece. Chromosome spreads were 
photographed using a PM-IOAK automatic exposure 
photomicrographic system and C-35AD4 camera back (Olympus 
Optical Co Ltd).
Photographs were taken on Kodak Technical Pan film rated 
at 32 iso and processed film was printed on Ilford 
Multigrade or Ilfospeed paper. Karyotypes were prepared 
after cutting individual chromosomes from the photographs
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6.2 Study design
6.2.1 Cytogenetic analysis of uncleaved oocytes.
Patients
A total of 653 uncleaved oocytes from 166 patients 
undergoing 188 cycles of IVF/GIFT were fixed for 
cytogenetic analysis (Table 6.2.1). All had multiple 
follicular growth induced using long course GnRH-a/hMG 
therapy and comprised three groups.
1. Four hundred and sixty-one oocytes from cases where 
semen parameters appeared normal.
2. Cases with impaired semen quality as defined in 2.4.4
(113 oocytes).
3. Seventy nine oocytes from 27 cycles in the study
investigating the effects of LORD and preinsemination
incubation (3.3.7).
Table 6.2.1
Cytogenetic analysis of uncleaved oocytes: cycles, 
recovered oocytes and fertilisation rates
Semen
Normal
Oualitv
Poor
Cycles (n) 141 20
Oocytes recovered (mean) 9.7 10.5
Fertilisation rate (% of 
viable oocytes) 48.2 1 1 . 0
Oocytes fixed 461 113
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Criteria for classification of ploidy
Preparations were classified as haploid if chromosome 
counts were 23+/-S and diploid if 46+/-S. These criteria 
allowed classification of cells with poorly spread or 
slightly distorted chromosomes.
Detailed analysis
Karyotype analysis was only carried out if the chromosomes 
were in a discrete group and an accurate count could be 
performed. The quality of each karyotype was assessed at 
the time of preparation. A score of one was given for 
preparations of outstanding quality, with well spread 
chromosomes of good morphology. Slightly poorer cells with 
either overlapping chromosomes or less defined chromatin 
were scored as two. Assessments of three and four were 
given for cells where placing of individual chromosomes 
proved difficult but counting and grouping were possible. 
Photographed spreads which proved ambiguous when 
karyotyping was attempted were discarded and assessment 
was made on the basis of ploidy alone. Haploid cells with 
fewer than 21 chromosomes were considered incomplete and 
not karyotyped.
Chromosome, centromere and chromatid breaks and gaps were 
ignored if components remained aligned and were attributed 
to fixation artefacts.
6.2.2 Cytogenetic analysis of early embryos
A total of 816 cleaved embryos from 187 ORs (164 patients) 
were mitotically arrested with colchicine and fixed for 
cytogenetic analysis (Table 6.2.2). The majority of 
patients (147 cycles) were undergoing IVF. This number 
includes four cases where partner's semen was assessed as 
poor and 36 patients included in the study investigating
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the effects of LORD and preinsemination incubation
(2.6.3). The fertilisation rate in GIFT cycles (n=40) was 
based on spare oocytes, inseminated for investigation of 
gamete compatibility, after selection of 'best' oocytes 
for immediate transfer.
Table 6.2.2
Cytogenetic analysis of embryos: cycles, treatment, 
recovered oocytes and fertilisation rates
Total
(n)
IVF
(n)
GIFT
(n)
Patients (n) 187 147 40
Oocytes recovered (mean) 10.7 1 1 . 0 9.5
Fertilisation rate 
(% of viable oocytes) 63.6 69.5 38.7
Embryos fixed (n) 816 678 138
Criteria for classification of ploidy
All haploid embryos were classified on the basis of 
complete grouping or karyotyping of one or more cells. 
Classification as diploid was based on a single cell only 
if grouping or full karyotyping was possible. An 
approximate count (46+/-S) was considered sufficient if 
more than one cell could be estimated. Triploidy was 
similarly assessed but all greater degrees of polyploidy 
were based on approximate counts of single metaphase 
spreads.
Detailed analysis
Criteria for detailed analyses and assessment of 
karyotypes were those used for oocytes (2.6.5).
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CHAPTER 7 
RESULTS
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7.1 Cytogenetic assessment of uncleaved oocytes: nuclear 
and cytoplasmic maturity
7.1.1 Assessment of nuclear status: total data
Analysis of uncleaved oocytes was possible in 71.4% 
(466/653) of attempted chromosome preparations (Table
7.1.1). The main reason for unsuccessful analysis (n=167) 
was the complete absence of chromosomes despite the 
visible outline of a zona pellucida. Estimation of ploidy 
was not possible in 2 0 cells due to insufficient spreading 
(n=1 0 ) or overdispersion of nuclear contents (n=1 0 ).
Human meiotic chromosomes were readily differentiated from 
those in mitotic metaphase by their curled chromatids, in 
close proximity only at the centromere. Figure 15a shows 
the haploid chromosome complement of a normal metaphase II 
oocyte which failed to fertilise after insemination in 
vitro.
Polar body chromosomes were fuzzy, indistinct and rarely 
analysable (Figure 16a). The group was spatially well 
defined and rarely interfered with observation of oocyte 
chromosomes. Elongated single stranded chromatids were 
identified as prematurely condensed chromosomes (PCC) of 
sperm, as originally described by Schmiady et ai. (1986; 
Figure 16b).
The majority of analysed oocytes (399; 85.6%) had a 
grossly haploid number of meiotic chromosomes consistent 
with metaphase II. This second 'resting' phase of meiosis 
is normally maintained until fertilisation triggers 
completion of the reduction division but the presence of 
condensed sperm chromosomes in 37 (9.3%) cells indicated 
that sperm penetration had occurred in some without 
response.
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Figure 15
Oocyte karyotypes: a) normal metaphase II (23,X) and 
b) diploid metaphase II with a 46,XX chromosome constitution.
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Figure 16
a) Polar body chromosomes and b) Premature condensation of 
sperm chromosomes in a metaphase II oocyte.
Table 7.1.1
Cytogenetic analysis of uncleaved oocytes: total data
Analysis Number of oocytes
Oocytes fixed 653
Uninformative analyses 187
No chromosomes found 167
Chromosomes unanalysable 10
Chromosomes overspread 10
Informative analyses 466
Metaphase II 362
Metaphase II + PCC 37
Metaphase 1 2
Diploid metaphase II 19
Diploid metaphase II + PCC 9
PCC sperm chromosomes only 7
Mitotic chromosomes 22
Haploid 3
Diploid 7
Triploid 1
Tetraploid 5
Polyploid 4
Undetermined 2
Other 8
PN chromosomes 3
Endoreduplication 1
Meiotic tetraploid 1
Polyploidy + PCC 1
Interphase nucleus 1
Elongated degenerated chromosomes 1
Fragmented chromosomes 38
Metaphase II 32
Diploid metaphase II 4
Unanalysable 2
Karyotyped cells 192
Metaphase II 178
Diploid metaphase II 8
Mitotic 5
Metaphase 1 1
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7.1.2 Nuclear status of oocytes failing to cleave after
insemination with normal and poor semen
Cytogenetic outcome of cases with normal and poor semen is 
detailed in Table 7.1.2. The proportion of cells which 
yielded informative analyses (72.1% and 69.9%) was similar 
in the two groups and it can be assumed that results are 
representative of each population. More than 90% of 
oocytes which failed to fertilise in the presence of 
deficient sperm were at metaphase II. None showed evidence 
of sperm penetration. Significantly more (chi-sq, p<0.01; 
20.9%) uncleaved oocytes in the group with normal 
semenology demonstrated fertilisation or oocyte 
activation.
Karyotype results from Tables 7.1.2 to 7.1.8 will be 
discussed in section 7.2.
Arrest at an earlier stage occurred in 28 cells which had 
undergone GVBD but retained the haploid set of PB 
chromosomes within the ooplasm (Figure 15b). These oocytes 
were classified as diploid metaphase II and a 
significantly higher (chi-sq, p<0.001) proportion (9/28; 
32.1%) contained PCC of sperm than metaphase II oocytes 
(37/399; 9.3%). The meiotic stage of seven cells which 
retained only sperm chromosomes after fixation could not 
be determined but multiple penetration had occurred in 
6/7. Only two oocytes, from the same cycle, remained 
paired in metaphase I. These were distinguished from 
endoreduplicated chromosomes by their meiotic morphology 
and observation of heterozygous polymorphisms of centric 
heterochromatin after C-banding.
Despite lack of cleavage, mitotic chromosomes were found 
in 22 oocytes. The largest single group (n=ll) were 
diploid but three had been parthenogenetically activated 
and triploidy, tetraploidy and polyploidy were detected.
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A number of individual anomalies which could not be 
included in the above categories are listed in Table 
7.1.1. Three cells contained haploid sets of single 
chromatids consistent with PN complements prior to 
replication.
Thirty-eight cells contained severely fragmented 
chromosomes. The proportion of metaphase II to diploid 
metaphase II cells (32:4) was similar to that in the total 
series (399 : 28).
Table 7.1.2
Cytogenetic analysis of oocytes from cycles with normal or 
impaired semen parameters
Analysis
Semen Oualitv 
Normal Poor 
(n) (n)
Oocytes fixed 461 113
Informative analyses (%) 335 (72.1)a 79 (69.9)
Metaphase II (%) 265 (79.1)b 73 (92.4)
Metaphase II + PCC 19 0
Diploid metaphase II 14 2
Diploid metaphase II + PCC 6 0
PCC sperm chromosomes only 7 0
Mitotic 17 3
Other 7 1
Karyotyped metaphase II cells 130 32
23,X 99 24
Aneuploid (%) 24 (18.5)0 6 (18.7)
Individual chromatids 7 (5.4) 2 (6.2)
Structural abnormality (%) 2 (1.5) 0 (0.0)
All abnormalities (%) 31 (23.8) 8 (25.0)
a Informative analyses expressed as a percentage of
fixed oocytes.
b Metaphase II oocytes expressed as a percentage of
informative analyses.
c Analyses expressed as a percentage of karyotyped
metaphase II cells.
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7.1.3 Nuclear status of uncleaved oocytes from short and
long lor d s; with and without preincubation
Patient selection for LORD study 2 ensured a high 
fertilisation rate (3.3.7). Cytogenetic analyses of 
oocytes which remained uncleaved in the four study groups 
are detailed in Table 7.1.3. Nuclear maturity was 
determined as metaphase II in 17/20 (85.0%) of informative 
S/0 cells; 11 (64.7%) of these contained prematurely 
condensed sperm chromosomes. During the total period of 
cytogenetic study only two cells in diakinesis were 
analysed. Both were recovered after a short LORD; one with 
and one without preinsemination incubation.
Table 7.1.3
Cytogenetic analysis of uncleaved oocytes: short and long 
LORD with or without preincubation
Analysis
LORD/Insemination 
S/0 S/5 L/0 
(n) (n) (n)
Time
L/5
(n)
Oocytes unfertilised 36 34 26 22
Oocytes fixed 28 19 13 19
Informative analyses 20 15 8 9
Metaphase II 6 9 5 4
Metaphase II + PCC 11 3 2 2
Diploid metaphase II 1 1 0 1
Diploid metaphase II + PCC 1 0 0 2
Mitotic 0 1 1 0
Other 1 1 0 0
Karyotyped
metaphase II cells 8 6 1 1
23,X 5 5 1 1
Aneuploid 2 0 0 0
Individual chromatids 1 1 0 0
Structural abnormality 0 0 0 0
All abnormalities 3 1 0 0
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7.1.4 The effect of insemination to fixation interval 
upon successful preparation and result of cytogenetic 
analysis
The proportion of oocytes which yielded an analysis was 
not different in those fixed on day 2 (67.6%), day 3 
(76.6%) or day 4 (69.7%: Table 7.1.4). Analytical failure 
rates due to lack of chromosomes were also similar (day 2 , 
27.8%; day 3, 21.8%; day 4, 28.8%).
Mitotic cells were found more frequently (chi-sq., 
p< 0 .0 0 1 ) in oocytes fixed after three days in culture 
(21.7%) than with those processed on either day 2 (3.3%) 
or day 3 (2.0%). Prolonged fixation delay was also 
associated with an increase in cells with only sperm 
chromosomes identified (day 4, 6.5% v day 2, 0.5% and day 
3, 1.3%) but the difference did not reach statistical 
significance. The incidences of chromosome fragmentation, 
aneuploidy and structural anomalies were not associated 
with culture time.
7.1.5 Relationship between nuclear status and indication 
for treatment
The majority of cycles treated had a tubal occlusion or 
unexplained infertility (Table 7.1.5). Eight had moderate 
or severe endometriosis as the primary indication and four 
had andrological problems. Eighteen patients with 
ovulatory dysfunction who had failed six cycles of 
ovulation induction with long course combined therapy 
(2.2) were treated with IVF.
No differences in the proportions of informative 
preparations or metaphase II complements were found. It is 
of interest that 91% of oocytes from patients with 
ovulatory problems were apparently normal.
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Table 7.1.4
Cytogenetic analysis of uncleaved oocytes related to 
interval between insemination and fixation
Analysis Day 2 
(n)
Day 3 
(n)
Day 4 
(n)
Oocytes fixed 309 197 66
Uninformative analyses 1 0 0 46 2 0
No chromosomes found 86 43 19
Chromosomes unanalysable 8 2 0
Chromosomes overspread 6 1 1
Informative analyses 209 151 46
Metaphase II 164 1 2 1 28
Metaphase II + PCC 23 9 3
Diploid metaphase II 4 12 0
Diploid metaphase II + PCC 7 1 0
Sperm chromosomes only 1 2 3
Mitotic 7 3 10
Other 3 3 2
Fragmented chromosomes 18 10 5
Karyotyped metaphase II cells 71 75 7
23,X 53 57 5
Aneuploid 15 11 2
Individual chromatids 4 6 0
Structural abnormality 1 1 0
All abnormalities 18 18 2
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Table 7.1.5
Cytogenetic analysis of uncleaved oocytes related to 
indication for treatment (tubal, unexplained, 
endometriosis, andrological or ovulatory)
Analysis Tubal
(n)
Indication 
Unexp. Endom. 
(n) (n)
Andro. 
(n)
Ovul. 
(n)
Cycles 1 0 0 58 8 4 18
Oocytes fixed 299 250 20 12 72
Informative analyses 218 169 15 10 54
Met II 159 132 15 17 49
Met II + PCC 27 6 0 2 2
Dip met I 9 10 0 0 0
Dip met I + PCC 7 0 0 1 1
PCC chroms only 2 5 0 0 0
Mitotic 9 11 0 0 2
Other 5 5 0 0 0
Karyotyped
metaphase II cells 86 57 8 5 22
23,X 64 44 5 4 18
Aneuploid 15 10 3 0 4
Individual c'tids 8 2 0 1 0
Struct abnorm 0 2 0 0 0
All abnorm 22 13 3 1 4
7.1.6 Relationship between nuclear status and degree of 
stimulation
The degree of stimulation was assessed by the number of 
oocytes recovered at OR (Table 7.1.6). Although 90% of 
oocytes from cycles with one to five recovered oocytes 
were at metaphase II, the proportion of oocytes at this 
stage of nuclear development was similar if an average 
number of oocytes were obtained (73.9%) or patients were 
highly stimulated (>10 oocytes; 79.7%).
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Table 7.1.6
Cytogenetic analysis of uncleaved oocytes: relationship 
with number of oocytes retrieved in cases with normal 
semenology
Analysis Oocvtes retrieved 
1-5 6-10 >10
Oocytes fixed 40 190 339
Informative analyses 25 142 241
Metaphase II 23 105 192
Metaphase II + PCC 1 9 23
Diploid metaphase II 1 6 8
Diploid metaphase II + PCC 0 3 5
All other 0 19 13
Karyotyped metaphase II cells 9 47 99
23,X 7 33 78
Aneuploid 1 11 18
Individual chromatids 1 4 2
Structural abnormalities 0 0 2
All abnormalities 2 14 21
7.1.7 Relationship between nuclear status, size of 
follicle of origin and cumulus expansion
The relationships among follicle size, cumulus expansion 
and fertilisation rates have been previously described 
(3.4). A higher incidence of developmental competence was 
associated with oocytes derived from large (>2.5ml) 
follicles and those with fully expanded cumuli. The 
cytogenetic analysis of uncleaved oocytes in each of these 
groups is shown in Tables 7.1.7 (follicle size) and 7.1.8 
(cumulus expansion). Paradoxically, the highest incidences 
of oocytes in metaphase II (without evidence of sperm 
penetration) were found in those groups with lower rates
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of fertilisation although differences did not reach 
statistical significance.
Table 7.1.7
Cytogenetic analysis of uncleaved oocytes: relationship 
with follicle size in cases with normal semenology
Analysis
Follicle
Small
(n)
size
Large
(n)
Oocytes fixed 79 158
Informative analyses 62 (78.5%)a 115 (72.8%)
Metaphase II 53 (85.5%)b 87 (75.6%)
Metaphase II + PCC 3 3
Diploid metaphase II 2 4
Diploid metaphase II + PCC 1 3
All other 3 18
Karyotyped metaphase II cells 23 41
23,X 18 32
Aneuploid 3 6
Individual chromatids 2 2
Structural abnormalities 0 2
All abnormalities 5 (2 1 .7%)c 9 (21.9%)
a Informative analyses expressed as a percentage of
fixed oocytes.
b Metaphase II oocytes expressed as a proportion of
informative analyses.
c Analyses expressed as a proportion of karyotyped
metaphase II cells.
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Table 7.1.8
Cytogenetic analysis of uncleaved oocytes: relationship 
with cumulus expansion in cases with normal semenology
Cumulus exoansion
Analysis Immature Mature
(n) (n)
Oocytes fixed 10 2 336
Informative analyses 75 (73.5%)a 241 (71.7%)
Metaphase II 63 (84.0%)b 183 (75.9%)
Metaphase II + PCC 2 17
Diploid metaphase II 1 13
Diploid metaphase II + PCC 1 5
All other 8 23
Karyotyped metaphase II cells 25 90
23,X 16 70
Aneuploid 6 16
Individual chromatids 3 4
Structural abnormalities 0 2
All abnormalities 9 (36.0%)c 2 0 (2 2 .2 %)
a Informative analyses expressed as a percentage of
fixed oocytes.
b Metaphase II oocytes expressed as a proportion of
informative analyses.
c Analyses expressed as a proportion of karyotyped
metaphase II cells. »
7.1.8 Nuclear status of oocytes failing to cleave after 
evidence of fertilisation
A small number (n=31) of oocytes in the study had failed 
to cleave after PN had been visualised on day 1 following 
insemination. The proportion of informative analyses was 
rather low (13/31; 42.0%); details are given in Table 
7.1.9. The only cell with a single PN, and 5/9 of 
apparently normally fertilised (2PN) oocytes remained at 
meiotic metaphase II with only one showing evidence of
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sperm penetration in the form of PCC of sperm. A high 
proportion of cells in this group (5/13; 38.5%) had nuclei 
undergoing mitotic division without cytokinesis. It is of 
interest that one oocyte with 2PN had a triploid 
chromosome constitution. Both cases with >3 PN contained 
multiple sets of PCC.
Table 7.1.9
Cytogenetic analysis of oocytes which remained uncleaved 
after PN formation
Analysis 1
(n)
Number
2
(n)
of PN 
3
(n)
>3
(n)
Oocytes fixed 1 25 3 2
Informative analyses 1 9 1 2
Metaphase II 1 4 0 0
Diploid metaphase 
II + PCC 0 1 0 0
PCC sperm 
chromosomes only 0 0 0 2
Mitotic 0 4 a 1 b 0
a Diploid X  2, triploid 
b Hexaploid
X  1, tetraploid x 1
7.1.9 Relationship between morphological and cytological 
assessment of nuclear status
Polar body status of oocytes was reassessed at the time of
fixation and the number present, related to nuclear status
is shown in Table 7.1.10. Absence of any PB is normally
interpreted as failure of the first meiotic division but
33/60 (55.0%) informative analyses in this category
displayed only metaphase II chromosomes, including eight
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with PCC. Nineteen oocytes (31.7%) did retain polar body 
chromosomes, two remained at metaphase I and one contained 
a tetraploid complement of meiotic chromosomes. Despite 
the presence of the first PB in the perivitelline space, a 
small proportion (8/331; 2.4%) of oocytes appeared to 
retain all meiotic chromosomes. The most common finding in 
this group was a metaphase II complement, as was the case 
in oocytes with two, three and fragmented PB.
Table 7.1.10
Cytogenetic analysis of uncleaved oocytes related to polar 
body status
Analysis 0
(n)
Number
1
(n)
of PB 
2
(n)
3/Frag
(n)
Oocytes fixed 77 452 21 7
Informative analyses 60 331 15 7
Metaphase II 25 284 11 5
Metaphase II + PCC 8 23 2 2
Diploid metaphase II 13 6 0 0
Diploid met 2 + PCC 6 2 0 0
PCC sperm chrom only 1 5 0 0
Mitotic 1 10 1 0
Other 6 1 1 0
7.1.10 Summary
The nuclear status of 466 (71.4% of 653) oocytes could be 
determined after cytogenetic preparation; the majority 
(399, 85.6%) were at meiotic metaphase II and had a 
haploid chromosome complement. The first polar body had 
not been extruded in 6 % (28) of oocytes which were 
classified as diploid metaphase II. Prematurely condensed 
chromatin of sperm chromosomes, indicating cytoplasmic 
immaturity were observed in 9.3% (37/399) of metaphase II 
cells and 32.1% (9/280) of diploid metaphase II oocytes.
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The same phenomenon was present in 11/17 oocytes remaining 
uncleaved after a short LORD and immediate insemination. 
Approximately 5% (22) of uncleaved oocytes had mitotic 
chromosomes, three had been parthenogenetically activated. 
Chromosome fragmentation was significantly higher 
(p<0.001) in women over 39 (9/20, 45.0%) than younger 
groups (<30, 3.7%; 30-34, 6.3%; 35-39, 7.6%).
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7.2 Cytogenetic assessment of uncleaved oocytes: detailed 
analysis
7.2.1 Incidence and types of chromosome abnormalities 
detected in uncleaved oocytes
Thirty-two of 178 (18.0%) karyotyped oocytes were 
aneuploid (Figures 17a and 17b), two (1.1%) had structural 
anomalies and 11 (6 .2 %) displayed individual chromatids of 
one homologue Figure 18. (Table 7.2.1). Overall, 43 
abnormal karyotypes were found, giving an estimate of 
24.2% abnormality in unfertilised oocytes. The overall 
incidence of abnormality was not different in cases with 
normal or deficient sperm (Table 7.1.2) or in cells with 
or without PCC of sperm chromosomes (Table 7.2.2). It 
should be noted that a small number of oocytes had both 
aneuploidy and structural defects and that total abnormal 
is not always the sum of individual abnormalities.
Chromosome analysis was successfully performed on eight 
diploid metaphase II oocytes, four of which contained PCC. 
All had a 46,XX karyotype (Figure 15b).
7.2.2 Karyotype quality of metaphase II oocytes
Detection rate of karyotypic anomaly did not differ in 
relation to preparation quality (Table 7.2.3). The highest 
incidence of abnormality occurred in grade 3 cells but the 
difference between good (1+2) and poor (3+4) preparations 
was not significant and the majority (129/177; 72.9%) of 
analyses were based on good preparations with minimal 
ambiguity.
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Figure 17
Oocyte karyotypes: metaphase II cells with a) an additional D group 
chromosome (24,X,+D) and b) nullosomy F (22,X,-F).
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Figure 18
Oocyte karyotype: metaphase II cell with individual chromatids of 
chromosome 16 (22,X,'16,+cht(16),+cht(16)).
Table 7.2.1
Karyotype details of analysed oocytes
Analysis n
Metaphase II 178
23, X 135
24, X,+C 1
24, X,+D 4
24, X,+D, cht sep(B) 1
24, X,+E 1
24, X,+18 2
24, X,+F 1
24, X,+G 4
24, X,+? 3
23, X,+D,-G 1
24, +?,+?,-C 1
2 2 ,-C 6
2 2 ,X,-D 1
2 2 ,X,-F 3
2 2 ,X,-G 1
2 1 ,X,-B,-C 1
23, -C,+ triradial 1
2 0 ,—C,—E,—G,+ cht(C) 1
2 2 ,X,-16,+ cht(16),+ cht(16) 6
2 2 ,X,-F,+ cht(F),+ cht(F) 2
2 2 ,X,-G,+ cht(G),+ cht(G) 2
Diploid metaphase II 8
46, XX 8
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Table 7.2.2
Cytogenetic analysis of uncleaved oocytes: incidence of 
abnormality in metaphase II cells with or without PCC
Karyotype
Cell Type 
Met 2 Met 2 + PCC Total 
(n) (n) (n)
Total cells 
23,X
Aneuploid
Individual
chromatids
Structural
abnormality
All
abnormalities
167
127
30
10
11
8
40 (23.9%) 3 (27.3%)
178 
135 
32 (18.0%)a
11 (6.2%)
2 (1.1%)
43 (24.2%)b
a Expressed as percentage of total cells
b Two cells had both aneuploidy and a structural
anomaly.
Table 7.2.3
Cytogenetic analysis of uncleaved oocytes: influence of 
preparation quality on ascertainment of chromosome 
abnormalities
Preparation
quality
Total
cells
Number
abnormal
Percentage
abnormal
69
60
24
24
14
16
9
4
20.3
26.7 
37.5
16.7
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7.2.3 Chromosomes involved in abnormalities of metaphase 
II oocytes
Table 7.2.4 details involvement of chromosome groups in 
aneuploidy and structural defects. Groups D, E and G were 
most frequently responsible for hyperploidy and groups C,
F and G for karyotypes deficient in whole chromosomes. Six 
of 11 karyotypes with individual chromatids involved 
chromosome 16. A composite picture is shown in Figure 19.
Table 7.2.4
Cytogenetic analysis of uncleaved oocytes: involvement 
of chromosome groups in abnormal karyotypes
Aneuploid Individual Total
Group Hyper Hypo chromatids Abnormalities
(n) (n) (n) (n)
A 0 0 0 0
B 0 1 0 1
C 1 8 1 10
D 6 1 0 7
E 3 1 6 10
F 1 3 2 6
G 4 3 2 9
Unknown 5 0 0 5
Total 20 17 11 48
7.2.4 Influence of maternal factors and IVF methodology
on the incidence of chromosome abnormalities in metaphase
II oocytes
The incidence of abnormality was not different in oocytes 
fixed on day 2, day 3 or day 4 after insemination (Table 
7.1.4). Patients with tubal and unexplained infertility 
had similar proportions of normal and abnormal oocytes 
(Table 7.1.5). Only 18% of oocytes from patients who had 
failed ovulation induction were abnormal. Follicle size
163
4  #  #  #
)  4  ^
%  %
(  ?  ^  ^
cht(16) cht(16) 17 18
Figure 19
Composite photograph of the E group of six oocytes 
with individual chromatids of chromosome 16.
(Table 7.1.7) did not affect the incidence of aneuploidy 
or individual chromatids. Oocytes with an immature cumulus 
at the time of OR had a higher incidence of abnormality 
(36.0%) than those classified as mature (22.2%) but the 
difference was not statistically significant (Table 
7.1.8) .
7.2.5 The influence of maternal age on nuclear status, 
chromosome morphology and the incidence of chromosome 
abnormality
The fertilisation rate of oocytes decreased with maternal 
age (Table 7.2.5). The difference was statistically 
significant between ages <30 and 30-34 (chi-sq., p<0.02), 
30-34 and 35-39 (chi-sq., p<0.03) and between those <35 
and those >35 (chi-sq., p<0.001). The proportions of 
informative cells and of those determined as metaphase II 
were similar in all age groups (Table 7.2.5). Nine of 20 
chromosome spreads from women >40 showed severe 
fragmentation. This incidence was significantly higher 
(chi-sq., p< 0 .0 0 1 ) than any other age group.
The proportion of metaphase II oocytes which could be 
karyotyped decreased with maternal age (Table 7.2.6). The 
difference was significant between ages <30 and 30-34 
(p<0.01), 30-34 and 35-39 (p<0.03) and between those <35 
and those >35 (chi-sq., p<0.001).
The overall incidence of abnormality was not different in 
the four age groups (Table 7.2.6) although the proportion 
which was aneuploid increased. The difference did not 
reach statistical significance but hyperhaploid cells were 
more frequent (chi-sq., p<0.01) in women >35 than the two 
younger groups.
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7.2.6 Summary
Karyotypes were prepared from 178 metaphase II and eight 
diploid metaphase II cells. Abnormalities were detected in 
43 (24.2%) haploid oocytes comprising 32 cells with whole 
chromosome aneuploidy, 11 with individual chromatids of 
one homologue, and two structural anomalies. Two cells had 
more than one abnormality and all diploid cells had a 
46,XX karyotype. Aneuploidy of acrocentric chromosomes (D 
and G group) was most frequent (10/20 hyperploid 
chromosomes) and 6 / 1 0  of cases with apparent pre-division 
of chromatids involved chromosome 16. The incidence of 
hyperploidy was significantly (p<0.05) higher in women >35 
(7/28; 25.0%) than those <35 (11/113; 9.7%). No 
association between abnormality and any aspect of IVF 
methodology was determined and selection against 
fertilisation of abnormal oocytes was not observed.
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7.3 Cytogenetic analysis of early embryos; assessment of 
ploidy
7.3.1 Ploidy assessment and reasons for failure of 
analysis
Analysis of ploidy was possible in 325 (39.8%) of embryo 
preparations and 215 (26.3%) were karyotyped (Table 
7.3.1). The main reason for analytic failure (n=219) was 
lack of chromosomes despite the presence of interphase 
nuclei. Only 37 embryos had no identifiable cells after 
fixation.
One hundred and seventeen embryos had chromosome 
complements which could not be assigned ploidy. The 
majority appeared diploid but did not meet criteria for 
confirmation and were recorded as unanalysable. Since 
multiple chromosome sets were generally present, 
overspreading of individual metaphase plates interfered 
with analysis in a large number (109; 13.4%) of embryos. 
Severe fragmentation was recorded in 9 preparations.
7.3.2 Relationship between number of PN and ploidy
Table 7.3.2 details ploidy analysis in relation to number 
of PN visualised on the day following insemination. When 
the number available for fixation was corrected by 
subtraction of those transferred in IVF cycles from total 
numbers, it appeared that abnormally fertilised embryos 
(1, 3 and 4PN) had been preferentially fixed.
The highest proportion of successfully analysed embryos 
were those with one (9/18; 50.0%) or 2PN (167/393; 42.5%). 
Only 9/35 late fertilised embryos (OPN) were analysable 
and eight appeared diploid. Parthenogenesis was not the 
origin of all single pronucleate embryos. A haploid 
chromosome complement was found in three preparations but 
5/9 were diploid and one was tetraploid. Activation of a
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diploid oocyte could be excluded in 2/3 karyotyped
preparations due to detection of 46,XY chromosome
constitutions.
Table 7.3.1
Cytogenetic analysis of embryos : total data
Analysis Number of embryos
Embryos fixed 816
Uninformative analyses 491
No cells 37
No chromosomes 219
Unanalysable 117
Overspread 109
Fragmented 9
Informative analyses 325
Haploid 7
Diploid 284
Triploid 22
Tetraploid 9
Polyploid 2
Other 1
Karyotyped cells 193
Haploid 5
Diploid 178
Triploid 11
Tetraploid 0
Polyploid 0
Other 1
Diploidy was confirmed in 155/167 (92.8%) of 2PN zygotes 
but one was haploid and four triploid. Three triploid 
embryos were fully karyotyped and two had sex chromosome 
complements compatible with fertilisation of an unreduced 
oocyte (XXX and XXY). However, the third was karyotyped as 
69,XYY and could only be explained by abnormal 
fertilisation. The remaining embryos in this group were 
tetraploid (n=4) or octaploid (n=l).
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A small number (n=12) of 3 PN zygotes were successfully 
analysed. The majority (n=9) were triploid but two were 
tetraploid and one hexaploid. No 4PN embryos were 
informative.
Table 7.3.2
Cytogenetic analysis of embryos: PN and subsequent ploidy
0
Number of PN 
1 2 3 . 4
Total embryos (n) 142 33 1293 89 8
Available for
fixation (n) 85 27 747 89 8
Embryos fixed
(n) 35 18 393 54 6
Proportion of
available (%) 41.2 66.7 52.6 60.7 75.0
Informative
analyses (n) 9 9 167 12 0
Informative
analyses (%) 25.7 50.0 42.5 2 2 . 2 0
Haploid 0 3 1 0 0
Diploid 8 5 155 0 0
Triploid 1 0 4 9 0
Tetraploid 0 1 5 2 0
Polyploid 0 0 1 1 0
Other 0 0 1 0 0
7.3.3 Relationship between ploidy and embryo quality
The relationship between cytogenetic analysis and embryo 
quality, as assessed by morphology and growth rate (EDR), 
is detailed in Table 7.3.3. Parameters of quality were not 
different in haploid, diploid and triploid embryos but 
those with >4n chromosome complements had significantly
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poorer (t-test, p<0 .0 0 1 ) morphology and lower (t-test, 
p<0.01) EDR. When embryos with abnormal ploidy were 
grouped, both assessment parameters were significantly 
poorer (t-test, morphology; p<0.001: EDR; p<0.05).
After fixation, slow growing embryos (EDR<81) had a 
significantly (chi-sq., p<0 .0 0 1 ) lower proportion 
(152/254; 59.8%) of cells in metaphase than other EDR 
groups (81-90, 91-100, >100; Table 7.3.4). Other groups 
had similar proportions of mitotically active cells.
Table 7.3.3
Cytogenetic analysis of embryos: relationship between 
embryo quality and chromosome constitution
Analysis
(n)
Oualitv assessment 
Morphology Growth Rate 
(Mean score) (Mean EDR)
Informative analyses
Haploid 7 7.0 1 0 2 . 1
Diploid 276 7.8 95.5
Triploid 22 7.2 94.7
Polyploid 11 5.9 a 80.4 b
All non-diploid 41 6 . 8  a 90.1 c
Karyotyped diploid 
embryos
46,XX or 46,XY 134 7.9 96.1
Non-mosaic
aneuploid 33 8 . 1 92.1
Significance of difference when compared with diploid
embryos (t-test): a p< 0 . 0 0 1  b p< 0 . 0 1 c p<0.05
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Table 7.3.4
Cytogenetic analysis of embryos: relationship between 
mitotic index at time of fixation and growth rate
0-80
EDR
81-90 91-100 > 1 0 0
Embryos analysed (n) 77 144 98 2 0 1
Metaphase cells (n) 152 a 394 243 497
Interphase cells (n) 10 2 129 66 2 0 2
Total cells (n) 254 523 309 699
Proportion of cells
in metaphase (%) 59.8 75.3 78.6 71.1
a Proportion of cells in metaphase significantly
(chi-sq., p<0 .0 0 1 ) lower than any other group.
7.3.4 Number of PN and ploidy analysis related to 
Indication for treatment
The largest group of embryos (n=494) studied were obtained 
from patients with tubal infertility (Table 7.3.5) and a 
further 206 derived from treatment of unexplained 
infertility. The only other group with significant numbers 
comprised patients who had failed ovulation induction 
therapy for ovulatory disorders.
Eighteen of 520 (3.5%) embryos had a single PN when 
checked on day 1. The proportion was highest in ovulatory 
(7.3%) indications but the difference from all other 
indications was not statistically significant. Three PN 
were observed in 10.4% of embryos with a significantly 
higher (chi-sq., p<0 .0 1 ) proportion (2 1 .8 %) in women with 
ovulatory dysfunction.
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Table 7.3.5
Number of PN, ploidy and karyotype of embryos related to 
indication for treatment (tubal, unexplained, 
endometriosis, andrological, ovulatory)
Analysis Tubal
(n)
Unexp.
(n)
Endom.
(n)
Andro. 
(n)
Ovul. 
(n)
Embryos fixed 494 206 22 4 90
Informative analyses 194 79 9 3 40
PN checked 322 135 4 4 55
IPN 7 7 0 0 4
2PN 244 106 3 4 36
3PN 35 6 1 0 12
>4PN 6 0 0 0 0
Ploidy
Haploid 4 2 1 0 0
Diploid 165 73 7 3 36
Triploid 18 1 0 0 3
Polyploid 7 2 1 0 1
Other 0 1 0 0 0
Karyotyped diploid
embryos 104 43 4 1 2 0
46,XX or 46,XY 85 31 4 0 18
Non-mosaic
aneuploid 19 12 0 1 2
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7.4 Cytogenetic assessment of early embryos: detailed 
analysis
7.4.1 Total data
Karyotype details of all diploid embryos are given in 
Table 7.4.1 and the results are summarised in Table 7.4.2. 
Karyotypes of haploid, triploid and other embryos are 
given in Table 7.4.3.
Three of five karyotyped haploid embryos had a 23,X 
complement (Figure 20a) and one was hyperhaploid with an 
additional C chromosome. The fifth embryo had two 'normal' 
cells and one with only 22 chromosomes. Genuine mosaicism 
or a preparation artefact may have been responsible.
One hundred and thirty-eight diploid embryos had an 
apparently normal chromosome complement (Figure 20b) with 
a ratio of XY to XX karyotypes of 1.15. This sex ratio was 
significantly (chi-sq., p<0.05) different from the 0.48 
ratio of aneuploid embryos. Thirty-four preparations 
showed consistent aneuploidy, four were mosaic and two 
exhibited structural anomalies; giving a total abnormality 
rate of 40/178 (22.5%). Involvement of chromosome groups 
in consistent hyperdiploidy and hypodiploidy is given in 
Table 7.4.4. Only chromosomes 16 (Figure 21a) and 18 could 
be identified individually in abnormal karyotypes and 
these chromosomes comprised 8/10 hyperploidies involving E 
group. Partial banding allowed the tentative diagnosis of 
45,X in one embryo but an XX sex chromosome constitution 
with a missing C could not be excluded. It should be noted 
that unbanded cells with a 45,X karyotype would be 
included in the hypoploid group. Only three embryos with a 
45,-C constitution were detected and two had a Y 
chromosome identified. Only one consistent case of 
chromosome rearrangement was identified in both cells of 
an embryo with a derived D group chromosome.
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Embryo karyotypes: a) a parthenogenetic embryo (23,X) and 
b) a normal 46,XX chromosome constitution.
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Figure 21
Ermbryo karyotypes: a) trisomy 16 (47,XX,+16) and 
b) tetrasomy 18 (48,XX,+18,+18).
Triploid karyotypes with large numbers of missing 
chromosomes may be artefacts but both hyperploidy (+16) 
and hypoploidy (-E) were superimposed on embryos with a 3n 
complement. A partially banded metaphase with 74 
chromosomes appeared to be fundamentally triploid with 
five 'extra' chromosomes. The sex chromosome constitutions 
of nine triploids were equally distributed between XXX,
XXY and XYY. No polyploid metaphase spreads could be fully 
analysed.
Three analysed metaphases from a four cell embryo had a 
29/29/32 chromosome constitution with non-random loss. Two 
pronuclei were observed on the day following insemination 
and the resulting embryo had even blastomeres with minimal 
fragmentation.
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Table 7.4.1
Karyotype details of diploid embryos
Analysis n
Diploid 178
46 XX 64
46 XY 74
47 XX +c 2
47 XY +c 1
47 XX +D 1
47 XY +D 1
47 XX +D or E 1
47 XX +E 1
47 XX + 16
47 XX + 18 1
47 XY + 18 1
47 XX +F 1
47 XX +G 1
47 XY +G
47 XX +? 1
45 XX -C 1
45 XY -C
45 X ?) 1
45 XX -D
45 XX -D or E 1
45 XX -E 1
45 XY -E 1
45 XX -F 1
45 XY -F 1
48 XX +18,+18 1
48 XX +D(?),+E(?)
46 XY +D,-C
44 XX —3, —G 1
44 X,--F,-C or G/Y 1
45 + 16 1
47 XX, +C / 46,XX 1
46 XX / 45,XX,-18 1
46 XX / 44,XX,-2,-21 1
46 XX / 44,XX,-C,-C 1
46 XX, -D,+FR (bisatellited) 1
46 XX / 45XX,-C,+FR,+FR 1
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Table 7.4.2
Cytogenetic analysis of diploid embryos: karyotype 
details
Analysis Number of embryos
Total karyotyped 178
Apparently normal 138 (77.5%) a
46,XX 64
46,XY 74
Aneuploid (non mosaic) 34 (19.1%)
Single chromosome 28 (15.7%)
Hyperploid 17
Hypoploid 11
Two chromosomes 5 (2 .8 %)
Hyper/hyper 2
Hyper/hypo 1
Hypo/hypo 2
Three chromosomes 1 (0 .6 %)
Hyper/hypo 1
Mosaic 4 (2 .2 %)
Structural anomalies 2 (1 .1 %)
Total abnormal 40 (22.5%)
a Expressed as percentageI of total karyotyped.
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Table 7.4.3
Karyotype details of non-diploid embryos
Analysis n
Haploid
23,X
24,X,+C
23,X / 23,X / 22, -C
Triploid
69,XXX 
69,XXY
69,XYY 
69
70,XXX,+16 
6 8 ,XYY,-E
64, XYY, — 1,-1,—2,—3,—6,-12,+18 
64,XXY,-3,-3,—C,—C, —C 
64,XXX,-18,-F,-G,-G,-G 
74,+5 chromosomes
Other
32 / 29 / 29
The proportion of embryos categorised as abnormal was not 
different in good (grades 1+ 2 ) quality preparations 
(29/138; 21.0%) and those considered poor (9/38; 23.7%, 
Table 7.4.5). The majority (138/176; 78.4%) of analyses 
were based on good quality metaphase spreads with minimal 
ambiguity.
178
Table 7.4.4
Cytogenetic analysis of embryos: involvement of 
chromosome groups in non-mosaic abnormal karyotypes
Aneuoloidv
Group Hyper Hypo Total
(n) (n) (n)
A 0 1 1
B 0 0 0
C 3 4 7
D 4 2 6
E 10 2 12
F 1 3 4
G 3 1 4
Sex chrom 0 1 1
Unknown 2 4 6
Total 23 18 41
Table 7.4.5
Cytogenetic analysis of embryos: influence of preparation
quality on ;ascertainment of chromosome abnormalities
Preparation Total Number Percentage
quality cells abnormal abnormal
1 79 18 2 2 . 8
2 59 11 18.6
3 24 8 33.3
4 14 1 7.1
As another internal control, the incidence of consistent 
aneuploidy in embryos with > 1 cell analysed was examined 
(Table 7.4.6). Nine of the forty two embryos (21.4%) in 
this category were aneuploid, a figure similar to the 
overall incidence. Forty-nine embryos had more than one 
cell karyotyped. Four (8.2%) were mosaic; all based on 
analysis of two cells.
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Table 7.4.6
Cytogenetic analysis of embryos: number 
individual analyses were based
of cells on which
Number of cells analvsed
Analysis 1 2 3 4
(n) (n) (n) (n)
All embryos 146 45 9 1
Diploid embryos 129 42 7 0
Apparently normal embryos 104 30 4 0
Aneuploid embryos 25 6 3 0
Mosaic embryos 0 4 0 0
Structural abnormalities 0 2 0 0
7.4.2 Factors influencing the incidence of aneuploidy in 
embryos
Embryo quality, as assessed by morphology and growth rate, 
was not different in apparently normal and aneuploid 
embryos (Table 7.3.3).
No significant influence of cause of infertility and 
aneuploidy was seen (Table 7.3.5) but, as in oocytes, the 
lowest incidence was observed in ovulatory indications.
Seventeen embryos derived from cycles with sperm problems 
were fixed and eight embryos were informative; all 
diploid. Of seven karyotyped embryos, five appeared normal 
and two were aneuploid.
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7.4.3 Effect of maternal age on the incidence of 
aneuploidy
The incidence of non-mosaic aneuploidy increased with 
maternal age (Table 7.4.7). Unlike oocytes, the proportion 
of successful analyses was similar in all age groups, a 
slight reduction in patients >40 being statistically non­
significant. The incidence of aneuploidy increased with 
maternal age but did not reach statistical significance. 
Hyperploidy and hypoploidy occurred with equal frequency 
in each age group and all four embryos with double and 
triple aneuploidy were found in the 30-34 group.
Table 7.4.7
Age distribution of successful analyses and non-mosaic 
aneuploidy in embryos.
Age All
n
Karyotyped 
n (%)
Embryos 
Aneuploid 
n (%)
Hyper Hypo 
n n
> 1
n
<30 223 52 (23.3)a 7 (13.5)b 4 3 0
30-34 396 91 (23.0) 18 (19.8) 8 6 4
35-39 109 26 (23.8) 6 (23.1) 3 3 0
>40 12 2 (16.7) 1 (50.0) 1 0 0
a Successfully karyotyped embryos expressed as a 
percentage of the total number fixed, 
b Aneuploid embryos expressed as a percentage of those 
karyotyped.
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7.4.4 Summary
Karyotype analysis of 178 diploid embryos revealed 
abnormalities in 40 (22.5%) cases. Single chromosome 
aneuploidy was detected in 19.1% of embryos, five cases 
(2 .8 %) involved two chromosomes and one embryo (0 .6 %) had 
both hyperploidy and hypoploidy involving three 
chromosomes. E group was most frequently involved in 
aneuploid karyotypes (10/23 hyperploid embryos) and 
trisomy 16 was detected in 2.2% of embryos. Two structural 
anomalies were recorded and four embryos were mosaic. The 
incidence of aneuploidy increased with maternal age but 
did not reach statistical significance (<30, 7/52 [13.5%]; 
30-34, 18/91 [19.8%]; 35-39, 6/26 [23.1%]; >40, 1/2 
[50.0%]). Embryo morphology and growth rate, assessed by 
EDR, did not distinguish between normal (mean score, 7.9; 
mean EDR, 96.1) and aneuploid (mean score 8.1; mean EDR,
92.1) embryos.
Numbers of hyperploid (n=17) and hypoploid (n=ll) embryos 
(non-mosaic cases involving single chromosomes) were not 
statistically different. Only one case of sex chromosome 
monosomy was detected. An excess of female karyotypes was 
detected in abnormal cases (sex ratio 0.48); this ratio 
was significantly (p<0.05) different from that observed in 
normal cases (74:64, XY:XX). Small numbers of karyotyped 
triploid embryos revealed equal proportions of XXX, XXY 
and XYY embryos (3:2:3).
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CHAPTER 8 
DISCUSSION
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8.1 Cytogenetic assessment of uncleaved oocytes: study
objectives and design
The cytogenetic study of oocytes remaining uncleaved after 
insemination in vitro had two aims. Firstly, to obtain 
corollary evidence to fertilisation rates and embryo 
quality for assessment of aspects of IVF methodology 
discussed previously. Secondly, metaphase of maternal 
meiosis II should reveal both the normal and abnormal 
products of the first meiotic division; the main source of 
chromosome anomaly in man (Hassold & Jacobs, 1984).
The initial division of data into three groups (6.2.1) was 
made to attempt to differentiate between these objectives. 
Oocytes remaining unfertilised in the presence of poor 
sperm should provide the most reliable information on the 
intrinsic abnormalities since they represent a largely 
unselected population. Oocytes remaining uncleaved after 
exposure to (apparently) good sperm may yield information 
on aspects of oocyte maturation which preclude normal 
fertilisation and/or cleavage. Differences between the two 
groups should suggest which, if any, chromosome 
abnormalities are incompatible with fertilisation.
Patients treated in the LORD study (2.5.3) were highly 
selected and have been considered separately.
Chromosome preparations were considered at two levels, 
requiring different degrees of quality. Accurate 
karyotyping for assessment of aneuploidy necessitated 
containment of the metaphase within a defined area and, 
conversely, with sufficient spreading of the chromosomes 
to allow unambiguous counting, grouping and karyotyping. 
Classification as meiotic or mitotic, estimation of ploidy 
and fragmentation and identification of penetrated sperm 
were considered adequate for more general study of oocyte 
maturity and development.
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8.2 Cytogenetic assessment of uncleaved oocytes: nuclear 
and cytoplasmic maturity
8.2.1 Absence of chromosomes
General analysis of 466 (71.4%) preparations was possible 
(Table 7.1.1). A proportion of the 167 preparations with 
apparent lack of chromosomes was certainly attributable to 
technical reasons but previous investigations suggest that 
some may reflect the true status of the oocyte.
A small proportion (4%) of whole oocytes stained with a 
fluorescent DNA specific stain showed lack of concentrated 
fluorescence within the ooplasm despite clear PB staining 
(Van Blerkom & Henry, 1988). Electron microscopy revealed 
chromosomes, each within a nuclear membrane, distributed 
throughout the oocyte. The phenomenon appeared to 
predominate in CC/hMG treated cycles and was not observed 
in a similar study (Van Wissen et â i » / 1991) of oocytes 
retrieved after hMG or GnRH-a/hMG stimulation. Small 
nuclei found in oocytes without identifiable chromosomes 
after conventional cytogenetic preparation (Wramsby & 
Fredga, 1987) may represent the same abnormality.
Complete lack of chromosomes after fixation has been 
reported at rates from 3.3 to 34% (Bongso et al.., 1988; Ma 
et a l . . 1989; Pellestor & Sele, 1988; Selva et al., 1991; 
Tarin et al., 1991a; Wramsby & Fredga, 1987; De Sutter et 
al., 1991), with the majority similar to the 25.6% 
observed in the present study. A relationship with 
extended in vitro culture time was excluded (Table 7.1.4). 
The widely used technique of oocyte fixation developed by 
Tarkowski (1966) (with or without modification) has been 
criticised for causing chromosome scatter (Mikamo & 
Kamiguchi, 1983a) and is unlikely to yield reliable 
information on any real developmental defect.
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8.2.2 Chromosome fragmentation
Total fragmentation of the chromosome complement was 
detected in 8.1% of informative analyses (Table 7.1.1).
The inherent nature of material available for cytogenetic 
analysis has led to the suspicion that fragmentation 
represents an in vitro ageing process (Veiga êi al., 1987) 
but no relationship with insemination to fixation interval 
was detected (Table 7.1.4). These data support results 
from Tarin gt a l ., (1991a) who compared non-inseminated
eggs fixed four hours after recovery with a group 
processed after 52 hours, following fertilisation failure.
Fragmentation was equally prevalent in age groups under 40 
but significantly higher (45.0%; p<0.001) in oocytes 
recovered from women over 39, possibly contributing to the 
reduced fertilisation rate in older women (Table 7.2.5). 
The suggestion that oocytes may be directly affected by an 
age related increase in FSH (Tarin ei ai., 1991a) should 
be treated with caution. Sub-optimal responses to ovarian 
stimulation in women with elevated FSH concentrations in 
the perimenstrual period (Toner gi a l . , 1991) have been 
reported and an influence of prolonged, high doses of 
exogenous gonadotrophins cannot be excluded.
8.2.3 Nuclear maturity
Meiosis had progressed to metaphase II in 85.6% of 
informative preparations (Table 7.1.1). Bivalent 
separation had occurred in 28 (6 .0 %) cells without 
evidence of migration of homologues to opposite poles. 
Classification of this stage has presented some 
difficulties since it is not a 'true' stage of meiosis; 
the term 'diploid metaphase II' has become accepted. The 
weight of evidence from experimental (Tarin et al., 1991a) 
and cytological (Chandley, 1971; Plachot ^  al., 1987) 
data suggests that these oocytes are arrested.
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High ovarian response to stimulation facilitated by GnRH-a 
suppression was reported to produce significantly more 
immature oocytes, unable to proceed through nuclear 
maturation (Tarin & Pellicer, 1990). This led to the 
suggestion that criteria for hCG administration should be 
changed in analog treated cycles to increase the follicle 
size, and oocyte maturity, at OR. The present study failed 
to show any relationship between the frequency of diploid 
metaphase 2 oocytes and either number of oocytes recovered 
(Table 7.1.6), follicle size (Table 7.1.7) or maturation 
time before insemination (Table 7.1.3).
8.2.4 Cytoplasmic maturity
Schmiady al. (1986) first described inappropriate 
condensation of G1 phase sperm chromosomes in apparently 
unfertilised metaphase II oocytes. The phenomenon has been 
explained by inability of the oocyte to respond to 
fertilisation and retention of chromosome condensing 
factors in the cytoplasm (Schmiady & Kentenich, 1989) . 
Cytoplasmic capacity to décondense sperm heads develops 
with nuclear maturity (Lopata & Leung, 1988) as critical 
factors accumulate in the ooplasm after GVBD (Clarke & 
Masui, 1986). Normal PN formation is possible after 
metaphase I/II transition (Lopata & Leung, 1988; Iwamatsu 
& Chang, 1972).
A possible relationship between diploid metaphase II and 
cytoplasmic immaturity is suggested by the higher rate of 
PCC of sperm chromosomes in diploid meiotic cells (32.1%) 
than in those which had completed the first division 
(9.3%).
Relatively few oocytes remained uncleaved during LORD 
study 2 , reflecting choice of patients for inclusion 
(2.5.3). The incidence of cytogenetic abnormality was 
high, with only 24/52 (46.1%) of informative oocytes in
187
metaphase II without evidence of fertilisation (Table 
7.1.3). Eleven of 17 (64.7%) metaphase II cells recovered 
after 34 hours and inseminated immediately contained 
prematurely condensed sperm chromosomes. This compares 
with an incidence of 6.7% in non-LORD cases with normal 
semen (Table 7.1.2 and, although numbers were small, 
appeared higher than other LORD groups which had matured 
longer before insemination. These data suggest asynchrony 
between completion of meiosis I and development of 
cytoplasmic competence, correctable by additional in vivo 
or in vitro maturation.
The incidence of PCC of sperm chromosomes appeared to 
increase with the degree of ovarian response (Table 
7.1.6). Development of more follicles, while applying the 
same day 0 criteria, would result in an increase in the 
number of medium and small follicles. Absence of an 
association between PCC and follicle volume (Table 7.1.7) 
did not support this hypothesis.
8.2.5 Zona/membrane permeability
Fertilisation rates were positively correlated with 
follicle size (Table 3.4.1) and cumulus expansion (Table
3.4.2). Despite their assumed immaturity, uncleaved 
oocytes from small follicles and those with an immature 
cumulus did not exhibit increased evidence of nuclear or 
cytoplasmic immaturity (Tables 7.1.7 and 7.1.8). Eighty- 
five percent of oocytes recovered from FF volumes <2.5ml 
and 84% lacking complete cumulus expansion were at 
metaphase II without evidence of sperm penetration. These 
data suggest that zona pellucida and/or vitelline membrane 
penetration may be dependent on the stage of follicular 
growth or optimal cumulus development; an association 
between these parameters has been demonstrated (Table
3.4.3).
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A change in zona resistance to sperm penetration is 
concurrent with metaphase I/II transition Tesarik ei â i *, 
(1988) and is associated with impregnation of the outer 
zona with cumulus cell-secreted proteoglycans (Tesarik & 
Kopecny, 1986). Changes are visible at the ultrastructural 
level (Familiari ei ab., 1988) and may be related to 
sperm-binding mechanisms.
It is of interest that total sperm penetration rates 
(fertilised oocytes + PCC , Tables 3.3.8 and 7.1.3) in 
LORD study 2 indicated that sperm penetration had occurred 
with equal frequency in each group. This suggests that a 
34 hour interval from initiation of lutéinisation to 
insemination is sufficient for final zona pellucida 
maturation, if development to that stage has been optimal.
8.2.6 Oocyte activation
Chromosome morphology was indicative of mitotic metaphase 
in 22 (4.7%) oocytes which had not cleaved. Only five of 
these oocytes had PN visualised prior to fixation. 
Colchicine had not been used during preparation and 
mitotic arrest rather than chance observation of the 
transient metaphase stage seems probable.
It is known that a proportion of oocytes fertilised in 
vitro subsequently fail to cleave (Fishel et a b ., 1988; 
Testart et ad., 1983b) and this explanation must account 
for the 46,XY karyotype in the present study. Cytoplasmic 
incompetence due to immaturity, ageing or an effect of 
manipulation may be implicated.
Mitotic chromosomes were rarely identified in oocytes 
fixed on day 2 or 3 after insemination but represented 
21.7% of informative cases fixed after 70 hours in culture 
(Table 7.1.4). In vitro ageing may eventually lead to an 
increase in zona permeability (Tesarik, 1989) with
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concurrent ooplasm degeneration preventing cleavage but 
the ability of mouse embryos to react to parthenogenetic 
stimuli also increases with time (Kubiak, 1989). 
Extrapolation to the human may not be valid since the 
phenomenon appears species specific (Zeilmaker & Verhamme, 
1974).
Three uncleaved oocytes with a haploid complement of 
mitotic chromosomes were parthenogenetic in origin (Table
7.1.1). This chromosome constitution is not incompatible 
with cleavage (Angell et a l ., 1986a, Table 7.3.1) but 
endoreduplication may be the origin of diploid (Angell eJt 
a l .. 1991) and tetraploid cases. Another origin was 
suggested by the data of Balakier and Casper (1991) who 
reported that 13% of oocytes fixed between 43 and 67 hours 
had undergone spontaneous activation while retaining PB2.
8.2.7 The relationship between cytologic and cytogenetic 
assessment of oocyte maturity
The presence of PBl in the vitelline space is generally 
considered evidence of successful completion of meiosis 1 
(Veeck, 1988). This observation appears to be subject to 
considerable error since only 22/60 oocytes with no PB 
visualised at the time of fixation (Table 7.1.10) had 
chromosome complements compatible with their PB status. 
Apparently normal metaphase II oocytes predominated. 
Degeneration (Balakier and Casper, 1991) or complete 
fragmentation may be responsible.
Metaphase II was correctly diagnosed by PBl extrusion in 
the majority of cases (Table 7.1.10) but eight appeared to 
retain all meiotic chromosomes. Misdiagnosis was also made 
in 13/15 cases with 2PB and all seven with three PB or 
fragmented material remained at metaphase II. Electron 
microscopy has shown retention of coronal material in the 
vitelline space after retraction of cytoplasmic processes
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(Sundstrora et a l ., 1985; Van Blerkom ei â l . , 1987); this 
may be mistaken for extruded ooplasm. Initial extrusion of 
PBl into two structures (Spielman et ai., 1985) and 
spontaneous division of PBl (Ortiz ^i 5lL« / 1983) have also 
been observed.
Thirty-one oocytes which failed to cleave after PN 
visualisation were fixed for analysis (Table 7.1.9). Five 
of 13 informative analyses were at metaphase II without 
evidence of sperm penetration. These errors may reflect 
the limitations of stereo microscopy for differentiating 
PN, restitution nuclei (Van Wissen ei a l ., 1991), vacuoles 
(Van Blerkom et al., 1987) and mitochondria/vesicle 
complexes (Sundstrom ei â l - / 1985).
Two oocytes with more than three PN were successfully 
analysed and showed only multiple sperm nuclei with PCC. 
Human oocytes penetrated by more than three sperm rarely 
undergo syngamy (Wiker ei ^ . , 1990), probably due to 
limited supply of cytoplasmic factors required for male PN 
formation (Tesarik & Kopecny, 1989). Penetration of mouse 
oocytes by more than six sperm caused decondensation or 
pycnosis of maternal chromosomes (Clarke & Masui, 1986). A 
similar process may explain the apparent lack of maternal 
chromosomes in oocytes with multiple PCC (Table 7.1.1).
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8.3 Cytogenetic assessment of uncleaved oocytes: detailed 
analysis
Abnormalities were detected in 24.2% of oocytes in this 
study (Table 7.2.2) and were more diverse than previous 
published studies (Bongso êi al., 1988; Ma et g b . , 1989; 
Wramsby & Fredga, 1987; Angell ei â l « / 1991). The majority 
of abnormalities (32/43; 74.4%) were conventional 
aneuploids (Tables 7.2.1, 7.2.2) and, although hyperploidy 
and hypoploidy occurred with equal frequency, acrocentric 
were over-represented in aneuploid karyotypes. An apparent 
increase in the incidence of aneuploidy with maternal age 
(Table 7.2.6) was not statistically significant.
In addition, 10 chromosome complements contained 22 whole 
chromosomes with the missing homologue replaced by two 
individual chromatids; the majority (n=6 ) involved 
chromosome 16. A single chromatid represented a missing C 
chromosome in a karyotype with two other deficiencies. Two 
structural anomalies were recorded.
The overall incidence of abnormality was not different in 
cases with normal or deficient sperm parameters (Table
7.1.2) or between metaphase II cells with and without PCC 
of sperm chromosomes (Table 7.2.2). These observations 
imply that no selection against aneuploid oocytes had 
occurred at fertilisation.
Chromosome analysis of human female meiotic material 
presents considerable technical difficulties attributable 
to four factors; chromosome morphology, chromosome 
scatter, inapplicability of banding techniques and the 
presence of only one cell per case. An internal quality 
control (Table 7.2.3) suggested that results accurately 
represent the incidence of numerical abnormalities in the 
material studied.
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8.4 Mechanisms leading to abnormality
8.4.1 Whole chromosome aneuploidy
Reciprocal hyperploidy and hypoploidy are implicit in 
classical non-disjunction, as described by Bridges (1913;
5.1.3) but other mechanisms lead primarily to chromosome 
loss (Ford & Lester, 1982; Eichenlaub-Ritter gt a l ..
1988). The presence of only one cell per slide in oocyte 
cytogenetic preparations facilitates accurate diagnosis of 
hyperploidy but interpretation of chromosomally deficient 
cells is more problematical. Because it is impossible to 
differentiate between a chromosome lost artificially and 
genuine hypoploidy, some authors have ignored all 
complements of <23 (Angell ^t a l ., 1991) or included them 
for discussion but expressed the aneuploidy rate as 2 x 
hyperploidy (Tarin et a l ., 1991a). This problem would be 
obviated if the karyotype could be verified from other 
cells, as is considered mandatory for diagnostic 
cytogenetics (Ferguson-Smith & Ferguson-Smith, 1983) .
Efforts were made to exclude over-spread cells and only 
metaphase spreads with > 2 0  chromosomes were included in 
this study. This cut-off point was made retrospectively 
after analysis of oocytes and embryos showed a maximum of 
two additional chromosomes in any cell. Within these 
limitations, it can be concluded that hyperhaploidy and 
hypohaploidy of single chromosomes occur with equal 
frequency in metaphase II oocytes. The observation that 
hypoploidy was confined to younger (<35, Table 7.2.6) was 
not supported by analysis of embryos (Table 7.4.7).
The preponderance of trisomie acrocentric chromosomes in 
human spontaneous abortions may represent an excess of 
these anomalies in female gametes (Table 5.2.2). Fifty 
percent of disomic oocytes in this study had an extra D or 
G group present, 12/12 hyperhaploid oocytes reported by
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Plachot et al. (1987) and 4/7 by Ma et al. (1989) involved 
groups D and G.
The phenomenon of satellite association between 
chromosomes carrying NORs was first observed in 1961 
(Ferguson-Smith & Handmaker, 1961) in stimulated 
lymphocytes. During mitotic interphase the NOR regions of 
chromosomes 13, 14, 15, 21 and 22, containing the 
ribosomal genes, become fused into common nucleoli 
(Schwarzacher et al., 1978). The fibrillar centre of this 
structure contains an argyophilic protein which decreases 
during mitosis (Schwarzacher et al., 1978) but is still 
present in the bridge joining associated chromosomes at 
metaphase. Mirre et al. (1980) studied prophase I oocytes 
from 16-24 week foetuses and confirmed that the ribosomal 
genes of 4-12 chromatids (1-3 bivalents) are juxtaposed in 
the same silver-staining structure during meiotic 
prophase. The possibility that this phenomenon might lead 
to non-disjunction has been widely discussed (Henderson et 
a l .. 1973; Nakagome, 1973; Hansson, 1979; Jacobs & Mayer, 
1981). Support for this theory comes from the observation 
that chromosome 2 1 is more commonly involved in satellite 
associations in parents of Down's syndrome children 
(Hansson & Mikkelsen, 1978) and an association between 
carriers of an acrocentric chromosome with a double NOR 
detected by silver staining and parents having children 
with Down's syndrome. The anomaly was found in the parent 
in which non-disjunction occurred but was not always on 
the trisomie chromosome (Jackson-Cook â Â . , 1984).
The applicability of mouse embryo cytogenetics to the 
human has been questioned since all mouse chromosomes are 
acrocentric. However, each mouse bivalent contains two 
independent nucleoli, without a common fibrillar centre. 
These important species differences suggest that attempts 
to find a model for human chromosome defects must consider 
more than simple chromosome morphology.
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Eight diploid metaphase II cells were karyotyped; all had 
a 46,XX chromosome complement. These oocytes arise from 
retention of PBl and thus contain all chromosomes present 
in the primary oocyte and would thus indicate the 
occurrence of pre-existing aneuploidy. This might arise 
from cryptic mosaicism in a parent or a de novo mitotic 
error in the ovary. This small number of analyses supports 
data from pachytene oocytes (Hulten ei a l ., 1985) which 
had a very low incidence (1/459; 0.2%) of supernumerary 
chromosomes suggesting a minimal contribution of pre­
existing aneuploidy to the genetic load in the female 
gamete.
8.4.2 Mechanisms leading to single chromatids in 
metaphase II oocytes
Angell (1991) was first to unambiguously describe single 
chromatids in unfertilised human oocytes although 6/411 
metaphase II cells examined by Jagiello et al.. (1976) 
"probably contained a separation of a small chromosome". 
Anomalies were detected in 5 of 44 completely analysed 
metaphase II cells. Four cells had 22 whole chromosomes 
plus 2 individual chromatids representing the missing 
homologue; groups D, E, F and G were involved. Only one 
cell had missing material; 22, +cht(C). It is of interest 
that these cases, and the present study, primarily 
detected cells with both chromatids present. Animal 
studies have almost exclusively reported missing or 
additional single chromatids (Hansmann & El-Nahass, 1979; 
Hummler et aJ^., 1987; Polani & Jagiello, 1976; De Boer & 
van der Hoeven, 1980; Mikamo & Kamiguchi, 1983b), and 
different mechanisms might be involved.
These examples involve spatially separated chromatids of 
individual chromosomes and apparently differ from the more 
general phenomenon of chromatid separation observed in 
20.2% of human oocytes (Tarin ei al., 1991a). However,
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artefact cannot be completely excluded (Polani & Jagiello, 
1976), especially when both chromatids are present.
Two meiotic anomalies leading to the existence of 
individual chromatids in metaphase II oocytes have been 
postulated. The first results from the presence of 
univalents during the first reduction division. Darlington 
(1937) indicated that the behaviour of unpaired 
chromosomes is similar, irrespective of their method of 
origin, thus information from hybrids, organisms with 
numerical abnormalities and failure of bivalent formation 
are relevant. Univalents lie at random on the spindle at 
metaphase and their subsequent behaviour is dependent on 
their position relative to the poles and equator. Those 
close to a pole become incorporated in a daughter cell, 
either oocyte or polar body (post-division) or become lost 
in the cytoplasm (Figure 22). Unpaired chromosomes near 
the equator are able to orient themselves axially and 
divide into single chromatids (pre-division) which migrate 
to opposite poles. The movement of both chromosomes and 
chromatids may be delayed, relative to normal bivalents 
(Figures 23 and 24)
The consequences of univalent formation may be species 
dependent. Approximately 5% of Drosophila melanoaaster X 
chromosomes do not undergo genetic exchange (Bond & 
Chandley, 1983), suggesting asynapsis. This incidence far 
exceeds that of aneuploid offspring and provides 
circumstantial evidence of regular segregation of unpaired 
bivalents. Cytogenetic examination of the univalent X 
chromosome of the mantid Humbertiella indica (Hughes- 
Schrader 1948) detected both lagging and segregation of 
chromatids to opposite poles. Michel and Burnham (1969) 
observed 13.1% equatorial division of univalents in maize 
and an additional chromatid was the most frequent 
abnormality detected in spermatocytes of trisomie newts 
(Guillemin, 1980).
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Figure 22
Illustration of random segregation of asynaptic univalents 
at metaphase I.
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Figure 23
Diagrammatic representation of predivision of asynaptic  
univalents during meiosis.
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Figure 24
Diagrammatic representation of predivision of desynaptic  
univalents during meiosis.
Interpretation of the present results and those of Angell 
(1991) as chromosome pre-division is dependent on the 
occurrence of univalents during the prolonged human 
prophase due to either failure or breakdown of synapsis. 
Wallace and Hulten (1985) observed univalents in 1/122 
pachytene preparations using light microscopy, an 
incidence similar to that detected by Speed (1985; 2/154). 
However, EM suggested a much higher rate of 10.5% (17/162; 
Speed, 1985); ten times the incidence of pairing anomalies 
detected in mouse by the same investigator (Speed & 
Chandley, 1983).
Combined data from Angell (1991) and the present study 
suggest that the majority of individual chromatids 
represent the smallest chromosome groups. Fourteen of 16 
cases involved chromosomes identified as D, E, F or Gs, 
which represent only 45% of the autosome complement. The 
smaller components of both mouse and Chinese hamster are 
most frequently involved in univalents (Luthardt ei a l .. 
1973a; Speed, 1977; Sugawara & Mikamo, 1983), possibly 
related to lower chiasma frequency (Henderson & Edwards, 
1968).
The relationship between univalents and aneuploidy at 
metaphase II has been questioned (Polani & Jagiello, 1976; 
Speed, 1977). The most convincing evidence of lack of 
relationship comes from investigation of the Chinese 
hamster (Sugawara & Mikamo, 1983), selected because of 
it's small number of chromosomes and four distinct 
morphological groups. Univalents were most frequent in the 
smallest class but hyperploidy occurred with equal 
frequency in all categories. A circumstantial relationship 
between univalent X and Y chromosomes during male meiosis 
in the human (Laurie & Hulten, 1985) and sex chromosome 
hyperploidy in sperm (Martin & Rademaker, 1990) does exist 
however.
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The second meiotic abnormality leading to individual 
chromatids was first described in Neurospora crassa by 
Threlkeld and Stoltz (1970). They postulated that one 
homologue of a bivalent could undergo precocious division 
during meiosis I. One daughter cell would inherit a 
complete chromosome and a chromatid, the other a single 
chromatid. This mechanism is compatible with observations 
in mouse (Hansmann & El-Nahass, 1979; Polani & Jagiello, 
1976) but the observed defects in human oocytes would 
require precocious division of both homologues.
Any relationship between individual chromatids present at 
metaphase II and subsequent trisomy would require 
retention of both chromatids within the oocyte nucleus 
after fertilisation and normal replication before syngamy. 
Little evidence exists but Ostergren (1947) reported 
equatorial division of univalents in Anthoxanthum 
resulting in single chromatids which were unable to divide 
at metaphase II and were lost from the spindle.
One consequence of this mechanism would be that 
centromeric markers would be heterozygous and, therefore, 
indistinguishable from the products of classic non- 
disjunction in the embryo (Figures 13, 23 and 24).
Chromosome 16
The involvement of chromosome 16 in 6/11 cases with 
individual chromatids in this study (Table 7.2.1) is of 
particular interest given the high incidence of trisomy 16 
in human abortions (Table 5.2.2). Circumstantial evidence 
has suggested that the number of detected cases cannot be 
wholly attributed to differential survival of equally 
frequent abnormalities since trisomies 13,18 and 21 all 
occur less frequently but appear to be subject to reduced 
selection; surviving to later gestations or to term.
198
Analysis of chromosome 21 (Sherman ei aj,., 1991) in 
trisomie individuals had shown a reduced frequency of 
genetic recombination. This would be consistent with a 
defect of synapsis which might predispose to univalent 
formation. The same pattern was not found in a similar 
investigation of 26 cases of trisomy 16 (Hassold si a l ., 
1991). However, univalent formation can result from both 
non-conjunction and desynapsis and different mechanisms 
might operate in the two chromosomes as suggested by the 
different distributions of maternal age (Hassold & Jacobs,
1984). The presence of a large heterochromatic block at 
the centromere of number 16 may be relevant (Angell,
1991). The only chromosome showing an increased frequency 
of disomy in human sperm is number 9 (Martin & Rademaker,
1990), which also has a large C-banding centromeric 
region. Reduced pairing of regions thought to correspond 
to centric heterochromatin in chromosomes 1, 9 and 16 has 
been observed at pachytene (Wallace & Hulten, 1985). No 
relationship between heterochromatic variants and 
reproductive failure has been found (Bobrow, 1985) 
although assessments have been largely subjective.
8.4.3 Structural abnormalities
Only two structural anomalies, of doubtful significance, 
were recorded during the study. This may under represent 
the incidence of chromosome breakage and/or rearrangement 
in unfertilised oocytes. The decision to ignore 
centromere, chromatid and chromosome gaps and breaks 
without major displacement of components was imposed by 
the material under analysis. The recognised phenomenon of 
chromatid separation (Tarin et. al., 1991a; Rodman, 1971) 
in mammalian metaphase II material and the propensity for 
fragmentation (Papadopoulos et a l ., 1989; Selva et a l ..
1991) encouraged conservative interpretation of anomalies 
which might be attributable to preparation artefact. This 
approach was supported by the low incidence of
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rearrangements detected in embryos (Table 7.4.1). Absence 
of banding also precluded identification of deletions, 
translocations and inversions which did not dramatically 
alter chromosome proportions.
Excluding chromatid separation, extensive fragmentation 
and PCC, combined data from nine studies (Angell et a l .. 
1991; Bongso ^  aJL., 1988; Djali ei al., 1988; Martin et 
a l .. 1986; Plachot et a l ., 1987; Tarin â i • / 1991a;b; 
Veiga ei a l ., 1987; Wramsby Qt a l ., 1987) which specified 
the presence or absence of this category of abnormality 
reported 4/853 (0.5%) structural abnormalities. Eighteen 
percent (24/132) of oocytes examined by Selva et a l ..
(1991) had 1-5 chromosome breaks. It is possible that, as 
in this study, authors have interpreted these anomalies as 
preparation artefacts.
8.4.4 Factors affecting the incidence of abnormality
The lack of association between the incidence of 
abnormality and any aspect of IVF methodology (7.2.4) is 
of considerable interest. It implies that IVF does not 
increase the genetic load during oocyte development and 
that the results of this study can be extrapolated to in 
vivo reproduction.
The overall incidence of abnormalities in oocytes was 
similar in all groups under the age of 40. However, 2/3 
cells in the over 40 group were aneuploid and the 
incidence of hyperploidy, the more reliable numerical 
abnormality because of the fixation method, was 
significantly higher (p<0.01) in women > 35 (Table 7.2.6). 
The marked reduction in preparation success with maternal 
age (Table 7.2.6) could not be fully explained by the 
concurrent increase in fragmentation (Table 7.2.5) but 
might be related to an age dependent effect on chromosome 
morphology, as found in the mouse (Speed, 1977).
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The detected contribution of maternal age to the incidence 
of aneuploidy in human oocytes has varied in published 
reports. Both the multi-centre study reported by Plachot 
et a l . (1988a) and smaller numbers from Ma âi* (1989)
detected an increase with age but Pellestor and Sele,
(1988), Selva ad. (1991) and Djalali et ad. (1988) 
failed to find an association. The last study reported a 
considerable excess of hypoploid cells and this may 
highlight a problem of interpretation in all studies.
The most extensive data on maternal age and trisomy has 
accumulated for Down's syndrome and two components to the 
rate of change have been described (Hook, 1985), 
consistent with an age dependent and an age independent 
contribution to the overall incidence, estimated at 35-50% 
and 50-65% respectively. Trisomy 18 shows a parallel 
pattern but the apparent age dependent component for 
trisomy 13 is less marked. The age related increase for 
trisomy 16 in spontaneous abortions is much less 
pronounced. In the light of evidence that more than one 
mechanism, affecting different chromosomes, induces 
abnormality in human oocytes, it is of considerable 
importance to obtain reliable information on all age 
groups. Less destructive techniques might yield better 
information in older women but the nature of the 
population undergoing IVF generally precludes study of 
those under 25.
The theory of pre-division of chromosomes is dependent on 
an increased frequency of univalents in older women. This 
relationship has been established in the mouse (Polani & 
Jagiello, 1976; Henderson & Edwards, 1968; Luthard gt a l ., 
1973) and Chinese hamster (Sugawara & Mikamo, 1983) but 
the mechanism underlying the increase remains 
problematical. Henderson and Edwards (1968) postulated the 
production-line theory which supposed that those oocytes 
which enter meiosis late in foetal life fail to form
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bivalents and that these are the last oocytes to ovulate. 
No relationship between foetal age and pairing defects was 
detected in two strains of mouse (Speed & Chandley, 1983) 
and an effect in the maternal gonad at the time of final 
maturation has been favoured (Speed & Chandley, 1983; 
Sugawara & Mikamo, 1983). However, evidence of reduced 
crossing-over in chromosome 21 in Down's suffers (Sherman 
et a l .. 1991) may redirect interest to foetal development.
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8.5 Cytogenetic assessment of early embryos
8.5.1 Incidence and types of abnormality in diploid
embryos
The incidence of abnormality detected in diploid embryos 
(40/178, 22.5%) was similar to that found in oocytes 
(24.2%). This is of interest given the almost exclusively 
maternal origin of the extra chromosome in trisomy 21, 
based on RFLP analysis (Antonarakis, 1991; Sherman et a l ..
1991). The data also implies a minimal contribution from 
metaphase II anomalies, when any temperature induced 
anomalies caused by IVF methodology would be manifest 
(Pickering et a l ., 1990).
This overall incidence is similar to that reported by 
Angell ei aJL. (1986a; 23%, 7/30) but the present study is 
the first with sufficient numbers to address the question 
of relative frequencies of abnormalities. All previous 
estimates of the types and incidence of abnormalities at 
conception have relied on extrapolation of data from early 
abortions, both spontaneous (Boue ei a l ., 1975) and 
induced (Burgoyne et a l ., 1991).
As in oocytes (Table 7.2.4), abnormalities were not 
detected with equal frequency in chromosome groups. Ten of 
23 trisomie chromosomes were from the E group with trisomy 
16 the most frequent single abnormality (Table 7.4.3), 
comprising 2.2% of diploid embryos. Whole chromosome 
aneuploidy for chromosome 16 was not seen in oocytes and 
the frequency of the anomaly in embryos provides 
corroborative evidence that pre-division, visualised as 
single chromatids at metaphase II, represents the origin 
of trisomy 16. Two embryos had one additional number 18 
and tetrasomy 18 was found in three analysable spreads of 
a four cell embryo (Figure 21b). This last example can be 
explained by either a first and second meiotic error in 
the oocyte (or sperm) or the same anomaly arising in both
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gametes. To the author's knowledge no similar tetrasomy 
has been identified in material from clinical pregnancies.
Hyperploidy of an A group was not found in either oocytes 
(Table 7.2.4) or embryos (Table 7.4.3). Trisomy 1 has not 
been detected in any clinical pregnancy but was found in a 
preimplantation embryo (Watt et âl»/ 1987) and attributed 
to the presence of two male contributions. Disomy 1 has 
also been identified in 4/6821 sperm chromosome 
complements (Martin & Rademaker, 1990); an incidence 
similar to other aneuploidies.
Two structural abnormalities were detected (Table 7.4.1) 
but only one was consistent. A two cell embryo with even 
blastomeres and minimal fragmentation had a missing D 
group chromosome replaced by an apparently bisatellited 
fragment in both cells. Unfortunately parental karyotypes 
could not be obtained but this embryo may represent de 
novo origin of a marker chromosome which has caused 
considerable problems during diagnostic chromosome 
analysis, especially prenatal diagnosis (Buckton êi a l ..
1985). The other anomaly involved apparent breakage of a C 
chromosome in 1/2 cells. Artefact cannot be excluded but 
Angell et ^ . , (1986a) has shown evidence of a break being
transmitted through at least two divisions.
The incidences of hyperploidy (n=17) and hypoploidy (n=ll) 
for single chromosomes were not statistically significant. 
In the absence of chromosome banding, the hypoploid group 
would include 45,X karyotypes which represent almost 20% 
of abnormalities in spontaneous abortions (Table 5.2.1). 
One embryo was tentatively assigned this diagnosis (Table 
7.4.1) but both sex chromosomes could be identified in all 
other embryos with a missing C group chromosome. This 
substantiates evidence that sex chromosome monosomy arises 
after fertilisation.
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Single chromosome aneuploidy was detected in 19.1%
(34/178) of diploid embryos, five (2.8%) embryos had 
double aneuploidy and one (0.6%) embryo has both 
hyperploidy and hypoploidy involving three chromosomes 
(Table 7.4.2). These incidences suggest that non­
disjunction of individual chromosomes occurred 
independently with double and triple aneuploidy occurring 
at frequencies predicted by the basic incidence. A similar 
relationship has been observed in spontaneous abortion 
material (Boue et ai-, 1985).
An excess of male karyotypes was found in normal embryos 
(7.4.2) and the sex ratio of 1.15 was significantly 
(p<0.05) different from that of those with abnormalities 
(0.48). Male karyotypes were also found in excess in 
normal spontaneous abortions (Boue et ^ . , 1985) but 
individual anomalies showed different patterns. The lowest 
sex ratio of 0.29 was found in trisomy 9, trisomy 16 has 
almost equal numbers of males and females and trisomy 21 
has a ratio of 1.67. These results have been attributed to 
differential survival of embryos. Additional data from 
embryos will be required to confirm this unexpected 
finding.
The presence of more than one analysable cell per embryo 
allowed corroboration of the analysis in 49 diploid and 
six other embryos (Table 7.4.6). The proportion of 
aneuploidy in these cases (26.5%) was not different to 
that detected in single cells (19.4%). Three of four 
diploid mosaic cases had one normal and one hypoploid 
cell, making artefactual loss the most likely explanation. 
An embryo with one apparently normal and one hypoploid 
cell may be of more interest given the suggested origin of 
mosaic cell lines in abortus material (Hassold, 1982). 
Accurate estimates of the extent of mosaicism are required 
to validate methods of preimplantation diagnosis. One
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unusual embryo with an unstable cell line (32/29/29) 
highlights this problem.
8.5.2 Incidence and types of abnormality in non-diploid 
embryos
Three of five successfully karyotyped haploid embryos had 
a 23,X complement and one was disomic for a C group 
chromosome; the fifth was mosaic, probably due to 
artefactual chromosome loss (Table 67). All reported 
haploids have had an X chromosome (Angell ei al., 1983, 
Plachot êi â l - / 1987), consistent with maternal origin and 
an incidence of aneuploidy similar to that detected in 
oocytes (26%; Plachot al., 1989).
Although only a small number of triploid embryos were 
fully karyotyped, it is worth comment that 3/8 cases where 
the sex chromosome constitution was established had an XYY 
complement. This substantiated observations by Plachot st 
a l . (1987), Ma et al. (1990) and Macas et (1988) and
confirms suggestions that under-representation of these 
cases in clinical pregnancies is due to very early 
pregnancy loss or ascertainment difficulties. An 
additional chromosome 16 was present in one embryo with 70 
chromosomes and four number 18s were identified in a 
triploid cell with several missing chromosomes.
The general availability of abnormally fertilised material 
has allowed extensive investigation revealing that most 
tripronuclear oocytes do not develop into triploid embryos 
(Kola et al., 1987; Angell et al., 1986b; Macas et a l .. 
1988). Three patterns of cytokinesis/chromosome behaviour 
have been observed (Kola et al., 1987). The most frequent 
(62%; 18/29) event involved cleavage directly into three 
cells resulting in severely abnormal, but not triploid, 
cells. Correction to a diploid complement occurred in 2/29 
cells after exclusion of one haploid complement; carrying
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the theoretical risk of hydatidiforra mole formation 
(Pattillo ^  al., 1981). Only 24% of 3PN embryos formed 
triploid embryos.
8.5.3 Success rate of preparations
The proportion of successfully karyotyped embryos 
(193/816; 23.6%) was similar to that reported by Angell et 
a l . . (1986a: 22/69; 31.9%) in a study of embryos generated 
for research purposes. This poor preparation efficiency 
has implications for preimplantation diagnosis which would 
be performed on those embryos intended for ET, rather than 
supernumerary examples such as the present study. Wilton & 
Kola (1990) have reported considerable success in 
analysing all cells of eight cell mouse embryos to the 
extent of identifying a specific translocation but it 
remains to be seen if preparations of sufficient quality 
for complete analysis can be obtained from human material 
with any reliability.
This series had disappointing results from 3PN and 4PN 
embryos. This may have been related to the development of 
the technique primarily for diploid embryos. Tarkowski 
(1966) commented that alterations in hypotonic exposure 
and concentration are necessary for different stages of 
embryo development.
8.5.4 The relationship between PN status and ploidy
Approximately 2% of oocytes in the study has a single PN 
visualised, an incidence similar to that reported by 
Plachot et ajL. (1988b) and indicative of parthenogenetic 
activation in the mouse (Kaufman, 1982). However, this 
diagnosis was only confirmed in three of nine cases; five 
embryos were diploid and the presence of a Y chromosome 
suggested normal fertilisation was probable in two cases. 
Although a simple error cannot be excluded, the transition
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of 2PN into a single structure has been observed (Angell 
et a l ., 1986a). Asynchrony of male and female PN might 
also occur and would explain the opposite situation where 
an additional PN appeared during culture (Staessen & Van 
Steirteghem, 1992).
Observation of 2PN within the normal examination period 
was associated with a diploid chromosome complement in the 
majority (155/167; 92.8%) of cases. A further five embryos 
were tetraploid. Duplication of a normal complement would 
be consistent with the proposed origin in spontaneous 
abortions (Kajii & Niikawa, 1977) and provides evidence 
that the anomaly could occur during the earliest stages of 
development. The origin of the additional set of 
chromosomes could not be determined in the 3/4 triploid 
embryos which had 2PN but the sex chromosome constitution 
of 2/3 karyotyped cases was compatible with fertilisation 
of a diploid oocyte. The XYY karyotype of the fourth 
embryo suggests abnormal fertilisation and failure to 
observe one PN since diploid sperm have not been 
determined.
8.5.5 Maternal age
The incidence of aneuploidy increased with maternal age 
but the difference did not reach statistical significance 
(Table 7.4.7). No other study has included sufficient 
embryos to draw conclusions on the influence of age on the 
rate of aneuploidy but Bongso &t al. (1991) found no 
difference between the mean age of women with normal 
embryos (35.5) and those with any abnormality (36.5); all 
embryos were normally fertilised and the abnormal category 
included aneuploidy, structural defects, mosaicism, PCC 
and chromosome fragmentation.
A relationship between maternal age and the incidence of 
trisomy 21, in spontaneous abortions (Hassold & Jacobs,
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1984), prenatally diagnosed cases (Ferguson-Smith, 1983), 
and births (Penrose, 1934) is undisputed but the situation 
at conception has only been deduced. The theory of relaxed 
selection (Ayrae & Lippman-Hand, 1982) is largely 
discredited (Hook, 1983) and an oocyte donation programme 
has implicated the age of the recipient (endometrial age) 
as the factor affecting implantation and that of the donor 
(oocyte age) as influencing subsequent abortion rates 
(Levran et al., 1991). These data imply an increased 
incidence of anomaly at the time of conception in older 
women and are supported by the present study.
8.5.6 Chromosome constitution and embryo quality
Although embryo morphology and growth rate were shown to 
predict implantation potential (3.1.2), these parameters 
did not distinguish between normal and aneuploid embryos 
(Table 7.3.3). It has been suggested that poor quality 
embryos might be aneuploid (Martin et a l ., 1986) and that 
embryos not selected for ET on morphological grounds would 
give an artificially high estimate of the true incidence. 
The present data contradict this suggestion and imply that 
transferred embryos carry a similar genetic load.
Similarly, haploid, diploid and triploid embryos could not 
be distinguished by morphological parameters (Table 
7.3.3.). This confirms observations by Mettler and 
Michelman (1985) and corroborates the pattern of energy 
metabolism seen in abnormally fertilised embryos which did 
not differ from normal until after 3.5 days in culture 
(Hardy et al., 1989). The EDR of triploid embryos may be 
artificially high since a proportion divide directly into 
three cells (Kola et al.., 1987).
Quality was significantly (p<0.01) impaired in polyploid 
cases, casting some doubt on the potential of the most 
abnormal group and suggesting that abnormal nuclear
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behaviour may reflect incipient degeneration. Support for 
this hypothesis comes from the high rate of post 
fertilisation polyploidy, detected by measurement of the 
DNA content of the nuclei, in normally fertilised embryos 
which did not yield mitoses for cytogenetic analysis 
(Angell et • / 1987).
No attempt was made to compensate for slow growth rates by 
extension of colchicine exposure during embryo processing 
and mitotic index was used as an objective assessment 
(Table 7.3.4) of the rate of cell division. The proportion 
of cells entering metaphase during the time in colchicine 
was compared with their EDR. The number of metaphase 
plates was similar in all groups with an EDR greater that 
80 but significantly (p<0.001) lower in the 'slowest' 
category. The mean colchicine time of 19.3 hours was 7.7 
hours more than the calculated cell cycle length for the 
population and mitotic index would therefore be expected 
to indicate only severely retarded growth. Slight 
differences in cell cycle length in the three higher EDR 
groups might not have been detected.
8.6 Implications for in vivo reproduction
Although there appears to be no increase in the incidence 
of chromosomally abnormal conceptions in spontaneous 
abortions (Roesler et. ai., 1989; Plachot, 1989) after I VF 
or in births after assisted conception (M.R.C., 1990), 
extrapolation of IVF cytogenetic data to in vivo 
fertilisation should consider several factors which might 
influence results.
Firstly, infertile patients might be predisposed towards 
cytogenetic abnormality. No significant relationship 
between infertility diagnosis and aneuploidy could be 
detected in oocytes (Table 7.1.5) or embryos (Table 7.3.5) 
although patients with ovulatory disorders appeared to
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have an increased incidence of one and 3PN at 
fertilisation and a low aneuploidy rate. Direct comparison 
of fertile and infertile patients are sparse. Tarin ei 
a l .. (1991b) reported a lower overall frequency of
anomalies in oocytes from women who underwent ovarian 
stimulation prior to sterilisation than non-inseminated 
oocytes from an IVF programme (Tarin êi ai., 1991a) but no 
hyperploidy was detected in either group. The difference 
was attributable to diploid oocytes and chromosome 
fragmentation.
Time required to diagnose infertility and waiting time for 
treatment results in a higher mean age in women undergoing 
IVF than the general pregnant population. Figure 25 shows 
the distribution of maternal age at OR during the present 
study compared with that of pregnant women undergoing 
alphafetoprotein (AFP) screening for neural tube defects 
in the West of Scotland.
Protocols for induction of multiple follicular growth have 
been reported to increase the proportion of chromosome 
abnormalities in spontaneous abortions (Boue and Boue,
1973). In the human, the cohort of follicles which grows 
during the follicular phase develops from follicles with a 
diameter of 4-6mm of which 50% show some evidence of 
atresia (Chikazawa et. ad., 1986). It has been suggested 
that mouse follicles in the early stages of atresia can be 
'rescued' by pregnant mare's serum gonadotrophin (PMSG) 
administration (Peters et ad., 1975) and that sheep 
oocytes from secondary and tertiary stages of atresia 
retain developmental competence (Moor & Trounson, 1977) . 
Evidence that 50% human of oocytes recovered from 
follicles in advanced stages of atresia had nuclear 
abnormalities (Sanyal, 1979) has led to the suggestion 
that follicles re-recruited by exogenous gonadotrophins or 
GnRH-a (Banka & Erickson, 1985) might contribute 
significantly to anomalies detected in oocytes and embryos
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Figure 25
Age distribution of women undergiong AFP screening  
for neural tube defects and IVF for infertility.
from stimulated cycles (Pellicer eJt a l ., 1988). However, 
histology of human ovarian tissue surgically removed after 
hMG stimulation (Gougeon & Testart, 1990) suggested that 
all follicles were healthy at the time of 
recruitment/initiation of exogenous gonadotrophin.
Collaborative data reported by Plachot et al. (1988b) 
showed no difference in the proportion of chromosome 
abnormalities in oocytes after stimulation with CC/hMG, 
hMG, FSH or GnRH-a/hMG. Dosage of gonadotrophin did not 
affect the rate of anomaly in oocytes or proportion of 1,
2 and 3PN after insemination. Pre-hCG lutéinisation, 
observed in 24% of cases, did not increase the incidence 
of non-disjunction in unfertilised, mature oocytes 
(Plachot et âi» / 1988a). Cytogenetic comparison of oocytes 
stimulated using CC/hMG had a significantly higher 
incidence of anomalies associated with immaturity than 
those from GnRH-a/hMG cycles but the incidence of 
aneuploidy was unaffected.
The incidence of sister chromatid exchange in considered a 
more sensitive marker of mutagenicity than visible damage 
(Perry & Evans, 1975). Exchanges were four times more 
frequent in embryos from superovulated mice than after 
spontaneous ovulation (Elbling & Colet, 1985). Increased 
breakage would dispose towards chromosome rearrangements.
Although haploid embryos have not been detected in any 
abortus material it is likely that the parthenogenetic 
nature of the 'embryo' would limit embryonic development 
(Whittingham, 1980). Some aspects of IVF methodology may 
dispose towards oocyte activation. Use of nitrous oxide 
for the pneumoperitoneum was implicated in the high 
incidence of haploid embryos in early studies by Angell êi 
al (1986a). This substance is known to induce 
parthenogenesis in mice (Kaufman, 1983).
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Triploid karyotypes are found in 1-3% of clinical 
pregnancies conceived in vivo and the majority are caused 
by polyspermy (Jacobs et a l ., 1978). This figure does not 
include 3PN zygotes which did not develop to triploids 
(Kola ei , 1987) and a proportion of XYY embryos 
thought to be lost in early pregnancies. The incidence of 
3 PN after in vitro fertilisation has been shown to be 
influenced by differences in methodology among IVF 
programmes. Excessive growth of the leading follicle (Ben- 
Rafael ^  , 1986a), oocyte maturation time (Table
3.3.8), preincubation of oocytes before insemination 
(Trounson et ai., 1982b), method of follicle aspiration 
(Lowe ei ^ . , 1988), the concentration of sperm for 
insemination (Wolf et a d ., 1984) and biochemical markers 
of lutéinisation (Ben-Rafael & 1 ., 1987; Webster gi a l ..
1985) have all been implicated.
8.7 Conclusions
Aneuploidy for different chromosomes occurs with variable 
frequency in human preimplantation embryos, probably due 
to different causative mechanisms during meiosis. 
Differential survival during development certainly 
operates and does eliminate the majority of hypoploid 
conceptions observed in preimplantation embryos. This 
mechanism is not totally responsible for the frequencies 
of abnormalities in spontaneous abortions.
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8.8 Future work
Strains of mouse which show a strong maternal age effect 
(Gosden, 1973) have, like the human (Gosden, 1984), a 
short reproductive life compared with longevity. The 
nature of this chronological effect has been investigated 
using unilateral ovariectomy (uni-ovx) of CBA mice (Baker 
et a l .. 1980) which results in compensatory ovulation from 
the contralateral ovary and depletion of primordial 
follicles at an earlier age. This phenomenon was utilised 
to compare aneuploidy rates due to physiological and 
chronological age. An increase in aneuploidy was seen 
earlier in the uni-ovx group suggesting that investigation 
of factors affecting rates should be directed away from 
ageing per se. This might provide evidence for the 
production line theory but it also supports the hypothesis 
that age related changes in hormones could be responsible 
(Lyon & Hawker, 1973; Crowley ^  a l ., 1979).
Two other groups subject to fluctuations in hormonal 
imbalance have an high incidence of aneuploidy. The 
proportion of pregnancies affected by chromosome imbalance 
may be higher in peri-pubertal girls (Erikson, 1978) than 
after established menstrual rhythm although reports are 
not consistent. A small number of women with Turner's 
syndrome have sufficient ovarian tissue to allow 
intermittent ovulation (Ferguson-Smith, 1965) and these 
pregnancies have a high incidence of pregnancy wastage and 
Do w n ’s offspring (Reyes et a l ., 1976, King et a l ., 1978). 
This theory would also find support from the abnormality 
rate detected in breakthrough pregnancies on contraception 
(Alberman, 1978, Harlap et a l ., 1979) and could account 
for the exponential nature of the age related rise in 
trisomy (Hassold & Jacobs, 1984)
This theory might be usefully investigated by using a 
marker of the end of reproductive life such as inter-cycle
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FSH which indicates potential lack of response to 
exogenous gonadotrophins and may be more important than 
actual age (Toner et ad., 1991). It is proposed to utilise 
ovarian tissue from women undergoing oophorectomy for 
gynaecological conditions not involving ovarian pathology 
to investigate the relationship between maternal age and 
aneuploidy. Preliminary data suggests that oocytes from 
unstimulated cycles can be successfully matured and 
fertilised in vitro (Cha et al., 1991). Hormone profiles 
will be obtained prior to surgery and attention will be 
particularly directed to the mechanisms leading to 
malsegregation of chromosomes at meiosis 1. In vitro 
maturation will also facilitate manipulation of the 
hormonal milieu.
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Appendix 1
EDR values of embryos assessed between 30 and 76h.
Cell number
Time PN 1 2 3 4 5 6 7 8 8+
30 90 100 118 137 156 167 176 185 195 233
31 87 97 114 133 151 161 170 179 189 226
32 84 94 111 129 147 156 165 174 183 219
33 82 91 107 125 142 152 160 168 177 212
34 79 88 104 121 138 147 155 164 172 206
35 77 86 101 118 134 143 151 159 167 200
36 75 83 98 115 130 139 147 154 162 194
37 73 81 96 112 127 135 143 150 158 189
38 71 79 93 109 124 132 139 146 153 184
39 69 77 91 106 120 128 136 142 150 179
40 67 75 89 104 117 125 132 139 146 175
41 66 73 87 101 115 122 129 135 143 171
42 64 71 85 99 112 119 126 132 139 167
43 63 70 83 97 109 116 123 129 136 163
44 61 68 81 94 107 114 120 126 133 159
45 60 67 79 92 104 111 118 123 130 156
46 59 65 77 90 102 109 115 121 127 152
47 57 64 75 88 100 106 123 118 124 149
48 56 62 74 86 98 104 110 116 122 146
49 55 61 72 85 96 102 108 113 119 143
50 54 60 71 83 94 100 106 111 117 140
51 53 59 70 81 92 98 104 109 115 137
52 52 58 68 80 90 96 102 107 112 135
53 51 57 67 78 89 94 100 105 110 132
54 50 56 66 77 87 93 98 103 108 130
55 49 55 65 75 85 91 96 101 106 127
56 48 54 63 74 84 89 95 99 104 125
57 47 53 62 73 82 88 93 97 103 123
58 46 52 61 72 81 86 91 96 101 120
59 46 51 60 70 80 85 90 94 99 118
60 45 50 59 69 78 83 88 92 97 117
61 44 49 58 68 77 82 87 91 96 115
62 44 48 57 67 76 81 85 90 94 113
63 43 48 56 66 75 79 84 88 93 111
64 42 47 55 65 73 78 83 87 91 109
65 42 46 55 64 72 77 82 85 90 108
66 41 45 54 63 71 76 80 84 89 106
67 40 45 53 62 70 75 79 83 87 105
68 40 44 52 61 69 73 78 82 86 103
69 39 43 51 60 69 72 76 81 85 101
70 39 43 51 59 67 71 75 79 84 100
71 38 42 50 58 66 70 74 78 82 99
72 37 42 49 57 65 69 73 77 81 97
73 37 41 48 57 64 68 72 76 80 96
74 36 41 48 56 63 68 71 75 79 95
75 36 40 47 55 63 67 70 74 78 93
76 35 39 47 54 62 66 69 73 77 92
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